<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>OPERATOR_BCSC1819_S06_C30IDX_p439-476_2aP</title>
		<link href="OPERATOR_BCSC1819_S06_C30IDX_p439-476_2aP-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="OPERATOR_BCSC1819_S06_C30IDX_p439-476_2aP" lang="en-US">
		<div id="_idContainer000" class="_idGenObjectStyleOverride-1">
			<p class="em-only_endmatter-title">Index</p>
			<p class="em-only_endmatter-idx1">(<span class="italic">f</span> <span class="symbol">=</span> figure; <span class="italic">t</span> <span class="symbol">=</span> &#173;table)</p>
			<p class="em-only_endmatter-idx-alpha ParaOverride-1">AAO. <span class="italic">See</span> American Acad&#173;emy of Ophthalmology</p>
			<p class="em-only_endmatter-idx1">AAP. <span class="italic">See</span> American Acad&#173;emy of Pediatrics</p>
			<p class="em-only_endmatter-idx1">Abatacept, 322</p>
			<p class="em-only_endmatter-idx1"><span class="italic">ABCA4</span> gene, 339</p>
			<p class="em-only_endmatter-idx1">Abducens nerve</p>
			<p class="em-only_endmatter-idx2">extraocular muscle innervation by, 19</p>
			<p class="em-only_endmatter-idx2">palsy of</p>
			<p class="em-only_endmatter-idx3">description of, 95–97, 96<span class="italic">f</span>, 140</p>
			<p class="em-only_endmatter-idx3">in M<span class="accent">ö</span>bius syndrome, 135</p>
			<p class="em-only_endmatter-idx1">Abduction</p>
			<p class="em-only_endmatter-idx2">definition of, 33</p>
			<p class="em-only_endmatter-idx2">lateral rectus muscle, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ab interno trabeculectomy, 287</p>
			<p class="em-only_endmatter-idx1">Ablepharon, 193</p>
			<p class="em-only_endmatter-idx1">Ablepharon-&#173;macrostomia syndrome, 193</p>
			<p class="em-only_endmatter-idx1">Abnormal head position (AHP), in torticollis, 82</p>
			<p class="em-only_endmatter-idx1">Abusive head trauma (AHT), 381–384, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">AC. <span class="italic">See</span> Accommodative convergence</p>
			<p class="em-only_endmatter-idx1">AC/A ratio. <span class="italic">See</span> Accommodative convergence/accommodation (AC/A) ratio</p>
			<p class="em-only_endmatter-idx1">Accidental trauma, 375–381, 377–378<span class="italic">f</span>, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Accommodation</p>
			<p class="em-only_endmatter-idx2">dynamic retinoscopy mea&#173;sure&#173;ments of, 9</p>
			<p class="em-only_endmatter-idx2">hypoaccommodation, 9</p>
			<p class="em-only_endmatter-idx1">Accommodative amplitude, 188</p>
			<p class="em-only_endmatter-idx1">Accommodative convergence (AC), 39, 59</p>
			<p class="em-only_endmatter-idx1">Accommodative convergence/accommodation (AC/A) ratio</p>
			<p class="em-only_endmatter-idx2">definition of, 71</p>
			<p class="em-only_endmatter-idx2">description of, 39</p>
			<p class="em-only_endmatter-idx2">high</p>
			<p class="em-only_endmatter-idx3">in accommodative esotropia, 90–92</p>
			<p class="em-only_endmatter-idx3">bifocal glasses for, 102</p>
			<p class="em-only_endmatter-idx3">in intermittent exotropia, 100</p>
			<p class="em-only_endmatter-idx2">mea&#173;sure&#173;ment of, 71</p>
			<p class="em-only_endmatter-idx2">response, 71</p>
			<p class="em-only_endmatter-idx2">stimulus, 71</p>
			<p class="em-only_endmatter-idx1">Accommodative esodeviations</p>
			<p class="em-only_endmatter-idx2">cycloplegic examinations for, 11</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 102</p>
			<p class="em-only_endmatter-idx1">Accommodative esotropia</p>
			<p class="em-only_endmatter-idx2">amblyopia associated with, 91</p>
			<p class="em-only_endmatter-idx2">definition of, 90</p>
			<p class="em-only_endmatter-idx2">description of, 57</p>
			<p class="em-only_endmatter-idx2">evaluation of, 91</p>
			<p class="em-only_endmatter-idx2">high AC/A ratio, 90–92</p>
			<p class="em-only_endmatter-idx2">management of, 91–92</p>
			<p class="em-only_endmatter-idx2">nonrefractive, 90</p>
			<p class="em-only_endmatter-idx2">partially, 90–92</p>
			<p class="em-only_endmatter-idx2">pathogenesis of, 90–91</p>
			<p class="em-only_endmatter-idx2">refractive, 90–92</p>
			<p class="em-only_endmatter-idx2">types of, 86<span class="italic">t</span>, 90–91</p>
			<p class="em-only_endmatter-idx1">Acetazolamide, for idiopathic intracranial hypertension, 371</p>
			<p class="em-only_endmatter-idx1">Acetylcholine receptor antibodies, 142</p>
			<p class="em-only_endmatter-idx1">Achromatopsia, 337–338</p>
			<p class="em-only_endmatter-idx1">Acid burns, 376</p>
			<p class="em-only_endmatter-idx1">Acne rosacea, 244</p>
			<p class="em-only_endmatter-idx1">Acoustic neuromas, 397</p>
			<p class="em-only_endmatter-idx1">Acquired nonaccommodative esotropia</p>
			<p class="em-only_endmatter-idx2">basic, 93</p>
			<p class="em-only_endmatter-idx2">consecutive esotropia, 95</p>
			<p class="em-only_endmatter-idx2">cyclic esotropia, 93</p>
			<p class="em-only_endmatter-idx2">description of, 92</p>
			<p class="em-only_endmatter-idx2">divergence insufficiency, 94</p>
			<p class="em-only_endmatter-idx2">near reflex spasm, 94</p>
			<p class="em-only_endmatter-idx2">sensory esotropia, 93–94</p>
			<p class="em-only_endmatter-idx2">types of, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Acquired strabismus, 16</p>
			<p class="em-only_endmatter-idx1"><span class="italic">ACTA2</span> gene, 268</p>
			<p class="em-only_endmatter-idx1">Active force generation test, 73</p>
			<p class="em-only_endmatter-idx1">Active pulley hypothesis, 28</p>
			<p class="em-only_endmatter-idx1">Acute lymphoblastic leukemia, 413</p>
			<p class="em-only_endmatter-idx1">Acute paralytic strabismus, 175</p>
			<p class="em-only_endmatter-idx1">Acute respiratory distress, 230</p>
			<p class="em-only_endmatter-idx1">Acyclovir, for herpes zoster, 243</p>
			<p class="em-only_endmatter-idx1">Adalimumab, 322</p>
			<p class="em-only_endmatter-idx1"><span class="italic">ADAMTS4</span> gene, 268</p>
			<p class="em-only_endmatter-idx1"><span class="italic">ADAMTS10</span> gene, 309</p>
			<p class="em-only_endmatter-idx1"><span class="italic">ADAMTSL4</span> gene, 268</p>
			<p class="em-only_endmatter-idx1">Adduction</p>
			<p class="em-only_endmatter-idx2">definition of, 33</p>
			<p class="em-only_endmatter-idx2">overdepression in</p>
			<p class="em-only_endmatter-idx3">&#173;causes of, 17, 116<span class="italic">t</span>, 116–118</p>
			<p class="em-only_endmatter-idx3">description of, 17</p>
			<p class="em-only_endmatter-idx3">pattern strabismus and, 107, 108<span class="italic">f</span>, 109</p>
			<p class="em-only_endmatter-idx3">superior oblique muscle overaction as cause of, 118, 118<span class="italic">f</span>, 137</p>
			<p class="em-only_endmatter-idx2">overelevation in</p>
			<p class="em-only_endmatter-idx3">&#173;causes of, 17, 116<span class="italic">t</span>, 116–118</p>
			<p class="em-only_endmatter-idx3">description of, 17</p>
			<p class="em-only_endmatter-idx3">inferior oblique muscle overaction as cause of, 117<span class="italic">f</span>, 117–118</p>
			<p class="em-only_endmatter-idx3">pattern strabismus and, 107, 108<span class="italic">f</span>, 109</p>
			<p class="em-only_endmatter-idx2">underdepression in, 17</p>
			<p class="em-only_endmatter-idx2">underelevation in, 17</p>
			<p class="em-only_endmatter-idx1">Adenovirus</p>
			<p class="em-only_endmatter-idx2">conjunctivitis caused by, 241–242</p>
			<p class="em-only_endmatter-idx2">keratitis caused by, 269</p>
			<p class="em-only_endmatter-idx2">pharyngoconjunctival fever caused by, 242</p>
			<p class="em-only_endmatter-idx1">Adherence syndrome, 172</p>
			<p class="em-only_endmatter-idx1">Adipose tissue, in orbit, 25</p>
			<p class="em-only_endmatter-idx1">Adjustable sutures, in extraocular muscle surgery, <br />165</p>
			<p class="em-only_endmatter-idx1">Adnexa</p>
			<p class="em-only_endmatter-idx2">abnormalities of, in craniosynostosis, 209</p>
			<p class="em-only_endmatter-idx2">in cryptophthalmos, 191</p>
			<p class="em-only_endmatter-idx2">description of, 181</p>
			<p class="em-only_endmatter-idx1">Adolescents, bacterial conjunctivitis in, 240<span class="italic">f</span>, 240–241</p>
			<p class="em-only_endmatter-idx1"><span class="greek_1">α</span><span class="subscript _idGenCharOverride-1">2</span>-&#173;Adrenergic agonists, 289<span class="italic">t</span>, 290</p>
			<p class="em-only_endmatter-idx1">Adult inclusion conjunctivitis, 241</p>
			<p class="em-only_endmatter-idx1">Advancement</p>
			<p class="em-only_endmatter-idx2">definition of, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">of inferior oblique muscle, 166</p>
			<p class="em-only_endmatter-idx2">of plica semilunaris, 171</p>
			<p class="em-only_endmatter-idx2">of thickened Tenon capsule too close to limbus, 171</p>
			<p class="em-only_endmatter-idx1">ADVIRC. <span class="italic">See</span> Autosomal dominant vitreoretinochoroidopathy</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Aedes aegypti,</span> 413</p>
			<p class="em-only_endmatter-idx1">Afferent pupillary defects, in amblyopia, 56</p>
			<p class="em-only_endmatter-idx1">Afterimage test, 51, 79, 79<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Agenesis</p>
			<p class="em-only_endmatter-idx2">corpus callosum, 361</p>
			<p class="em-only_endmatter-idx2">definition of, 183<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Age-&#173;related distance esotropia, 94</p>
			<p class="em-only_endmatter-idx1">Aggressive posterior retinopathy of prematurity <br />(AP-&#173;ROP), 326, 327<span class="italic">t</span>, 330<span class="italic">f</span>, 333</p>
			<p class="em-only_endmatter-idx1">Agonist, 33</p>
			<p class="em-only_endmatter-idx1">AHP. <span class="italic">See</span> abnormal head position</p>
			<p class="em-only_endmatter-idx1">AHT. <span class="italic">See</span> Abusive head trauma</p>
			<p class="em-only_endmatter-idx1">Aicardi syndrome, 338–339, 339<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Alagille syndrome, 255</p>
			<p class="em-only_endmatter-idx1">Albinism</p>
			<p class="em-only_endmatter-idx2">definition of, 406</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 406–408</p>
			<p class="em-only_endmatter-idx2">iris transillumination associated with, 265, 406, 407<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">treatment of, 408</p>
			<p class="em-only_endmatter-idx2">types of, 408<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Alexander’s law, 147</p>
			<p class="em-only_endmatter-idx1">Alignment, ocular. <span class="italic">See</span> Ocular alignment</p>
			<p class="em-only_endmatter-idx1">Alkali burns, 376</p>
			<p class="em-only_endmatter-idx1">Allen figures, 7</p>
			<p class="em-only_endmatter-idx1">Allergic conjunctivitis, 246<span class="italic">f</span>, 246–248</p>
			<p class="em-only_endmatter-idx1">Allergic reactions, 170, 171<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Allergic shiners, 246</p>
			<p class="em-only_endmatter-idx1">Allergy, ocular, 246<span class="italic">f</span>, 246–249, 247<span class="italic">t</span>, 248<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Alport syndrome, 391</p>
			<p class="em-only_endmatter-idx1">Alstr<span class="accent">ö</span>m syndrome, 391</p>
			<p class="em-only_endmatter-idx1">Alternate cover test</p>
			<p class="em-only_endmatter-idx2">description of, 65–66, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">exodeviation evaluations, 100</p>
			<p class="em-only_endmatter-idx2">prism, 65–66, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Alternating fixation, 16</p>
			<p class="em-only_endmatter-idx1">Alternating heterotropia, 64</p>
			<p class="em-only_endmatter-idx1">Alternating suppression, 49</p>
			<p class="em-only_endmatter-idx1">Amaurosis, Leber congenital, 335–336, 337<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Amblyopia</p>
			<p class="em-only_endmatter-idx2">in accommodative esotropia, 91</p>
			<p class="em-only_endmatter-idx2">afferent pupillary defects in, 56</p>
			<p class="em-only_endmatter-idx2">anisometropic</p>
			<p class="em-only_endmatter-idx3">clinical features of, 54–55</p>
			<p class="em-only_endmatter-idx3">critical period for, 45</p>
			<p class="em-only_endmatter-idx3">occlusion therapy for, 58</p>
			<p class="em-only_endmatter-idx3">strabismus amblyopia versus, 54–55</p>
			<p class="em-only_endmatter-idx2">cataracts as cause of</p>
			<p class="em-only_endmatter-idx3">congenital, 55</p>
			<p class="em-only_endmatter-idx3">removal of, 57</p>
			<p class="em-only_endmatter-idx2">&#173;causes of, 45–46</p>
			<p class="em-only_endmatter-idx2">classification of, 54–56</p>
			<p class="em-only_endmatter-idx2">corneal opacities as cause of, 262</p>
			<p class="em-only_endmatter-idx2">crowding phenomenon associated with, 56</p>
			<p class="em-only_endmatter-idx2">definition of, 5, 53</p>
			<p class="em-only_endmatter-idx2">detection of, 56</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 56–57</p>
			<p class="em-only_endmatter-idx2">epidemiology of, 53</p>
			<p class="em-only_endmatter-idx2">evaluation of, 56–57</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery in, 160</p>
			<p class="em-only_endmatter-idx2">fixation preference testing, 56–57</p>
			<p class="em-only_endmatter-idx2">grating acuity associated with, 54, 56–57</p>
			<p class="em-only_endmatter-idx2">infantile esotropia and, 87–89</p>
			<p class="em-only_endmatter-idx2">isoametropic, 55</p>
			<p class="em-only_endmatter-idx2">meridional, 46</p>
			<p class="em-only_endmatter-idx2">monofixation syndrome and, 52</p>
			<p class="em-only_endmatter-idx2">occlusion therapy for, 58, 96, 102</p>
			<p class="em-only_endmatter-idx2">optical defocus caused by, 45</p>
			<p class="em-only_endmatter-idx2">pathophysiology of, 53–54</p>
			<p class="em-only_endmatter-idx2">post–&#173;cataract surgery management of, 304</p>
			<p class="em-only_endmatter-idx2">prevalence of, 53</p>
			<p class="em-only_endmatter-idx2">recurrence of, 61</p>
			<p class="em-only_endmatter-idx2">refractive, 54–55</p>
			<p class="em-only_endmatter-idx2">reverse, 55–56, 59–60</p>
			<p class="em-only_endmatter-idx2">screening for, 56</p>
			<p class="em-only_endmatter-idx2">severity assessments, 56–57</p>
			<p class="em-only_endmatter-idx2">strabismic</p>
			<p class="em-only_endmatter-idx3">anisometropic amblyopia versus, 54–55</p>
			<p class="em-only_endmatter-idx3">clinical features of, 54</p>
			<p class="em-only_endmatter-idx3">critical period for, 45</p>
			<p class="em-only_endmatter-idx3">development of, 46–47</p>
			<p class="em-only_endmatter-idx3">eccentric fixation in, 54</p>
			<p class="em-only_endmatter-idx3">grating acuity associated with, 54, 56</p>
			<p class="em-only_endmatter-idx3">occlusion therapy for, 58</p>
			<p class="em-only_endmatter-idx3">pathophysiology of, 54</p>
			<p class="em-only_endmatter-idx3">visual acuity in, 54</p>
			<p class="em-only_endmatter-idx2">with third nerve palsy, 138</p>
			<p class="em-only_endmatter-idx2">trauma as cause of, 375</p>
			<p class="em-only_endmatter-idx2">treatment of</p>
			<p class="em-only_endmatter-idx3">atropine sulfate, 59</p>
			<p class="em-only_endmatter-idx3">binocular, 59</p>
			<p class="em-only_endmatter-idx3">cataract removal, 57</p>
			<p class="em-only_endmatter-idx3">challenges associated with, 59–61</p>
			<p class="em-only_endmatter-idx3">complications of, 59–61</p>
			<p class="em-only_endmatter-idx3">cycloplegics, 59</p>
			<p class="em-only_endmatter-idx3">lack of adherence to, 60</p>
			<p class="em-only_endmatter-idx3">occlusion therapy, 58, 96</p>
			<p class="em-only_endmatter-idx3">optical, 58–59</p>
			<p class="em-only_endmatter-idx3">pharmacologic, 58–59</p>
			<p class="em-only_endmatter-idx3">plus lenses, 59</p>
			<p class="em-only_endmatter-idx3">recurrence of, 61</p>
			<p class="em-only_endmatter-idx3">refractive correction, 57–58</p>
			<p class="em-only_endmatter-idx3">strabismus secondary to, 59–60</p>
			<p class="em-only_endmatter-idx3">termination of, 61</p>
			<p class="em-only_endmatter-idx3">unresponsiveness to, 60–61</p>
			<p class="em-only_endmatter-idx2">unresponsiveness of, to treatment, 60–61</p>
			<p class="em-only_endmatter-idx2">vision development and, 53</p>
			<p class="em-only_endmatter-idx2">vision loss associated with, 53, 56</p>
			<p class="em-only_endmatter-idx2">visual acuity assessments in, 56</p>
			<p class="em-only_endmatter-idx2">visual deficits caused by, 53–54</p>
			<p class="em-only_endmatter-idx2">visual deprivation</p>
			<p class="em-only_endmatter-idx3">&#173;causes of, 55</p>
			<p class="em-only_endmatter-idx3">congenital cataracts as cause of, 55</p>
			<p class="em-only_endmatter-idx3">congenital nevocellular nevi as cause of, 200</p>
			<p class="em-only_endmatter-idx3">corneal blood staining as cause of, 379</p>
			<p class="em-only_endmatter-idx3">critical period for, 53</p>
			<p class="em-only_endmatter-idx3">reverse amblyopia, 55–56</p>
			<p class="em-only_endmatter-idx1">Amblyoscope, major, 70, 70<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Amblyoscope testing</p>
			<p class="em-only_endmatter-idx2">description of, 51</p>
			<p class="em-only_endmatter-idx2">sensory adaptation assessments using, 79–80</p>
			<p class="em-only_endmatter-idx1">American Acad&#173;emy of Ophthalmology (AAO)</p>
			<p class="em-only_endmatter-idx2">Initiative in Vision Rehabilitation, 189</p>
			<p class="em-only_endmatter-idx2">retinopathy of prematurity screening guidelines, 329</p>
			<p class="em-only_endmatter-idx2">vision rehabilitation guidelines from, 189</p>
			<p class="em-only_endmatter-idx1">American Acad&#173;emy of Pediatrics (AAP)</p>
			<p class="em-only_endmatter-idx2">retinopathy of prematurity screening guidelines, <br />329</p>
			<p class="em-only_endmatter-idx2">uveitis screening in juvenile idiopathic arthritis, <br />314</p>
			<p class="em-only_endmatter-idx1">American Association for Pediatric Ophthalmology and Strabismus retinopathy of prematurity screening guidelines, 329</p>
			<p class="em-only_endmatter-idx1">Anderson procedure, for nystagmus, 155</p>
			<p class="em-only_endmatter-idx1">Anesthesia</p>
			<p class="em-only_endmatter-idx2">for extraocular muscle surgery, 174–175</p>
			<p class="em-only_endmatter-idx2">general, 174</p>
			<p class="em-only_endmatter-idx2">peribulbar, 174</p>
			<p class="em-only_endmatter-idx2">retrobulbar, 174</p>
			<p class="em-only_endmatter-idx1">Aneurysmal bone cyst, 222</p>
			<p class="em-only_endmatter-idx1">Angiofibromas, facial, 397</p>
			<p class="em-only_endmatter-idx1">Angiotensin-&#173;converting enzyme, 319</p>
			<p class="em-only_endmatter-idx1">&#173;Angle kappa</p>
			<p class="em-only_endmatter-idx2">definition of, 67</p>
			<p class="em-only_endmatter-idx2">negative, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">pictorial repre&#173;sen&#173;ta&#173;tion of, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">positive, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">&#173;Angle surgery, in Sturge-&#173;Weber syndrome, 402</p>
			<p class="em-only_endmatter-idx1">Aniridia, 266<span class="italic">f</span>, 266–267, 285</p>
			<p class="em-only_endmatter-idx1">Anisocoria, 275</p>
			<p class="em-only_endmatter-idx1">Anisometropia</p>
			<p class="em-only_endmatter-idx2">abnormal visual experience caused by, 44</p>
			<p class="em-only_endmatter-idx2">anterior polar cataracts associated with, 295</p>
			<p class="em-only_endmatter-idx1">Anisometropic amblyopia</p>
			<p class="em-only_endmatter-idx2">clinical features of, 54–55</p>
			<p class="em-only_endmatter-idx2">critical period for, 45</p>
			<p class="em-only_endmatter-idx2">epibulbar dermoids as cause of, 256</p>
			<p class="em-only_endmatter-idx2">occlusion therapy for, 58</p>
			<p class="em-only_endmatter-idx2">strabismus amblyopia versus, 54–55</p>
			<p class="em-only_endmatter-idx1">Ankyloblepharon, 193–194, 194<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ankyloblepharon–&#173;ectodermal dysplasia–&#173;clefting syndrome. <span class="italic">See</span> Hay-&#173;Wells syndrome</p>
			<p class="em-only_endmatter-idx1">Ankyloblepharon filiforme adnatum, 193–194, 194<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Annular ring, 182</p>
			<p class="em-only_endmatter-idx1">Annulus of Zinn</p>
			<p class="em-only_endmatter-idx2">horizontal rectus muscles from, 20</p>
			<p class="em-only_endmatter-idx2">inferior rectus muscle from, 20</p>
			<p class="em-only_endmatter-idx2">superior oblique muscle from, 20</p>
			<p class="em-only_endmatter-idx2">superior rectus muscle from, 20</p>
			<p class="em-only_endmatter-idx2">vertical rectus muscles from, 20</p>
			<p class="em-only_endmatter-idx1">Anomalous binocular vision, 50</p>
			<p class="em-only_endmatter-idx1">Anomalous ret&#173;i&#173;nal correspondence (ARC)</p>
			<p class="em-only_endmatter-idx2">afterimage test for, 79<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">definition of, 50</p>
			<p class="em-only_endmatter-idx2">diplopia and visual confusion eliminated with, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">eccentric fixation versus, 51</p>
			<p class="em-only_endmatter-idx2">harmonious, 76</p>
			<p class="em-only_endmatter-idx2">Maddox rod testing in, 68</p>
			<p class="em-only_endmatter-idx2">major amblyoscope for, 70</p>
			<p class="em-only_endmatter-idx2">red-&#173;glass test findings in, 76<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">&#173;after strabismus surgery, 50</p>
			<p class="em-only_endmatter-idx2">testing for, 50–51</p>
			<p class="em-only_endmatter-idx2">unharmonious, 76</p>
			<p class="em-only_endmatter-idx1">Anophthalmia, 209, 210<span class="italic">f</span>, 263</p>
			<p class="em-only_endmatter-idx1">Antagonist</p>
			<p class="em-only_endmatter-idx2">contralateral, inhibitional palsy of, 120–121, 121<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">definition of, 33</p>
			<p class="em-only_endmatter-idx1">Anterior capsule, 302</p>
			<p class="em-only_endmatter-idx1">Anterior chamber</p>
			<p class="em-only_endmatter-idx2">growth and development of, 181</p>
			<p class="em-only_endmatter-idx2">paracentesis, 414</p>
			<p class="em-only_endmatter-idx1">Anterior chamber &#173;angle crowding, retinopathy of prematurity as risk &#173;factor for, 334</p>
			<p class="em-only_endmatter-idx1">Anterior ciliary artery, 23</p>
			<p class="em-only_endmatter-idx1">Anterior lens opacities, 295</p>
			<p class="em-only_endmatter-idx1">Anterior polar cataracts (APCs), 55, 295, 295<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Anterior segment. <span class="italic">See also</span> Cornea; Iris</p>
			<p class="em-only_endmatter-idx2">blood supply to</p>
			<p class="em-only_endmatter-idx3">description of, 172</p>
			<p class="em-only_endmatter-idx3">extraocular muscle blood supply and, 30</p>
			<p class="em-only_endmatter-idx2">disorders of</p>
			<p class="em-only_endmatter-idx3">characteristics of, 320<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">cornea. <span class="italic">See</span> Corneal disorders</p>
			<p class="em-only_endmatter-idx3">description of, 253</p>
			<p class="em-only_endmatter-idx3">globe anomalies, 263</p>
			<p class="em-only_endmatter-idx3">iris anomalies, 264–267, 264–267<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">pupil abnormalities, 267–268, 268<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">examination of</p>
			<p class="em-only_endmatter-idx3">in &#173;children, 10, 187</p>
			<p class="em-only_endmatter-idx3">in nystagmus evaluations, 154</p>
			<p class="em-only_endmatter-idx2">inflammation of, in uveitis, 320</p>
			<p class="em-only_endmatter-idx2">ischemia of, 172–173, 173<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in primary congenital glaucoma, 282, 282<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">tumors of, 271–274</p>
			<p class="em-only_endmatter-idx1">Anterior uveitis</p>
			<p class="em-only_endmatter-idx2">description of, 312</p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 312<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">idiopathic &#173;causes of, 316</p>
			<p class="em-only_endmatter-idx2">juvenile idiopathic arthritis as cause of, 312–315, 313–314<span class="italic">t</span>, 314<span class="italic">f</span>, 322</p>
			<p class="em-only_endmatter-idx2">juvenile spondyloarthropathies as cause of, <br />315, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">Kawasaki disease as cause of, 316</p>
			<p class="em-only_endmatter-idx2">laboratory tests for, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">screening for, 314–315</p>
			<p class="em-only_endmatter-idx2">trauma as cause of, 316</p>
			<p class="em-only_endmatter-idx2">tubulointerstitial nephritis and uveitis syndrome as cause of, 316</p>
			<p class="em-only_endmatter-idx1">Antibiotics</p>
			<p class="em-only_endmatter-idx2">blepharitis treated with, 245</p>
			<p class="em-only_endmatter-idx2">congenital nasolacrimal duct obstruction treated with, 231–232, 234</p>
			<p class="em-only_endmatter-idx2">corneal abrasion treated with, 376</p>
			<p class="em-only_endmatter-idx1">Anti-&#173;elevation syndrome, 168–169</p>
			<p class="em-only_endmatter-idx1">Antihistamines, for ocular allergies, 247<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Anti-&#173;inflammatory drugs, for ocular allergies, 247<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Antimetabolites, for uveitis, 322</p>
			<p class="em-only_endmatter-idx1">Anti-&#173;VEGF agents, for retinopathy of prematurity, 333</p>
			<p class="em-only_endmatter-idx1">A-&#173;pattern strabismus</p>
			<p class="em-only_endmatter-idx2">clinical features of, 109</p>
			<p class="em-only_endmatter-idx2">clinically significant, 109</p>
			<p class="em-only_endmatter-idx2">definition of, 107</p>
			<p class="em-only_endmatter-idx2">etiology of, 107–109, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">exotropia, 108<span class="italic">f</span>, 112</p>
			<p class="em-only_endmatter-idx2">in exotropia, 109</p>
			<p class="em-only_endmatter-idx2">heterotopy as cause of, 28</p>
			<p class="em-only_endmatter-idx2">horizontal rectus muscle transposition for, 112</p>
			<p class="em-only_endmatter-idx2">identification of, 109</p>
			<p class="em-only_endmatter-idx2">intorsion as cause of, 107, 110</p>
			<p class="em-only_endmatter-idx2">medial rectus muscle displacement for, 110, 111<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">palpebral fissure slanting associated with, 196</p>
			<p class="em-only_endmatter-idx2">superior oblique muscle overaction associated with, 107</p>
			<p class="em-only_endmatter-idx2">superior oblique tenotomy for, 112</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 112, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">APCs. <span class="italic">See</span> Anterior polar cataracts</p>
			<p class="em-only_endmatter-idx1">Apert syndrome, 206–207, 207<span class="italic">f</span>, 209<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Aphakia</p>
			<p class="em-only_endmatter-idx2">congenital, 305</p>
			<p class="em-only_endmatter-idx2">post–&#173;cataract surgery management of, 304</p>
			<p class="em-only_endmatter-idx1">Aphakic glaucoma, 285</p>
			<p class="em-only_endmatter-idx1">Apoptosis, ret&#173;i&#173;nal ganglion cell, 44</p>
			<p class="em-only_endmatter-idx1">Apraclonidine, 275, 289<span class="italic">t</span>, 290</p>
			<p class="em-only_endmatter-idx1">AP-&#173;ROP. <span class="italic">See</span> Aggressive posterior retinopathy of prematurity</p>
			<p class="em-only_endmatter-idx1">Arachnodactyly, 307, 308<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">ARC. <span class="italic">See</span> Anomalous ret&#173;i&#173;nal correspondence</p>
			<p class="em-only_endmatter-idx1">Arc of contact, 32</p>
			<p class="em-only_endmatter-idx1">ARS. <span class="italic">See</span> Axenfeld-&#173;Rieger syndrome</p>
			<p class="em-only_endmatter-idx1">Arteriohepatic dysplasia, 255</p>
			<p class="em-only_endmatter-idx1">Arteriovenous malformations, orbital, 222</p>
			<p class="em-only_endmatter-idx1">Arthritis</p>
			<p class="em-only_endmatter-idx2">enteropathic, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">enthesitis-&#173;related, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">juvenile idiopathic, 312–315, 313–314<span class="italic">t</span>, 314<span class="italic">f</span>, 322</p>
			<p class="em-only_endmatter-idx2">reactive, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Association, 183</p>
			<p class="em-only_endmatter-idx1">Asthenopia, 101</p>
			<p class="em-only_endmatter-idx1">Astrocytic hamartomas, 353, 397, 399<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ataxia-&#173;telangiectasia, 393<span class="italic">t</span>, 403<span class="italic">f</span>, 403<span class="italic">t</span>, 403–404</p>
			<p class="em-only_endmatter-idx1">Atopic keratoconjunctivitis, 249</p>
			<p class="em-only_endmatter-idx1"><span class="italic">ATP7B</span> gene, 270</p>
			<p class="em-only_endmatter-idx1">Atropine sulfate</p>
			<p class="em-only_endmatter-idx2">amblyopia treated with, 59</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 11, 11<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Autosomal dominant vitreoretinochoroidopathy (ADVIRC), 341</p>
			<p class="em-only_endmatter-idx1">Axenfeld-&#173;Rieger syndrome (ARS)</p>
			<p class="em-only_endmatter-idx2">description of, 255, 255<span class="italic">f</span>, 264–265, 264–265<span class="italic">f</span>, 268<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">glaucoma associated with, 285</p>
			<p class="em-only_endmatter-idx1">Axial length, in primary congenital glaucoma, 283</p>
			<p class="em-only_endmatter-idx1">Azathioprine, for uveitis, 322</p>
			<p class="em-only_endmatter-idx-alpha">Bacterial conjunctivitis, 240<span class="italic">f</span>, 240–241</p>
			<p class="em-only_endmatter-idx1">Bacterial orbital cellulitis, 213, 214<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Bagolini striated lenses</p>
			<p class="em-only_endmatter-idx2">description of, 51–52</p>
			<p class="em-only_endmatter-idx2">sensory adaptation testing using, 77<span class="italic">f</span>, 77–78</p>
			<p class="em-only_endmatter-idx1">Bailey-&#173;Lovie chart, 8</p>
			<p class="em-only_endmatter-idx1">Balloon dacryoplasty, 234–235, 235<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Band keratopathy, 322</p>
			<p class="em-only_endmatter-idx1">Bardet-&#173;Biedl syndrome, 391, 391<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">Bartonella henselae,</span> 240–241, 369</p>
			<p class="em-only_endmatter-idx1">Base-&#173;out prisms</p>
			<p class="em-only_endmatter-idx2">convergence insufficiency and, 103</p>
			<p class="em-only_endmatter-idx2">convergence paralysis and, 106</p>
			<p class="em-only_endmatter-idx2">dissociated vertical deviation and, 129</p>
			<p class="em-only_endmatter-idx2">nystagmus treated with, 155</p>
			<p class="em-only_endmatter-idx1">Basic acquired nonaccommodative esotropia, 93</p>
			<p class="em-only_endmatter-idx1">Basic intermittent exotropia, 101</p>
			<p class="em-only_endmatter-idx1">Bathopsis, 43</p>
			<p class="em-only_endmatter-idx1">Batten, Spielmeyer-&#173;Vogt disease, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Bear tracks, 349</p>
			<p class="em-only_endmatter-idx1">BEAT-&#173;ROP. <span class="italic">See</span> Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity</p>
			<p class="em-only_endmatter-idx1">Behr optic atrophy, 368</p>
			<p class="em-only_endmatter-idx1">Bell phenomenon, 126<span class="italic">f</span>, 197</p>
			<p class="em-only_endmatter-idx1">Bergmeister papilla, 298, 366</p>
			<p class="em-only_endmatter-idx1">Best disease, 340–342, 342<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">BEST1</span> gene, 340–342</p>
			<p class="em-only_endmatter-idx1">Bestrophinopathies, 341</p>
			<p class="em-only_endmatter-idx1">Beta-blockers. <span class="italic">See</span> β-Blockers</p>
			<p class="em-only_endmatter-idx1">Betaxolol, 288, 289<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Bevacizumab</p>
			<p class="em-only_endmatter-idx2">Coats disease treated with, 360</p>
			<p class="em-only_endmatter-idx2">retinopathy of prematurity treated with, 333</p>
			<p class="em-only_endmatter-idx1">Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity (BEAT-&#173;ROP), 333</p>
			<p class="em-only_endmatter-idx1">Bicanalicular intubation, 234</p>
			<p class="em-only_endmatter-idx1">Bielschowsky head-tilt test, 75, 122</p>
			<p class="em-only_endmatter-idx1">Bifocals, for high AC/A ratio accommodative esotropia, 91–92</p>
			<p class="em-only_endmatter-idx1">Binocular function</p>
			<p class="em-only_endmatter-idx2">field of single binocular vision assessment, 81–82, 82<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">prism adaptation test, 82</p>
			<p class="em-only_endmatter-idx1">Binocular fusion, 60, 91</p>
			<p class="em-only_endmatter-idx1">Binocular treatment, for amblyopia, 59</p>
			<p class="em-only_endmatter-idx1">Binocular vision</p>
			<p class="em-only_endmatter-idx2">abnormalities of</p>
			<p class="em-only_endmatter-idx3">diplopia, 47–48</p>
			<p class="em-only_endmatter-idx3">visual confusion, 47, 47<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">anomalous, 50</p>
			<p class="em-only_endmatter-idx2">in cyclic strabismus, 93</p>
			<p class="em-only_endmatter-idx2">development of, 43</p>
			<p class="em-only_endmatter-idx2">fusion, 42–43</p>
			<p class="em-only_endmatter-idx2">monocular visual deprivation effects on, 45</p>
			<p class="em-only_endmatter-idx2">Panum’s area of single, 42, 42<span class="italic">f</span>, 48</p>
			<p class="em-only_endmatter-idx2">ret&#173;i&#173;nal correspondence, 41–42</p>
			<p class="em-only_endmatter-idx2">single, 81–82, 82<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Blau syndrome, 319</p>
			<p class="em-only_endmatter-idx1">Blepharitis, 244–245, 244–245<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Blepharophimosis–&#173;ptosis–&#173;epicanthus inversus syndrome (BPES), 197–198, 198<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Blindness</p>
			<p class="em-only_endmatter-idx2">congenital stationary night, spasmus nutans syndrome associated with, 151</p>
			<p class="em-only_endmatter-idx2">from retinopathy of prematurity, 335</p>
			<p class="em-only_endmatter-idx1">Blinking, excessive, 201–202</p>
			<p class="em-only_endmatter-idx1">Blink reflex, 185</p>
			<p class="em-only_endmatter-idx1"><span class="greek_1">β</span>-&#173;Blockers</p>
			<p class="em-only_endmatter-idx2">childhood glaucoma treated with, 288, 289<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">hemangioma treated with, 220</p>
			<p class="em-only_endmatter-idx1">Block-&#173;Sulzberger syndrome. <span class="italic">See</span> Incontinentia pigmenti</p>
			<p class="em-only_endmatter-idx1">Blowout fracture, 379</p>
			<p class="em-only_endmatter-idx1">Blue-&#173;cone monochromatism, 337–338</p>
			<p class="em-only_endmatter-idx1">Blue dyschromatopsia, 368</p>
			<p class="em-only_endmatter-idx1">Blunt injury/trauma, 378–379</p>
			<p class="em-only_endmatter-idx1">Bone cyst, aneurysmal, 222</p>
			<p class="em-only_endmatter-idx1">Bone growth disorders, nonsynostotic, 212</p>
			<p class="em-only_endmatter-idx1">Botryoid tumors, 217</p>
			<p class="em-only_endmatter-idx1">Botulinum toxin injections</p>
			<p class="em-only_endmatter-idx2">adverse effects of, 176</p>
			<p class="em-only_endmatter-idx2">chemodenervation using, 175–176</p>
			<p class="em-only_endmatter-idx2">complications of, 176</p>
			<p class="em-only_endmatter-idx2">in extraocular muscle symmetric surgery, 160</p>
			<p class="em-only_endmatter-idx2">in eyelids, 146</p>
			<p class="em-only_endmatter-idx2">indications for, 175–176</p>
			<p class="em-only_endmatter-idx2">infantile esotropia treated with, 89</p>
			<p class="em-only_endmatter-idx2">mechanism of action, 175</p>
			<p class="em-only_endmatter-idx2">near reflex spasm treated with, 94</p>
			<p class="em-only_endmatter-idx2">pharmacology of, 175</p>
			<p class="em-only_endmatter-idx2">results of, 175–176</p>
			<p class="em-only_endmatter-idx2">strabismus treated with, 175</p>
			<p class="em-only_endmatter-idx2">techniques for, 175–176</p>
			<p class="em-only_endmatter-idx1">Bourneville disease. <span class="italic">See</span> Tuberous sclerosis</p>
			<p class="em-only_endmatter-idx1">BPES. <span class="italic">See</span> Blepharophimosis–&#173;ptosis–&#173;epicanthus inversus syndrome</p>
			<p class="em-only_endmatter-idx1">Brachycephaly, 205</p>
			<p class="em-only_endmatter-idx1">Brain lesions, of tuberous sclerosis, 398<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Branchial arch syndromes, 210–211, 210–211<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Brimonidine, 289<span class="italic">t</span>, 290</p>
			<p class="em-only_endmatter-idx1">Brittle cornea syndrome, 262</p>
			<p class="em-only_endmatter-idx1">Brown syndrome</p>
			<p class="em-only_endmatter-idx2">acquired, 136</p>
			<p class="em-only_endmatter-idx2">clinical features of, 136–137, 137<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">congenital, 136</p>
			<p class="em-only_endmatter-idx2">as congenital cranial dysinnervation disorder, 131</p>
			<p class="em-only_endmatter-idx2">description of, 117</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 137</p>
			<p class="em-only_endmatter-idx2">forced duction test for, 137</p>
			<p class="em-only_endmatter-idx2">iatrogenic, 168</p>
			<p class="em-only_endmatter-idx2">inferior oblique muscle palsy versus, 124, 125<span class="italic">t</span>, <br />137</p>
			<p class="em-only_endmatter-idx2">management of, 137–138</p>
			<p class="em-only_endmatter-idx2">primary position hypotropia with, 137</p>
			<p class="em-only_endmatter-idx2">rheumatoid arthritis and, 137</p>
			<p class="em-only_endmatter-idx2">superior oblique muscle weakening for, 138, <br />166</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 138</p>
			<p class="em-only_endmatter-idx1">Brown tumor of bone, 222</p>
			<p class="em-only_endmatter-idx1">Br<span class="accent">ü</span>ckner test</p>
			<p class="em-only_endmatter-idx2">in amblyopia screening, 56</p>
			<p class="em-only_endmatter-idx2">description of, 9, 67–68</p>
			<p class="em-only_endmatter-idx1">Brushfield spots, 272</p>
			<p class="em-only_endmatter-idx1">Buphthalmos, 283</p>
			<p class="em-only_endmatter-idx1">Burkitt lymphoma, 218</p>
			<p class="em-only_endmatter-idx1">Burns, 376</p>
			<p class="em-only_endmatter-idx-alpha">Caf<span class="accent">é</span>-&#173;au-&#173;lait spots, 392, 395<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Calvarium, 203</p>
			<p class="em-only_endmatter-idx1">Canaliculus, 378</p>
			<p class="em-only_endmatter-idx1">Capsulorrhexis, 302</p>
			<p class="em-only_endmatter-idx1">Carbonic anhydrase inhibitors, 289<span class="italic">t</span>, 290</p>
			<p class="em-only_endmatter-idx1">Cardiff Acuity Test, 9, 187</p>
			<p class="em-only_endmatter-idx1">Cardinal positions of gaze, 31, 32<span class="italic">f</span>, 35, 64</p>
			<p class="em-only_endmatter-idx1">Cataracts</p>
			<p class="em-only_endmatter-idx2">acquired, 293</p>
			<p class="em-only_endmatter-idx2">amblyopia caused by, 55, 57</p>
			<p class="em-only_endmatter-idx2">anterior polar, 55, 295, 295<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">autosomal dominant transmission of, 294</p>
			<p class="em-only_endmatter-idx2">bilateral, 293, 294<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">congenital, 293</p>
			<p class="em-only_endmatter-idx2">corticosteroids as cause of, 321</p>
			<p class="em-only_endmatter-idx2">etiology of, 294, 294–295<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">evaluation of, 299<span class="italic">t</span>, 299–301</p>
			<p class="em-only_endmatter-idx2">general features of, 293–294</p>
			<p class="em-only_endmatter-idx2">history-&#173;taking for, 299<span class="italic">t</span>, 300</p>
			<p class="em-only_endmatter-idx2">infantile, 293</p>
			<p class="em-only_endmatter-idx2">laboratory workup for, 299<span class="italic">t</span>, 301</p>
			<p class="em-only_endmatter-idx2">lamellar, 55, 296, 296<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">morphology of, 294–299, 295<span class="italic">t</span>, 295–298<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">next-&#173;generation gene sequencing for, 301</p>
			<p class="em-only_endmatter-idx2">nuclear</p>
			<p class="em-only_endmatter-idx3">infantile, 295, 296<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">in rubella, 410</p>
			<p class="em-only_endmatter-idx2">ocular anomalies associated with, 293, 294<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">ocular examination of, 300</p>
			<p class="em-only_endmatter-idx2">peripheral vacuolar, 298</p>
			<p class="em-only_endmatter-idx2">per&#173;sis&#173;tent fetal vasculature associated with, 298<span class="italic">f</span>, 298–299</p>
			<p class="em-only_endmatter-idx2">polar, 55</p>
			<p class="em-only_endmatter-idx2">posterior capsular, 387<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">posterior lenticonus associated with, 296–297, 297<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">posterior subscapular, 297</p>
			<p class="em-only_endmatter-idx2">removal of, 57</p>
			<p class="em-only_endmatter-idx2">retinoscopy evaluations, 299</p>
			<p class="em-only_endmatter-idx2">in rubella, 410</p>
			<p class="em-only_endmatter-idx2">sectoral, 297–298</p>
			<p class="em-only_endmatter-idx2">slit-&#173;lamp examination of, 300</p>
			<p class="em-only_endmatter-idx2">types of, 293</p>
			<p class="em-only_endmatter-idx2">visual deprivation amblyopia caused by, 55</p>
			<p class="em-only_endmatter-idx2">visual function affected by, 300</p>
			<p class="em-only_endmatter-idx2">workup for, 299<span class="italic">t</span>, 301</p>
			<p class="em-only_endmatter-idx1">Cataract surgery</p>
			<p class="em-only_endmatter-idx2">amblyopia managed with, 57, 304</p>
			<p class="em-only_endmatter-idx2">anterior capsule management in, 302</p>
			<p class="em-only_endmatter-idx2">aphakia management &#173;after, 304</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 301–305</p>
			<p class="em-only_endmatter-idx2">complications of, 304–305</p>
			<p class="em-only_endmatter-idx2">corneal decompensation &#173;after, 304</p>
			<p class="em-only_endmatter-idx2">endophthalmitis &#173;after, 305</p>
			<p class="em-only_endmatter-idx2">glaucoma &#173;after, 304</p>
			<p class="em-only_endmatter-idx2">glaucoma secondary to, 285</p>
			<p class="em-only_endmatter-idx2">intraocular lens placement</p>
			<p class="em-only_endmatter-idx3">description of, 301</p>
			<p class="em-only_endmatter-idx3">issues associated with, 303–304</p>
			<p class="em-only_endmatter-idx3">lensectomy with, 302–304</p>
			<p class="em-only_endmatter-idx3">posterior capsulectomy/vitrectomy with, 303</p>
			<p class="em-only_endmatter-idx3">power calculations, 303</p>
			<p class="em-only_endmatter-idx2">lensectomy, 302</p>
			<p class="em-only_endmatter-idx2">macular edema &#173;after, 304–305</p>
			<p class="em-only_endmatter-idx2">medical therapy &#173;after, 304</p>
			<p class="em-only_endmatter-idx2">postoperative care &#173;after, 304</p>
			<p class="em-only_endmatter-idx2">primary posterior capsulectomy, 303</p>
			<p class="em-only_endmatter-idx2">ret&#173;i&#173;nal detachment &#173;after, 304</p>
			<p class="em-only_endmatter-idx2">strabismus &#173;after, 304</p>
			<p class="em-only_endmatter-idx2">timing of, 301</p>
			<p class="em-only_endmatter-idx2">in uveitis patients, 323</p>
			<p class="em-only_endmatter-idx1">Cat-&#173;scratch disease, 240, 369</p>
			<p class="em-only_endmatter-idx1">Cavernous sinus thrombosis, 214</p>
			<p class="em-only_endmatter-idx1">CCDDs. <span class="italic">See</span> Congenital cranial dysinnervation disorders</p>
			<p class="em-only_endmatter-idx1">CCT. <span class="italic">See</span> Central corneal thickness</p>
			<p class="em-only_endmatter-idx1">CDCR. <span class="italic">See</span> Conjunctivodacryocystorhinostomy</p>
			<p class="em-only_endmatter-idx1">Cecocentral scotomata, 368</p>
			<p class="em-only_endmatter-idx1">Cellulitis</p>
			<p class="em-only_endmatter-idx2">orbital, 213–215, 214<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">preseptal, 170, 212–214</p>
			<p class="em-only_endmatter-idx1">Central, Steady, and Maintained (CSM) method, 6</p>
			<p class="em-only_endmatter-idx1">Central corneal thickness (CCT), 181, 281</p>
			<p class="em-only_endmatter-idx1">Central corneal transparency disorders, 257–258<span class="italic">t</span>, 257–263, 258<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Central fusion, 42</p>
			<p class="em-only_endmatter-idx1">Central fusion disruption, 48, 79, 104</p>
			<p class="em-only_endmatter-idx1">Central posterior keratoconus, 259</p>
			<p class="em-only_endmatter-idx1">Central scotomata, 368</p>
			<p class="em-only_endmatter-idx1">Central suppression, 48</p>
			<p class="em-only_endmatter-idx1">Central suppression scotoma, 4<span class="greek_1">Δ</span> base-&#173;out prism test for, 79</p>
			<p class="em-only_endmatter-idx1">Central vestibular instability nystagmus, 149</p>
			<p class="em-only_endmatter-idx1">Ce&#173;re&#173;bral hemi&#173;sphere abnormalities, 361</p>
			<p class="em-only_endmatter-idx1">Ce&#173;re&#173;bral palsy, hypoaccommodation in, 9</p>
			<p class="em-only_endmatter-idx1">Ce&#173;re&#173;bral visual impairment (CVI), 186–187</p>
			<p class="em-only_endmatter-idx1">Cerebrotendinous xanthomatosis, 387<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">CFEOM. <span class="italic">See</span> Congenital fibrosis of the extraocular muscles</p>
			<p class="em-only_endmatter-idx1">Chalazia, 198–199, 199<span class="italic">f</span>, 244</p>
			<p class="em-only_endmatter-idx1">CHARGE syndrome, 364</p>
			<p class="em-only_endmatter-idx1">Chavasse theory, of infantile esotropia, 87</p>
			<p class="em-only_endmatter-idx1">CHED. <span class="italic">See</span> Congenital hereditary endothelial dystrophy</p>
			<p class="em-only_endmatter-idx1">Ch<span class="accent">é</span>diak-&#173;Higashi syndrome, 407</p>
			<p class="em-only_endmatter-idx1">Chemical conjunctivitis, 239</p>
			<p class="em-only_endmatter-idx1">Chemical injury, 376</p>
			<p class="em-only_endmatter-idx1">Chemotherapy, for retinoblastoma, 356–357</p>
			<p class="em-only_endmatter-idx1">Cherry-red spot myoclonus syndrome, 388<span class="italic">t</span>, 390</p>
			<p class="em-only_endmatter-idx1">Chiasmal glioma, 396</p>
			<p class="em-only_endmatter-idx1">Chickenpox, 242–243</p>
			<p class="em-only_endmatter-idx1">Child abuse</p>
			<p class="em-only_endmatter-idx2">abusive head trauma, 381–384, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ocular trauma caused by, 381, 384</p>
			<p class="em-only_endmatter-idx1">Childhood glaucoma</p>
			<p class="em-only_endmatter-idx2">algorithm for, 279<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">aphakic, 285</p>
			<p class="em-only_endmatter-idx2">classification of, 277, 278<span class="italic">t</span>, 279<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">corticosteroids as cause of, 284</p>
			<p class="em-only_endmatter-idx2">definition of, 277</p>
			<p class="em-only_endmatter-idx2">follow-up of, 290–291</p>
			<p class="em-only_endmatter-idx2">ge&#173;ne&#173;tics of, 277–278</p>
			<p class="em-only_endmatter-idx2">juvenile open-&#173;angle glaucoma, 278, 284</p>
			<p class="em-only_endmatter-idx2">primary congenital glaucoma</p>
			<p class="em-only_endmatter-idx3">anterior segment findings in, 282, 282<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">axial length in, 283</p>
			<p class="em-only_endmatter-idx3">central corneal thickness in, 281</p>
			<p class="em-only_endmatter-idx3">clinical manifestations of, 279–280, 280<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">corneal edema in, 279–280</p>
			<p class="em-only_endmatter-idx3">corneal findings in, 280<span class="italic">f</span>, 280–281</p>
			<p class="em-only_endmatter-idx3">definition of, 278</p>
			<p class="em-only_endmatter-idx3">diagnostic examination for, 280–283, 282–283<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">differential diagnosis of, 281<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">ge&#173;ne&#173;tics of, 277–278</p>
			<p class="em-only_endmatter-idx3">gonioscopy for, 282, 282<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">goniotomy for, 285, 286<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">incidence of, 278</p>
			<p class="em-only_endmatter-idx3">natu&#173;ral history of, 283–284</p>
			<p class="em-only_endmatter-idx3">optical coherence tomography of, 283</p>
			<p class="em-only_endmatter-idx3">optic nerve findings in, 282–283, 283<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">pathophysiology of, 278</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 285–287, 286<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">tonometry in, 281–282</p>
			<p class="em-only_endmatter-idx3">trabeculotomy, 286<span class="italic">f</span>, 286–287</p>
			<p class="em-only_endmatter-idx2">prognosis for, 290–291</p>
			<p class="em-only_endmatter-idx2">secondary</p>
			<p class="em-only_endmatter-idx3">acquired condition, 284</p>
			<p class="em-only_endmatter-idx3">&#173;after cataract surgery, 285</p>
			<p class="em-only_endmatter-idx3">classification of, 278<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">nonacquired conditions associated with, 284<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">treatment of</p>
			<p class="em-only_endmatter-idx3"><span class="greek_1">β</span>-&#173;blockers, 288, 289<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">cyclocryotherapy, 287</p>
			<p class="em-only_endmatter-idx3">description of, 285</p>
			<p class="em-only_endmatter-idx3">endoscopic photocoagulation, 287–288, 288<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">goniotomy for, 285, 286<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">medical/medications, 288–290, 289<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">surgery, 285–288, 286<span class="italic">f</span>, 288<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">trabeculotomy, 286<span class="italic">f</span>, 286–287</p>
			<p class="em-only_endmatter-idx3">tube shunt implantation surgery, 287</p>
			<p class="em-only_endmatter-idx2">vision loss caused by, 290</p>
			<p class="em-only_endmatter-idx1">&#173;Children</p>
			<p class="em-only_endmatter-idx2">amblyopia in, 5</p>
			<p class="em-only_endmatter-idx2">bacterial conjunctivitis in, 240<span class="italic">f</span>, 240–241</p>
			<p class="em-only_endmatter-idx2">cataracts in. <span class="italic">See</span> Cataracts</p>
			<p class="em-only_endmatter-idx2">cataract surgery in, 301–305</p>
			<p class="em-only_endmatter-idx2">confrontation visual field testing in, 4, 10</p>
			<p class="em-only_endmatter-idx2">conjunctivitis in, 240<span class="italic">f</span>, 240–241. <span class="italic">See also</span> Conjunctivitis</p>
			<p class="em-only_endmatter-idx2">difficult, eye examination in, 5</p>
			<p class="em-only_endmatter-idx2">eyedrop administration in, 11–12</p>
			<p class="em-only_endmatter-idx2">eye examination in</p>
			<p class="em-only_endmatter-idx3">anterior segment examination, 10</p>
			<p class="em-only_endmatter-idx3">Br<span class="accent">ü</span>ckner test, 9</p>
			<p class="em-only_endmatter-idx3">communication during, 4</p>
			<p class="em-only_endmatter-idx3">cycloplegic refraction, 10–12</p>
			<p class="em-only_endmatter-idx3">difficult child, 5</p>
			<p class="em-only_endmatter-idx3">distance fixation targets, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">dynamic retinoscopy, 9</p>
			<p class="em-only_endmatter-idx3">fundus, 12</p>
			<p class="em-only_endmatter-idx3">general considerations and strategies for, 3–5</p>
			<p class="em-only_endmatter-idx3">intraocular pressure mea&#173;sure&#173;ment, 10</p>
			<p class="em-only_endmatter-idx3">1 toy, 1 look rule, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">in outpatient setting, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">practitioner positioning during, 4</p>
			<p class="em-only_endmatter-idx3">pupil testing, 10</p>
			<p class="em-only_endmatter-idx3">red reflex, 9</p>
			<p class="em-only_endmatter-idx3">“safe” environment for, 4</p>
			<p class="em-only_endmatter-idx3">slit-&#173;lamp examination, 4–5</p>
			<p class="em-only_endmatter-idx3">tonometry, 10</p>
			<p class="em-only_endmatter-idx3">visual acuity assessment. <span class="italic">See</span> &#173;Children, visual acuity assessment</p>
			<p class="em-only_endmatter-idx3">visual field testing, 10</p>
			<p class="em-only_endmatter-idx3">vocabulary during, 4</p>
			<p class="em-only_endmatter-idx2">history-&#173;taking in, 3–5</p>
			<p class="em-only_endmatter-idx2">intraocular pressure in</p>
			<p class="em-only_endmatter-idx3">mea&#173;sure&#173;ment of, 181</p>
			<p class="em-only_endmatter-idx3">normal level of, 282</p>
			<p class="em-only_endmatter-idx2">iris heterochromia in, 274, 274<span class="italic">t</span>, 274<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">nasolacrimal duct obstruction in, 235</p>
			<p class="em-only_endmatter-idx2">nystagmus in, 147–157. <span class="italic">See also</span> Nystagmus</p>
			<p class="em-only_endmatter-idx2">optic neuritis in, 369, 369<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">orbital inflammation in, 215–216</p>
			<p class="em-only_endmatter-idx2">preverbal, visual acuity assessment in, 8–9, 154</p>
			<p class="em-only_endmatter-idx2">ptosis in, 198</p>
			<p class="em-only_endmatter-idx2">slit-&#173;lamp examination in, 4–5</p>
			<p class="em-only_endmatter-idx2">uveitis in. <span class="italic">See</span> Uveitis</p>
			<p class="em-only_endmatter-idx2">vision rehabilitation in, 188–189, 189<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">visual acuity assessment in</p>
			<p class="em-only_endmatter-idx3">age-&#173;specific approaches, 5</p>
			<p class="em-only_endmatter-idx3">alternative methods, 8–9</p>
			<p class="em-only_endmatter-idx3">Central, Steady, and Maintained method of, 6</p>
			<p class="em-only_endmatter-idx3">eye charts for, 6<span class="italic">t</span>, 6–8, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">fixation and following be&#173;hav&#173;ior for, 5</p>
			<p class="em-only_endmatter-idx3">fixation be&#173;hav&#173;ior, 5–6</p>
			<p class="em-only_endmatter-idx3">HOTV test, 6, 6<span class="italic">t</span>, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">induced tropia test, 6</p>
			<p class="em-only_endmatter-idx3">in nystagmus, 8</p>
			<p class="em-only_endmatter-idx3">occluders used in, 8</p>
			<p class="em-only_endmatter-idx3">optotypes for, 6<span class="italic">t</span>, 6–8, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">preferential looking, 5, 8–9, 9<span class="italic">f</span>, 182, 300</p>
			<p class="em-only_endmatter-idx3">preverbal &#173;children, 8–9, 154</p>
			<p class="em-only_endmatter-idx3">sequence of, 8</p>
			<p class="em-only_endmatter-idx3">symbol charts for, 7</p>
			<p class="em-only_endmatter-idx3">visual evoked potential for, 9, 182, 300</p>
			<p class="em-only_endmatter-idx2">visual impairment in, 186–187</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Chlamydia trachomatis</span></p>
			<p class="em-only_endmatter-idx2">conjunctivitis caused by, 238–239, 239<span class="italic">f</span>, 241</p>
			<p class="em-only_endmatter-idx2">trachoma caused by, 241</p>
			<p class="em-only_endmatter-idx1">Chloroma, 218</p>
			<p class="em-only_endmatter-idx1">Chorioret&#173;i&#173;nal coloboma, 364</p>
			<p class="em-only_endmatter-idx1">Chorioret&#173;i&#173;nal lacunae, 338, 339<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Chorioretinitis</p>
			<p class="em-only_endmatter-idx2">syphilitic, 412</p>
			<p class="em-only_endmatter-idx2"><span class="italic">Toxoplasma,</span> 409, 410<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Choristoma, 223, 256</p>
			<p class="em-only_endmatter-idx1">Choristomatous tumors, 225–226</p>
			<p class="em-only_endmatter-idx1">Choroidal hemangioma, 401</p>
			<p class="em-only_endmatter-idx1">Choroidal lesions, 349–350</p>
			<p class="em-only_endmatter-idx1">Choroidal neovascular membranes (CNVMs), 342, 343<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Choroidal nevi, 349</p>
			<p class="em-only_endmatter-idx1">Choroidal osteoma, 349</p>
			<p class="em-only_endmatter-idx1"><span class="italic">CHRLD1</span> gene, 254</p>
			<p class="em-only_endmatter-idx1">Chromosomal abnormalities, 385, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Chronic progressive external ophthalmoplegia (CPEO), 141–142, 143<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">CHRPE. <span class="italic">See</span> Congenital hypertrophy of the retinal pigment epithelium</p>
			<p class="em-only_endmatter-idx1">CHSD. <span class="italic">See</span> Congenital hereditary stromal dystrophy</p>
			<p class="em-only_endmatter-idx1">CI. <span class="italic">See</span> Convergence insufficiency</p>
			<p class="em-only_endmatter-idx1">Ciancia syndrome, 88, 95</p>
			<p class="em-only_endmatter-idx1">Cigarette burns, 376</p>
			<p class="em-only_endmatter-idx1">Ciliary artery, 23</p>
			<p class="em-only_endmatter-idx1">Ciliary body tumors, 273<span class="italic">f</span>, 273–274</p>
			<p class="em-only_endmatter-idx1">Ciliary muscle, 20</p>
			<p class="em-only_endmatter-idx1">Ciliary spasm, 94</p>
			<p class="em-only_endmatter-idx1">Ciliochoroidal effusion, 284</p>
			<p class="em-only_endmatter-idx1">Ciliopathies, 336, 391–392, 391–392<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Clindamycin, for toxoplasmosis, 410</p>
			<p class="em-only_endmatter-idx1">CMN. <span class="italic">See</span> Congenital motor nystagmus</p>
			<p class="em-only_endmatter-idx1">CMV. <span class="italic">See</span> Cytomegalovirus</p>
			<p class="em-only_endmatter-idx1">CNLDO. <span class="italic">See</span> Congenital nasolacrimal duct <br />obstruction</p>
			<p class="em-only_endmatter-idx1">CNVMs. <span class="italic">See</span> Choroidal neovascular membranes</p>
			<p class="em-only_endmatter-idx1">Coats disease</p>
			<p class="em-only_endmatter-idx2">clinical findings of, 358, 359<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">diagnosis of, 359–360</p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 360</p>
			<p class="em-only_endmatter-idx2">fluorescein angiography findings, 359, 359<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">gender predilection of, 358</p>
			<p class="em-only_endmatter-idx2">retinoblastoma versus, 352–353, 360</p>
			<p class="em-only_endmatter-idx2">treatment of, 360</p>
			<p class="em-only_endmatter-idx1">Co-&#173;contractive retraction with jaw–&#173;eyelid synkinesis syndrome. <span class="italic">See</span> Marcus Gunn jaw-&#173;winking syndrome</p>
			<p class="em-only_endmatter-idx1">Cogan syndrome, 269</p>
			<p class="em-only_endmatter-idx1"><span class="italic">COL2A1</span> gene, 345</p>
			<p class="em-only_endmatter-idx1"><span class="italic">COL18A1</span> gene, 346–347</p>
			<p class="em-only_endmatter-idx1"><span class="italic">COL25A1</span> gene, 133</p>
			<p class="em-only_endmatter-idx1">Coloboma</p>
			<p class="em-only_endmatter-idx2">chorioret&#173;i&#173;nal, 364</p>
			<p class="em-only_endmatter-idx2">as craniofacial malformation, 209</p>
			<p class="em-only_endmatter-idx2">eyelid, 193, 193<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">globe, 263</p>
			<p class="em-only_endmatter-idx2">inferonasal disc, 365<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">iris, 266, 266<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">lens, 305<span class="italic">f</span>, 305–306</p>
			<p class="em-only_endmatter-idx2">optic nerve, 364–365<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Colobomatous cyst, 224</p>
			<p class="em-only_endmatter-idx1">Combined hamartoma of the ret&#173;ina and ret&#173;i&#173;nal pigment epithelium, 350</p>
			<p class="em-only_endmatter-idx1">Comitant deviations</p>
			<p class="em-only_endmatter-idx2">definition of, 16</p>
			<p class="em-only_endmatter-idx2">in infantile esotropia, 88</p>
			<p class="em-only_endmatter-idx1">Complete achromatopsia, 337–338</p>
			<p class="em-only_endmatter-idx1">Cone–&#173;rod dystrophy, in Stargardt disease, 340</p>
			<p class="em-only_endmatter-idx1">Cones, foveal density of, 44</p>
			<p class="em-only_endmatter-idx1">Confrontation visual field testing, 4, 10</p>
			<p class="em-only_endmatter-idx1">Congenital aphakia, 305</p>
			<p class="em-only_endmatter-idx1">Congenital cranial dysinnervation disorders (CCDDs)</p>
			<p class="em-only_endmatter-idx2">Brown syndrome as, 131</p>
			<p class="em-only_endmatter-idx2">congenital fibrosis of the extraocular muscles, 134–135</p>
			<p class="em-only_endmatter-idx2">definition of, 131</p>
			<p class="em-only_endmatter-idx2">Duane retraction syndrome. <span class="italic">See</span> Duane retraction syndrome</p>
			<p class="em-only_endmatter-idx2">M<span class="accent">ö</span>bius syndrome, 97, 135–136, 136<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Congenital esotropia, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">amblyopia associated with, 87–89</p>
			<p class="em-only_endmatter-idx2">botulinum toxin injections for, 89</p>
			<p class="em-only_endmatter-idx2">Chavasse theory of, 87</p>
			<p class="em-only_endmatter-idx2">Ciancia syndrome, 88, 95</p>
			<p class="em-only_endmatter-idx2">clinical features of, 87–88</p>
			<p class="em-only_endmatter-idx2">cross-&#173;fixation associated with, 87–88, 88<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">cyclopegic refraction for, 88</p>
			<p class="em-only_endmatter-idx2">definition of, 87</p>
			<p class="em-only_endmatter-idx2">evaluation of, 87–88</p>
			<p class="em-only_endmatter-idx2">management of, 88–89</p>
			<p class="em-only_endmatter-idx2">medial rectus muscle recession for, 89</p>
			<p class="em-only_endmatter-idx2">&#173;mental illness and, 87</p>
			<p class="em-only_endmatter-idx2">ocular alignment in, 88–89</p>
			<p class="em-only_endmatter-idx2">pathogenesis of, 87</p>
			<p class="em-only_endmatter-idx2">prematurity as risk &#173;factor for, 87</p>
			<p class="em-only_endmatter-idx2">smooth-&#173;pursuit asymmetry associated with, 88</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 89</p>
			<p class="em-only_endmatter-idx2">Worth “sensory” concept of, 87</p>
			<p class="em-only_endmatter-idx1">Congenital Esotropia Observational Study, 89</p>
			<p class="em-only_endmatter-idx1">Congenital fibrosis of the extraocular muscles (CFEOM), 134–135</p>
			<p class="em-only_endmatter-idx1">Congenital glaucoma</p>
			<p class="em-only_endmatter-idx2">corneal opacities associated with, 257<span class="italic">t</span>, 260, 261<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">primary. <span class="italic">See</span> Primary congenital glaucoma</p>
			<p class="em-only_endmatter-idx1">Congenital hereditary endothelial dystrophy (CHED), 257<span class="italic">t</span>, 258<span class="italic">f</span>, 258–259</p>
			<p class="em-only_endmatter-idx1">Congenital hereditary stromal dystrophy (CHSD), <br />257<span class="italic">t</span>, 259</p>
			<p class="em-only_endmatter-idx1">Congenital hypertrophy of the ret&#173;i&#173;nal pigment epithelium (CHRPE), 349, 349<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Congenital iris ectropion syndrome, 267</p>
			<p class="em-only_endmatter-idx1">Congenital lacrimal fistula, 228, 229<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Congenital miosis, 267–268</p>
			<p class="em-only_endmatter-idx1">Congenital motor nystagmus (CMN), 148–149, 149<span class="italic">t</span>, 153–154</p>
			<p class="em-only_endmatter-idx1">Congenital mydriasis, 268</p>
			<p class="em-only_endmatter-idx1">Congenital nasolacrimal duct obstruction (CNLDO)</p>
			<p class="em-only_endmatter-idx2">antibiotics for, 231–232, 234</p>
			<p class="em-only_endmatter-idx2">balloon dacryoplasty for, 234–235, 235<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">bilateral, 232<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">clinical features of, 230, 232<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">complex, 230, 233–234</p>
			<p class="em-only_endmatter-idx2">description of, 227, 230</p>
			<p class="em-only_endmatter-idx2">examination of, 230</p>
			<p class="em-only_endmatter-idx2">infantile glaucoma versus, 230</p>
			<p class="em-only_endmatter-idx2">intubation for, 234–235</p>
			<p class="em-only_endmatter-idx2">massage for, 231–232</p>
			<p class="em-only_endmatter-idx2">nasolacrimal probing for, 232–235, 233<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">nonsurgical management of, 231–232</p>
			<p class="em-only_endmatter-idx2">prevalence of, 230</p>
			<p class="em-only_endmatter-idx2">recurrence of, 234</p>
			<p class="em-only_endmatter-idx2">&#173;simple, 230, 231<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">spontaneous resolution of, 231</p>
			<p class="em-only_endmatter-idx2">stents for, 234–235</p>
			<p class="em-only_endmatter-idx2">surgical management of, 232–233</p>
			<p class="em-only_endmatter-idx2">tearing caused by, 230</p>
			<p class="em-only_endmatter-idx1">Congenital nevocellular nevi, 200–201, 201<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Congenital sensory nystagmus, 149, 150<span class="italic">t</span>, 154</p>
			<p class="em-only_endmatter-idx1">Congenital stationary night blindness (CSNB)</p>
			<p class="em-only_endmatter-idx2">electroretinography findings, 338</p>
			<p class="em-only_endmatter-idx2">spasmus nutans syndrome associated with, 151</p>
			<p class="em-only_endmatter-idx1">Congenital strabismus, 16</p>
			<p class="em-only_endmatter-idx1">Congenital superior oblique palsy, 69</p>
			<p class="em-only_endmatter-idx1">Congenital syphilis, 269, 412–413</p>
			<p class="em-only_endmatter-idx1">Congenital tarsal kink, 194–195</p>
			<p class="em-only_endmatter-idx1">Conjugate horizontal gaze, 182</p>
			<p class="em-only_endmatter-idx1">Conjunctival disorders</p>
			<p class="em-only_endmatter-idx2">epithelial inclusion cysts, 250</p>
			<p class="em-only_endmatter-idx2">nevi, 250, 250<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ocular melanocytosis, 250–251, 251<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">papillomas, 250</p>
			<p class="em-only_endmatter-idx2">Stevens-&#173;Johnson syndrome, 251–252, 252<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">toxic epidermal necrolysis, 251–252</p>
			<p class="em-only_endmatter-idx1">Conjunctival hyperemia, 237, 238<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Conjunctival scarring, 146</p>
			<p class="em-only_endmatter-idx1">Conjunctival telangiectasia, 303<span class="italic">f</span>, 403</p>
			<p class="em-only_endmatter-idx1">Conjunctivitis</p>
			<p class="em-only_endmatter-idx2">adenoviral, 241–242</p>
			<p class="em-only_endmatter-idx2">adult inclusion, 241</p>
			<p class="em-only_endmatter-idx2">allergic, 246<span class="italic">f</span>, 246–248</p>
			<p class="em-only_endmatter-idx2">bacterial, 240<span class="italic">f</span>, 240–241</p>
			<p class="em-only_endmatter-idx2">blepharitis as cause of, 244–245, 244–245<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">chemical, 239</p>
			<p class="em-only_endmatter-idx2"><span class="italic">Chlamydia trachomatis</span> as cause of, 238–239, 239<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Epstein-&#173;Barr virus as cause of, 243</p>
			<p class="em-only_endmatter-idx2">follicular, 241, 243</p>
			<p class="em-only_endmatter-idx2">herpes simplex virus as cause of, 239, 242</p>
			<p class="em-only_endmatter-idx2">infectious, 237–243</p>
			<p class="em-only_endmatter-idx2">ligneous, 249</p>
			<p class="em-only_endmatter-idx2">molluscum contagiosum as cause of, 243, 244</p>
			<p class="em-only_endmatter-idx2">neonatal inclusion, 238</p>
			<p class="em-only_endmatter-idx2">ophthalmia neonatorum</p>
			<p class="em-only_endmatter-idx3"><span class="italic">Chlamydia trachomatis</span> as cause of, 238–239, 239<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">definition of, 237</p>
			<p class="em-only_endmatter-idx3">epidemiology of, 237</p>
			<p class="em-only_endmatter-idx3">etiology of, 237</p>
			<p class="em-only_endmatter-idx3">herpes simplex virus as cause of, 239</p>
			<p class="em-only_endmatter-idx3"><span class="italic">Neisseria gonorrhoeae</span> as cause of, 238<span class="italic">f</span>, 238–239</p>
			<p class="em-only_endmatter-idx3"><span class="italic">Neisseria meningitidis</span> as cause of, 238</p>
			<p class="em-only_endmatter-idx3">prevalence of, 237</p>
			<p class="em-only_endmatter-idx3">prophylaxis for, 239</p>
			<p class="em-only_endmatter-idx2">perennial allergic, 246–248</p>
			<p class="em-only_endmatter-idx2">seasonal allergic, 246<span class="italic">f</span>, 246–248</p>
			<p class="em-only_endmatter-idx2">signs and symptoms of, 237</p>
			<p class="em-only_endmatter-idx2">varicella-&#173;zoster virus as cause of, 242–243</p>
			<p class="em-only_endmatter-idx2">viral, 241–243, 243–244<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Conjunctivodacryocystorhinostomy (CDCR), 227–228</p>
			<p class="em-only_endmatter-idx1">Conjunctivoplasty, 172</p>
			<p class="em-only_endmatter-idx1">Connective tissue tumors, 222</p>
			<p class="em-only_endmatter-idx1">Consecutive esotropia, 95</p>
			<p class="em-only_endmatter-idx1">Consecutive exotropia, 16, 104</p>
			<p class="em-only_endmatter-idx1">Consecutive strabismus, 16</p>
			<p class="em-only_endmatter-idx1">Constant exotropia, 103–105, 104<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Constant suppression, 49</p>
			<p class="em-only_endmatter-idx1">Contact lenses</p>
			<p class="em-only_endmatter-idx2">amblyopia treated with, 304</p>
			<p class="em-only_endmatter-idx2">lens dislocation treated with, 310</p>
			<p class="em-only_endmatter-idx1">Contour interaction bars, 7<span class="italic">f</span>, 8</p>
			<p class="em-only_endmatter-idx1">Contour stereopsis, 81</p>
			<p class="em-only_endmatter-idx1">Contralateral antagonist, inhibitional palsy of, 120–121, 121<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Convergence</p>
			<p class="em-only_endmatter-idx2">accommodative, 39, 59</p>
			<p class="em-only_endmatter-idx2">assessment of, 71</p>
			<p class="em-only_endmatter-idx2">definition of, 39</p>
			<p class="em-only_endmatter-idx2">fusional, 39, 43, 72</p>
			<p class="em-only_endmatter-idx2">near point of, 71</p>
			<p class="em-only_endmatter-idx2">proximal (instrument), 39</p>
			<p class="em-only_endmatter-idx2">symmetric, 41</p>
			<p class="em-only_endmatter-idx2">tonic, 40</p>
			<p class="em-only_endmatter-idx2">voluntary, 40</p>
			<p class="em-only_endmatter-idx1">Convergence insufficiency (CI), 103</p>
			<p class="em-only_endmatter-idx1">Convergence paralysis, 105–106</p>
			<p class="em-only_endmatter-idx1">Convergence-&#173;retraction nystagmus, 152–153</p>
			<p class="em-only_endmatter-idx1">Convergence spasm, 94</p>
			<p class="em-only_endmatter-idx1">Corectopia, 268</p>
			<p class="em-only_endmatter-idx1">Cornea</p>
			<p class="em-only_endmatter-idx2">abrasion of, 376</p>
			<p class="em-only_endmatter-idx2">clouding of, 179, 385, 387<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">delle of, 172, 172<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">dia&#173;meter of, 179, 281</p>
			<p class="em-only_endmatter-idx2">epithelial defects of, 376</p>
			<p class="em-only_endmatter-idx2">foreign body in, 376</p>
			<p class="em-only_endmatter-idx2">growth and development of, 181</p>
			<p class="em-only_endmatter-idx2">keratitis-&#173;related scarring of, 245<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">penetrating injury to, 376</p>
			<p class="em-only_endmatter-idx2">in primary congenital glaucoma, 280<span class="italic">f</span>, 280–281</p>
			<p class="em-only_endmatter-idx2">shield ulcer of, 248, 249<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">thermal injury to, 376</p>
			<p class="em-only_endmatter-idx2">tumors of, 271</p>
			<p class="em-only_endmatter-idx1">Corneal decompensation, &#173;after cataract surgery, 304</p>
			<p class="em-only_endmatter-idx1">Corneal disorders</p>
			<p class="em-only_endmatter-idx2">acquired, 269</p>
			<p class="em-only_endmatter-idx2">central corneal transparency, 257–258<span class="italic">t</span>, 257–263, 258<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">congenital hereditary endothelial dystrophy, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">congenital hereditary stromal dystrophy, 257<span class="italic">t</span>, 259</p>
			<p class="em-only_endmatter-idx2">cornea plana, 255, 255<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in cystinosis, 270, 387<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">dermolipoma, 256–257</p>
			<p class="em-only_endmatter-idx2">diffuse corneal transparency, 257–258<span class="italic">t</span>, 257–263, 258<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">epibulbar dermoid, 256, 256<span class="italic">f</span>, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">in Fabry disease, 270, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">in familial dysautonomia, 270</p>
			<p class="em-only_endmatter-idx2">forceps injury, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">infections, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">keratitis, 269</p>
			<p class="em-only_endmatter-idx2">keratoconus, 254</p>
			<p class="em-only_endmatter-idx2">keratoglobus, 254</p>
			<p class="em-only_endmatter-idx2">keratoplasty for, 262–263</p>
			<p class="em-only_endmatter-idx2">megalocornea, 253<span class="italic">f</span>, 253–254</p>
			<p class="em-only_endmatter-idx2">microcornea, 254, 254<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in mucopolysaccharidoses, 257<span class="italic">t</span>, 270, 385, 387<span class="italic">f</span>, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">peripheral corneal transparency, 255–256<span class="italic">f</span>, 255–257</p>
			<p class="em-only_endmatter-idx2">posterior corneal defect, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">posterior embryotoxon, 255, 255<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in Schnyder corneal dystrophy, 270, 387<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">sclerocornea, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">size-&#173; or shape-&#173;related, 253–254, 253–254<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">systemic conditions that cause, 269–271</p>
			<p class="em-only_endmatter-idx2">treatment of, 262–263</p>
			<p class="em-only_endmatter-idx2">in tyrosinemia type II, 270</p>
			<p class="em-only_endmatter-idx2">ulcers, 248, 249<span class="italic">f</span>, 262–263</p>
			<p class="em-only_endmatter-idx2">in Waardenburg syndrome, 270</p>
			<p class="em-only_endmatter-idx2">in Wilson disease, 270</p>
			<p class="em-only_endmatter-idx1">Corneal edema</p>
			<p class="em-only_endmatter-idx2">acute, 254</p>
			<p class="em-only_endmatter-idx2">in primary congenital glaucoma, 279–280</p>
			<p class="em-only_endmatter-idx1">Corneal exposure, 207</p>
			<p class="em-only_endmatter-idx1">Corneal haze, 270</p>
			<p class="em-only_endmatter-idx1">Corneal light reflex tests</p>
			<p class="em-only_endmatter-idx2">Hirschberg test, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Krimsky test, 67, 68<span class="italic">f</span>, 104<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ocular alignment assessments using, 67–68, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Corneal opacities</p>
			<p class="em-only_endmatter-idx2">congenital hereditary endothelial dystrophy as cause of, 257<span class="italic">t</span>, 258<span class="italic">f</span>, 258–259</p>
			<p class="em-only_endmatter-idx2">congenital hereditary stromal dystrophy as cause of, 259</p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">infantile glaucoma as cause of, 257<span class="italic">t</span>, 260, 261<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Peters anomaly, 259, 260<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">posterior corneal depression, 259</p>
			<p class="em-only_endmatter-idx2">primary, 258<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">sclerocornea, 260, 261<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">secondary, 258<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">STUMPED mnemonic for, 257<span class="italic">t</span>, 257–258</p>
			<p class="em-only_endmatter-idx2">total, 260, 261<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Cornea plana, 255, 255<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Corneoscleral lacerations, 377</p>
			<p class="em-only_endmatter-idx1">Coronary artery aneurysm, 316</p>
			<p class="em-only_endmatter-idx1">Corpus callosum agenesis, 361</p>
			<p class="em-only_endmatter-idx1">Cortical inattention, 186</p>
			<p class="em-only_endmatter-idx1">Cortical visual impairment, 186</p>
			<p class="em-only_endmatter-idx1">Corticosteroids</p>
			<p class="em-only_endmatter-idx2">cataracts caused by, 321</p>
			<p class="em-only_endmatter-idx2">glaucoma caused by, 321</p>
			<p class="em-only_endmatter-idx2">glaucoma secondary to, 284</p>
			<p class="em-only_endmatter-idx2">intravitreal implants, 321</p>
			<p class="em-only_endmatter-idx2">ocular allergies treated with, 247<span class="italic">t</span>, 248</p>
			<p class="em-only_endmatter-idx2">optic neuritis treated with, 369</p>
			<p class="em-only_endmatter-idx2">risks associated with long-&#173;term use of, 321</p>
			<p class="em-only_endmatter-idx2">sub-&#173;Tenon injections of, 320</p>
			<p class="em-only_endmatter-idx2">Thygeson superficial punctate keratitis treated with, 269</p>
			<p class="em-only_endmatter-idx2">toxoplasmosis treated with, 409–410</p>
			<p class="em-only_endmatter-idx2">uveitis treated with, 320–321</p>
			<p class="em-only_endmatter-idx2">vernal keratoconjunctivitis treated with, 249</p>
			<p class="em-only_endmatter-idx1">Cover tests</p>
			<p class="em-only_endmatter-idx2">alternate, 65–66, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">cover-&#173;uncover test, 64, 65<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ocular alignment assessments using, 64–67, 65–66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Cover-&#173;uncover test, 64, 65<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">CPEO. <span class="italic">See</span> Chronic progressive external ophthalmoplegia</p>
			<p class="em-only_endmatter-idx1">Cranial nerve III. <span class="italic">See</span> Oculomotor nerve</p>
			<p class="em-only_endmatter-idx1">Cranial nerve IV. <span class="italic">See</span> Trochlear nerve</p>
			<p class="em-only_endmatter-idx1">Cranial nerve VI. <span class="italic">See</span> Abducens nerve</p>
			<p class="em-only_endmatter-idx1">Cranial nerve VII palsy, 136<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Cranial sutures, 203–204, 204<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Craniofacial malformations</p>
			<p class="em-only_endmatter-idx2">anophthalmia, 209, 210<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Apert syndrome, 206–207, 207<span class="italic">f</span>, 209<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">branchial arch syndromes, 210–211, 210–211<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Crouzon syndrome, 206, 206<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">fetal alcohol syndrome, 211–212, 212<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">nonsynostotic, 209–212</p>
			<p class="em-only_endmatter-idx2">Pfeiffer syndrome, 207</p>
			<p class="em-only_endmatter-idx2">Pierre Robin sequence, 211</p>
			<p class="em-only_endmatter-idx2">Saethre-&#173;Chotzen syndrome, 207, 208<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Treacher Collins syndrome, 211, 211<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Craniometaphyseal dysplasia, 212</p>
			<p class="em-only_endmatter-idx1">Craniosynostosis</p>
			<p class="em-only_endmatter-idx2">anatomy of, 203–204</p>
			<p class="em-only_endmatter-idx2">Apert syndrome, 206–207, 207<span class="italic">f</span>, 209<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">brachycephaly, 205</p>
			<p class="em-only_endmatter-idx2">complications of</p>
			<p class="em-only_endmatter-idx3">corneal exposure, 207</p>
			<p class="em-only_endmatter-idx3">globe luxation, 207–208</p>
			<p class="em-only_endmatter-idx3">ocular adnexal abnormalities, 209</p>
			<p class="em-only_endmatter-idx3">optic nerve abnormalities, 208–209</p>
			<p class="em-only_endmatter-idx3">proptosis, 207</p>
			<p class="em-only_endmatter-idx3">strabismus, 208</p>
			<p class="em-only_endmatter-idx2">Crouzon syndrome, 206, 206<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">definition of, 203</p>
			<p class="em-only_endmatter-idx2">dolichocephaly, 205</p>
			<p class="em-only_endmatter-idx2">etiology of, 205–206</p>
			<p class="em-only_endmatter-idx2">Kleeblattsch<span class="accent">ä</span>del, 205</p>
			<p class="em-only_endmatter-idx2">Pfeiffer syndrome, 207</p>
			<p class="em-only_endmatter-idx2">plagiocephaly, 204–205</p>
			<p class="em-only_endmatter-idx2">Saethre-&#173;Chotzen syndrome, 207, 208<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">scaphocephaly, 205</p>
			<p class="em-only_endmatter-idx2">syndromes associated with, 206–207</p>
			<p class="em-only_endmatter-idx1">Cri-&#173;du-&#173;chat syndrome, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Crossed diplopia, 75</p>
			<p class="em-only_endmatter-idx1">Cross-&#173;fixation, in infantile esotropia, 87–88, 88<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Crouzon syndrome, 206, 206<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Crowding phenomenon</p>
			<p class="em-only_endmatter-idx2">in amblyopia, 56</p>
			<p class="em-only_endmatter-idx2">definition of, 54</p>
			<p class="em-only_endmatter-idx1">Cryotherapy for Retinopathy of Prematurity <br />(CRYO-&#173;ROP), 326, 331</p>
			<p class="em-only_endmatter-idx1">Cryptophthalmos, 191, 193, 193<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">CSM method. <span class="italic">See</span> Central, Steady, and Maintained (CSM) method</p>
			<p class="em-only_endmatter-idx1">CSNB. <span class="italic">See</span> Congenital stationary night blindness </p>
			<p class="em-only_endmatter-idx1"><span class="italic">CTNS</span> gene, 270</p>
			<p class="em-only_endmatter-idx1">Cupping, of optic disc, 187, 402<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">CVI. <span class="italic">See</span> Ce&#173;re&#173;bral visual impairment</p>
			<p class="em-only_endmatter-idx1">Cyclic esotropia, 93</p>
			<p class="em-only_endmatter-idx1">Cyclic strabismus, 93</p>
			<p class="em-only_endmatter-idx1">Cyclocryotherapy, 287</p>
			<p class="em-only_endmatter-idx1">Cyclodeviations</p>
			<p class="em-only_endmatter-idx2">double Maddox rod test for, 69, 69<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">fusion affected by, 79</p>
			<p class="em-only_endmatter-idx1">Cyclopentolate hydrochloride, 11, 11<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Cycloplegic agents</p>
			<p class="em-only_endmatter-idx2">adverse effects of, 11–12</p>
			<p class="em-only_endmatter-idx2">amblyopia treated with, 59</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 11–12</p>
			<p class="em-only_endmatter-idx2">corneal abrasion treated with, 376</p>
			<p class="em-only_endmatter-idx2">near reflex spasm treated with, 94</p>
			<p class="em-only_endmatter-idx1">Cycloplegic refraction</p>
			<p class="em-only_endmatter-idx2">agents used in, 11–12</p>
			<p class="em-only_endmatter-idx2">in amblyopia treatment, 57</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 10–12</p>
			<p class="em-only_endmatter-idx2">in infantile esotropia, 88</p>
			<p class="em-only_endmatter-idx2">technique of, 11</p>
			<p class="em-only_endmatter-idx1">Cyclosporine, for vernal keratoconjunctivitis, 249</p>
			<p class="em-only_endmatter-idx1">Cyclovergence, fusional, 40</p>
			<p class="em-only_endmatter-idx1">Cyclovertical strabismus, 162</p>
			<p class="em-only_endmatter-idx1"><span class="italic">CYP1B1</span> gene, 259, 277</p>
			<p class="em-only_endmatter-idx1">Cyst(s)</p>
			<p class="em-only_endmatter-idx2">colobomatous, 224</p>
			<p class="em-only_endmatter-idx2">dermoid, 223–224, 223–224<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">epithelial inclusion, 250</p>
			<p class="em-only_endmatter-idx2">iris, 272<span class="italic">f</span>, 272–273</p>
			<p class="em-only_endmatter-idx2">microphthalmia with, 224, 225<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Cystathionine <span class="greek_1">β</span>-&#173;synthase, 308</p>
			<p class="em-only_endmatter-idx1">Cysteamine, 270</p>
			<p class="em-only_endmatter-idx1">Cystinosis, 270, 387<span class="italic">f</span>, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Cytomegalovirus (CMV), 411, 411<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx-alpha">Dacryocystitis, acute, 229</p>
			<p class="em-only_endmatter-idx1">Dacryocystocele, 213, 225, 228–230, 229<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Dacryocystorhinostomy, for nasolacrimal duct obstruction, 236</p>
			<p class="em-only_endmatter-idx1">DALK. <span class="italic">See</span> Deep anterior lamellar keratoplasty</p>
			<p class="em-only_endmatter-idx1">Dark adaptation, in congenital stationary night blindness, 338</p>
			<p class="em-only_endmatter-idx1">Decussation, optic nerve, 43</p>
			<p class="em-only_endmatter-idx1">Deep anterior lamellar keratoplasty (DALK), 263, 270</p>
			<p class="em-only_endmatter-idx1">Deformational plagiocephaly, 204–205</p>
			<p class="em-only_endmatter-idx1">Delayed visual maturation (DVM), 186–187</p>
			<p class="em-only_endmatter-idx1">Deletion 4p, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Deletion 5p, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Deletion 18p, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Deletion 18q, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Delle, 172, 172<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Demarcation line, in retinopathy of prematurity, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">Demodex,</span> 245</p>
			<p class="em-only_endmatter-idx1">Demodicosis, 245</p>
			<p class="em-only_endmatter-idx1">de Morsier syndrome. <span class="italic">See</span> Septo-&#173;optic dysplasia</p>
			<p class="em-only_endmatter-idx1">Denervation and extirpation, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Deorsumduction, 33</p>
			<p class="em-only_endmatter-idx1">Deorsumversion, 37</p>
			<p class="em-only_endmatter-idx1">Depression of eye, 33, 38</p>
			<p class="em-only_endmatter-idx1">Deprivation amblyopia, 55, 379</p>
			<p class="em-only_endmatter-idx1">Depth perception, stereopsis versus, 43</p>
			<p class="em-only_endmatter-idx1">Dermoid cysts, 223–224, 223–224<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Dermolipomas, 210, 256–257</p>
			<p class="em-only_endmatter-idx1">Derry disease, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Descemet membrane</p>
			<p class="em-only_endmatter-idx2">breaks in</p>
			<p class="em-only_endmatter-idx3">description of, 260</p>
			<p class="em-only_endmatter-idx3">in primary congenital glaucoma, 280, 280<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">traumatic, 262, 262<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">tears in, 254</p>
			<p class="em-only_endmatter-idx1">Desmoid tumors, 222</p>
			<p class="em-only_endmatter-idx1">Deviations</p>
			<p class="em-only_endmatter-idx2">comitant</p>
			<p class="em-only_endmatter-idx3">definition of, 16</p>
			<p class="em-only_endmatter-idx3">in infantile esotropia, 88</p>
			<p class="em-only_endmatter-idx2">esodeviations</p>
			<p class="em-only_endmatter-idx3">accommodative, 90. <span class="italic">See also</span> Accommodative esotropia</p>
			<p class="em-only_endmatter-idx3">definition of, 85</p>
			<p class="em-only_endmatter-idx3">in divergence insufficiency, 94</p>
			<p class="em-only_endmatter-idx3">epidemiology of, 85</p>
			<p class="em-only_endmatter-idx3">extraocular muscle surgery amounts for, 160, 160<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">risk &#173;factors for, 85</p>
			<p class="em-only_endmatter-idx3">types of, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">exodeviations</p>
			<p class="em-only_endmatter-idx3">control of, 100</p>
			<p class="em-only_endmatter-idx3">convergence insufficiency, 103</p>
			<p class="em-only_endmatter-idx3">definition of, 99</p>
			<p class="em-only_endmatter-idx3">exotropia. <span class="italic">See</span> Exotropia</p>
			<p class="em-only_endmatter-idx3">extraocular muscle surgery amounts for, 160, 161<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">latent, 99</p>
			<p class="em-only_endmatter-idx3">manifest, 99</p>
			<p class="em-only_endmatter-idx3">risk &#173;factors for, 99</p>
			<p class="em-only_endmatter-idx2">incomitant, 16</p>
			<p class="em-only_endmatter-idx2">primary, 38</p>
			<p class="em-only_endmatter-idx2">secondary, 39</p>
			<p class="em-only_endmatter-idx2">strabismic amblyopia and, 46–47</p>
			<p class="em-only_endmatter-idx2">terminology used to describe, 15–16</p>
			<p class="em-only_endmatter-idx2">variations in size of, 16</p>
			<p class="em-only_endmatter-idx2">vertical. <span class="italic">See</span> Vertical deviations</p>
			<p class="em-only_endmatter-idx1">Dexamethasone, for toxoplasmosis, 410</p>
			<p class="em-only_endmatter-idx1">Dextrocycloversion, 38</p>
			<p class="em-only_endmatter-idx1">Dextroversion, 37</p>
			<p class="em-only_endmatter-idx1">DHD. <span class="italic">See</span> Dissociated horizontal deviation</p>
			<p class="em-only_endmatter-idx1">Diabetes mellitus, 408–409</p>
			<p class="em-only_endmatter-idx1">Diabetic retinopathy, 408–409</p>
			<p class="em-only_endmatter-idx1">Diagnostic positions of gaze, 64</p>
			<p class="em-only_endmatter-idx1">DIDMOAD syndrome, 408–409</p>
			<p class="em-only_endmatter-idx1">Diffuse corneal transparency disorders, 257–258<span class="italic">t</span>, 257–263, 258<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Diffuse infiltrative retinoblastoma, 353</p>
			<p class="em-only_endmatter-idx1">Diffuse neonatal hemangiomatosis, 220</p>
			<p class="em-only_endmatter-idx1">Diffuse soft-&#173;tissue histiocytosis, 219</p>
			<p class="em-only_endmatter-idx1">Diffuse superficial keratitis, 242</p>
			<p class="em-only_endmatter-idx1">Diktyoma. <span class="italic">See</span> Medulloepithelioma</p>
			<p class="em-only_endmatter-idx1">Diplopia</p>
			<p class="em-only_endmatter-idx2">crossed, 75</p>
			<p class="em-only_endmatter-idx2">description of, 47–48</p>
			<p class="em-only_endmatter-idx2">esotropia and, 102</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery as cause of, 168</p>
			<p class="em-only_endmatter-idx2">heteronymous, 75</p>
			<p class="em-only_endmatter-idx2">homonymous, 75</p>
			<p class="em-only_endmatter-idx2">in orbital floor fractures, 127–128</p>
			<p class="em-only_endmatter-idx2">paradoxical, 50, 50<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">physiologic, 48</p>
			<p class="em-only_endmatter-idx2">postoperative, 168</p>
			<p class="em-only_endmatter-idx2">press-on prisms for, 96</p>
			<p class="em-only_endmatter-idx2">prisms for, 72</p>
			<p class="em-only_endmatter-idx2">red-&#173;glass test for, 75</p>
			<p class="em-only_endmatter-idx2">in sixth nerve palsy, 96</p>
			<p class="em-only_endmatter-idx2">suppression of, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">testing for, 75</p>
			<p class="em-only_endmatter-idx2">in third nerve palsy, 139</p>
			<p class="em-only_endmatter-idx2">in thyroid eye disease, 140–141</p>
			<p class="em-only_endmatter-idx2">uncrossed, 75</p>
			<p class="em-only_endmatter-idx1">Dislocated lens</p>
			<p class="em-only_endmatter-idx2">conditions associated with, 306<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">description of, 306</p>
			<p class="em-only_endmatter-idx2">ectopia lentis et pupillae, 267–268, 307, 307<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in homocystinuria, 308–309</p>
			<p class="em-only_endmatter-idx2">illustration of, 306<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">inborn errors of metabolism and, 306</p>
			<p class="em-only_endmatter-idx2">iridodonesis with, 306</p>
			<p class="em-only_endmatter-idx2">isolated/simple ectopia lentis, 307</p>
			<p class="em-only_endmatter-idx2">in Marfan syndrome, 307–308, 308<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">refractive error caused by, 310</p>
			<p class="em-only_endmatter-idx2">in sulfite oxidase deficiency, 310</p>
			<p class="em-only_endmatter-idx2">treatment of, 310</p>
			<p class="em-only_endmatter-idx2">in Weill-&#173;Marchesani syndrome, 309</p>
			<p class="em-only_endmatter-idx1">Dissociated horizontal deviation (DHD), 17, 105, 129</p>
			<p class="em-only_endmatter-idx1">Dissociated strabismus complex (DSC), 17, 105<span class="italic">f</span>, 129</p>
			<p class="em-only_endmatter-idx1">Dissociated torsional deviation (DTD), 17, 129</p>
			<p class="em-only_endmatter-idx1">Dissociated vertical deviation (DVD)</p>
			<p class="em-only_endmatter-idx2">age at onset, 129</p>
			<p class="em-only_endmatter-idx2">clinical features of, 129, 129<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">definition of, 129</p>
			<p class="em-only_endmatter-idx2">description of, 17, 105, 111, 115–116</p>
			<p class="em-only_endmatter-idx2">hypertropia and, 115</p>
			<p class="em-only_endmatter-idx2">inferior oblique anterior transposition for, 166</p>
			<p class="em-only_endmatter-idx2">inferior oblique muscle overaction versus, 129–130</p>
			<p class="em-only_endmatter-idx2">management of, 130</p>
			<p class="em-only_endmatter-idx1">Distance–&#173;near incomitance, 162</p>
			<p class="em-only_endmatter-idx1">Distichiasis, 195, 195<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Divergence</p>
			<p class="em-only_endmatter-idx2">fusional, 40, 72</p>
			<p class="em-only_endmatter-idx2">fusional vertical, 40</p>
			<p class="em-only_endmatter-idx2">synergistic, 133</p>
			<p class="em-only_endmatter-idx1">Divergence insufficiency, 94</p>
			<p class="em-only_endmatter-idx1">Divergent strabismus, 15</p>
			<p class="em-only_endmatter-idx1">Dolichocephaly, 205</p>
			<p class="em-only_endmatter-idx1">Doll’s head maneuver, 88</p>
			<p class="em-only_endmatter-idx1">Dominant optic atrophy, 367–368, 368<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Donder’s law, 31</p>
			<p class="em-only_endmatter-idx1">Dorsal midbrain syndrome, 105</p>
			<p class="em-only_endmatter-idx1">Double-&#173;elevator palsy. <span class="italic">See</span> Monocular elevation deficiency</p>
			<p class="em-only_endmatter-idx1">Double Maddox rod test, 69, 69<span class="italic">f</span>, 120</p>
			<p class="em-only_endmatter-idx1">Double ring sign, 361, 362<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Double vision. <span class="italic">See</span> Diplopia</p>
			<p class="em-only_endmatter-idx1">Downbeat nystagmus, 152</p>
			<p class="em-only_endmatter-idx1">Downgaze, 38</p>
			<p class="em-only_endmatter-idx1">Down syndrome</p>
			<p class="em-only_endmatter-idx2">hypoaccommodation in, 9</p>
			<p class="em-only_endmatter-idx2">idiopathic intracranial hypertension associated with, 372</p>
			<p class="em-only_endmatter-idx2">ocular findings in, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">pseudopapilledema associated with, 372</p>
			<p class="em-only_endmatter-idx1">Downward-&#173;slanting palpebral fissure</p>
			<p class="em-only_endmatter-idx2">description of, 196</p>
			<p class="em-only_endmatter-idx2">pattern strabismus and, 107, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">syndromes with, 196</p>
			<p class="em-only_endmatter-idx1">Dragged-&#173;fovea diplopia syndrome, 145</p>
			<p class="em-only_endmatter-idx1">Drusen, optic disc, 373<span class="italic">f</span>, 373–374</p>
			<p class="em-only_endmatter-idx1">DSC. <span class="italic">See</span> Dissociated strabismus complex</p>
			<p class="em-only_endmatter-idx1">DTD. <span class="italic">See</span> Dissociated torsional deviation</p>
			<p class="em-only_endmatter-idx1">Duane retraction syndrome</p>
			<p class="em-only_endmatter-idx2">bilateral, 132</p>
			<p class="em-only_endmatter-idx2">classification of, 132–133</p>
			<p class="em-only_endmatter-idx2">clinical features of, 132–133</p>
			<p class="em-only_endmatter-idx2">definition of, 131</p>
			<p class="em-only_endmatter-idx2">electromyographic studies of, 132</p>
			<p class="em-only_endmatter-idx2">esotropic, 95–97, 132<span class="italic">f</span>, 133</p>
			<p class="em-only_endmatter-idx2">exotropic, 105, 132, 132<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ge&#173;ne&#173;tics of, 132</p>
			<p class="em-only_endmatter-idx2">globe retraction in, 134</p>
			<p class="em-only_endmatter-idx2">incomitant hypertropia associated with, 125</p>
			<p class="em-only_endmatter-idx2">management of, 133–134</p>
			<p class="em-only_endmatter-idx2">“ocular splits,” 133</p>
			<p class="em-only_endmatter-idx2">overdepression in adduction caused by, 117</p>
			<p class="em-only_endmatter-idx2">overelevation in adduction caused by, 117</p>
			<p class="em-only_endmatter-idx2">prevalence of, 133</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 133–134</p>
			<p class="em-only_endmatter-idx2">synergistic divergence associated with, 133</p>
			<p class="em-only_endmatter-idx2">systemic/syndromic defects associated with, 131</p>
			<p class="em-only_endmatter-idx2">type 1, 132<span class="italic">f</span>, 132–133</p>
			<p class="em-only_endmatter-idx2">type 2, 132, 132<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">type 3, 132–134, 133<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ductions</p>
			<p class="em-only_endmatter-idx2">description of, 33, 83</p>
			<p class="em-only_endmatter-idx2">forced. <span class="italic">See</span> Forced duction testing</p>
			<p class="em-only_endmatter-idx2">in infantile esotropia, 37</p>
			<p class="em-only_endmatter-idx1">DVD. <span class="italic">See</span> Dissociated vertical deviation</p>
			<p class="em-only_endmatter-idx1">DVM. <span class="italic">See</span> Delayed visual maturation</p>
			<p class="em-only_endmatter-idx1">Dynamic retinoscopy</p>
			<p class="em-only_endmatter-idx2">accommodation mea&#173;sure&#173;ments using, 9</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 9</p>
			<p class="em-only_endmatter-idx1">Dysconjugate nystagmus, 151–152</p>
			<p class="em-only_endmatter-idx1">Dyscoria, 267</p>
			<p class="em-only_endmatter-idx1">Dysraphism, 183<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Dystopia canthorum, 191, 192<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx-alpha">Early Treatment for Retinopathy of Prematurity (ETROP), 326, 331<span class="italic">t</span>, 332</p>
			<p class="em-only_endmatter-idx1">Early Treatment of Diabetic Retinopathy Study (ETDRS) chart, 8</p>
			<p class="em-only_endmatter-idx1">Eccentric fixation</p>
			<p class="em-only_endmatter-idx2">anomalous ret&#173;i&#173;nal correspondence versus, 51</p>
			<p class="em-only_endmatter-idx2">definition of, 54</p>
			<p class="em-only_endmatter-idx2">in strabismic amblyopia, 54</p>
			<p class="em-only_endmatter-idx1">ECP. <span class="italic">See</span> Endoscopic photocoagulation</p>
			<p class="em-only_endmatter-idx1">Ectodermal dysplasia, 194</p>
			<p class="em-only_endmatter-idx1">Ectopia lentis, isolated/simple, 307</p>
			<p class="em-only_endmatter-idx1">Ectopia lentis et pupillae, 267–268, 307, 307<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ec&#173;topic lacrimal gland, 226</p>
			<p class="em-only_endmatter-idx1">Ec&#173;topic tissue masses, 223–225<span class="italic">f</span>, 223–226</p>
			<p class="em-only_endmatter-idx1">Ectropion, congenital</p>
			<p class="em-only_endmatter-idx2">of eyelid, 194</p>
			<p class="em-only_endmatter-idx2">of iris, 267</p>
			<p class="em-only_endmatter-idx1">Ectropion uveae, 267</p>
			<p class="em-only_endmatter-idx1">Edwards syndrome, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">“Egg yolk” stage, of Best disease, 341, 342<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">EKC. <span class="italic">See</span> Epidermic keratoconjunctivitis</p>
			<p class="em-only_endmatter-idx1">Electromyography</p>
			<p class="em-only_endmatter-idx2">definition of, 32</p>
			<p class="em-only_endmatter-idx2">motor units on, 32</p>
			<p class="em-only_endmatter-idx1">Electro-&#173;oculography (EOG)</p>
			<p class="em-only_endmatter-idx2">Best disease findings, 342</p>
			<p class="em-only_endmatter-idx2">hereditary ret&#173;i&#173;nal disease evaluations using, 335</p>
			<p class="em-only_endmatter-idx1">Electroretinography (ERG)</p>
			<p class="em-only_endmatter-idx2">achromatopsia findings, 337</p>
			<p class="em-only_endmatter-idx2">congenital stationary night blindness findings, 338</p>
			<p class="em-only_endmatter-idx2">hereditary ret&#173;i&#173;nal disease evaluations, 335</p>
			<p class="em-only_endmatter-idx2">Knobloch syndrome findings, 347</p>
			<p class="em-only_endmatter-idx2">Leber congenital amaurosis findings, 336</p>
			<p class="em-only_endmatter-idx1">Elevation of eye, 33, 37–38</p>
			<p class="em-only_endmatter-idx1">Emmetropization, 180</p>
			<p class="em-only_endmatter-idx1">Empirical horopter, 41, 42<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Encephalocele, 225</p>
			<p class="em-only_endmatter-idx1">Encephalofacial angiomatosis. <span class="italic">See</span> Sturge-&#173;Weber syndrome</p>
			<p class="em-only_endmatter-idx1">Endophthalmitis, &#173;after cataract surgery, 305</p>
			<p class="em-only_endmatter-idx1">Endophytic retinoblastoma, 352, 352<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Endoscopic photocoagulation (ECP), for childhood glaucomas, 287–288, 288<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Enteropathic arthritis, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Enthesitis-&#173;related arthritis, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Entropion, congenital, 194</p>
			<p class="em-only_endmatter-idx1">EOG. <span class="italic">See</span> Electro-&#173;oculography</p>
			<p class="em-only_endmatter-idx1">Eosinophilic granuloma, 219, 219<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Epiblepharon, 194, 195<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Epibulbar dermoid, 256, 256<span class="italic">f</span>, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Epibulbar limbal dermoids, 210</p>
			<p class="em-only_endmatter-idx1">Epicanthus, 196, 196<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Epicanthus inversus, 196</p>
			<p class="em-only_endmatter-idx1">Epicanthus palpebralis, 196, 196<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Epicanthus supraciliaris, 196</p>
			<p class="em-only_endmatter-idx1">Epicanthus tarsalis, 196, 196<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Epidemic keratoconjunctivitis (EKC), 213, 242</p>
			<p class="em-only_endmatter-idx1">Epidermoid cysts, 223</p>
			<p class="em-only_endmatter-idx1">Epiret&#173;i&#173;nal membrane, ret&#173;i&#173;nal distortion caused by, 145</p>
			<p class="em-only_endmatter-idx1">Epithelial cyst, 170–171</p>
			<p class="em-only_endmatter-idx1">Epithelial inclusion cysts, 250</p>
			<p class="em-only_endmatter-idx1">Epstein-&#173;Barr virus, 243</p>
			<p class="em-only_endmatter-idx1">ERG. <span class="italic">See</span> Electroretinography</p>
			<p class="em-only_endmatter-idx1">Erythromycin, for chlamydial infections, 239</p>
			<p class="em-only_endmatter-idx1">Eso- (prefix), 15</p>
			<p class="em-only_endmatter-idx1">Esodeviations</p>
			<p class="em-only_endmatter-idx2">accommodative, 90. <span class="italic">See also</span> Accommodative <br />esotropia</p>
			<p class="em-only_endmatter-idx2">definition of, 85</p>
			<p class="em-only_endmatter-idx2">in divergence insufficiency, 94</p>
			<p class="em-only_endmatter-idx2">epidemiology of, 85</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery amounts for, 160, 160<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">risk &#173;factors for, 85</p>
			<p class="em-only_endmatter-idx2">types of, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Esotropia</p>
			<p class="em-only_endmatter-idx2">accommodative</p>
			<p class="em-only_endmatter-idx3">amblyopia associated with, 91</p>
			<p class="em-only_endmatter-idx3">definition of, 90</p>
			<p class="em-only_endmatter-idx3">description of, 57</p>
			<p class="em-only_endmatter-idx3">evaluation of, 91</p>
			<p class="em-only_endmatter-idx3">high AC/A ratio, 90–92</p>
			<p class="em-only_endmatter-idx3">management of, 91–92</p>
			<p class="em-only_endmatter-idx3">nonrefractive, 90</p>
			<p class="em-only_endmatter-idx3">partially, 90–92</p>
			<p class="em-only_endmatter-idx3">pathogenesis of, 90–91</p>
			<p class="em-only_endmatter-idx3">refractive, 90–92</p>
			<p class="em-only_endmatter-idx3">types of, 86<span class="italic">t</span>, 90–91</p>
			<p class="em-only_endmatter-idx2">acquired nonaccommodative</p>
			<p class="em-only_endmatter-idx3">basic, 93</p>
			<p class="em-only_endmatter-idx3">consecutive esotropia, 95</p>
			<p class="em-only_endmatter-idx3">cyclic esotropia, 93</p>
			<p class="em-only_endmatter-idx3">description of, 92</p>
			<p class="em-only_endmatter-idx3">divergence insufficiency, 94</p>
			<p class="em-only_endmatter-idx3">near reflex spasm, 94</p>
			<p class="em-only_endmatter-idx3">sensory esotropia, 93–94</p>
			<p class="em-only_endmatter-idx3">types of, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">age-&#173;related distance, 94</p>
			<p class="em-only_endmatter-idx2">botulinum toxin injection for, 97</p>
			<p class="em-only_endmatter-idx2">congenital. <span class="italic">See</span> Esotropia, infantile</p>
			<p class="em-only_endmatter-idx2">in congenital fibrosis of the extraocular muscles (CFEOM), 135</p>
			<p class="em-only_endmatter-idx2">consecutive, 16, 95</p>
			<p class="em-only_endmatter-idx2">cyclic, 93</p>
			<p class="em-only_endmatter-idx2">diplopia and, 102</p>
			<p class="em-only_endmatter-idx2">in Duane retraction syndrome, 95–97, 132<span class="italic">f</span>, 133</p>
			<p class="em-only_endmatter-idx2">exotropia following, 16</p>
			<p class="em-only_endmatter-idx2">high myopia and, 97, 143–144</p>
			<p class="em-only_endmatter-idx2">Hirschberg test for, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">incomitant, 95–97, 96<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">infantile, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">amblyopia associated with, 87–89</p>
			<p class="em-only_endmatter-idx3">botulinum toxin injections for, 89</p>
			<p class="em-only_endmatter-idx3">Chavasse theory of, 87</p>
			<p class="em-only_endmatter-idx3">Ciancia syndrome, 88, 95</p>
			<p class="em-only_endmatter-idx3">clinical features of, 87–88</p>
			<p class="em-only_endmatter-idx3">cross-&#173;fixation associated with, 87–88, 88<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">cyclopegic refraction for, 88</p>
			<p class="em-only_endmatter-idx3">definition of, 87</p>
			<p class="em-only_endmatter-idx3">evaluation of, 87–88</p>
			<p class="em-only_endmatter-idx3">management of, 88–89</p>
			<p class="em-only_endmatter-idx3">medial rectus muscle recession for, 89</p>
			<p class="em-only_endmatter-idx3">&#173;mental illness and, 87</p>
			<p class="em-only_endmatter-idx3">ocular alignment in, 88–89</p>
			<p class="em-only_endmatter-idx3">pathogenesis of, 87</p>
			<p class="em-only_endmatter-idx3">prematurity as risk &#173;factor for, 87</p>
			<p class="em-only_endmatter-idx3">smooth-&#173;pursuit asymmetry associated with, 88</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 89</p>
			<p class="em-only_endmatter-idx3">V-&#173;pattern strabismus associated with, 109, <br />112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">Worth “sensory” concept of, 87</p>
			<p class="em-only_endmatter-idx2">large-&#173;angle, 87</p>
			<p class="em-only_endmatter-idx2">negative &#173;angle kappa and, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">nystagmus and, 86<span class="italic">t</span>, 95</p>
			<p class="em-only_endmatter-idx2">nystagmus blockage syndrome as cause of, 155</p>
			<p class="em-only_endmatter-idx2">postoperative, 102</p>
			<p class="em-only_endmatter-idx2">postsurgical, 102</p>
			<p class="em-only_endmatter-idx2">postsurgical consecutive, 95</p>
			<p class="em-only_endmatter-idx2">prevalence of, 85</p>
			<p class="em-only_endmatter-idx2">primary inferior oblique muscle overaction associated with, 117</p>
			<p class="em-only_endmatter-idx2">pseudoesotropia, 85–87, 86<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">risk &#173;factors for, 85</p>
			<p class="em-only_endmatter-idx2">sensory, 93–94</p>
			<p class="em-only_endmatter-idx2">small-&#173;angle, 102</p>
			<p class="em-only_endmatter-idx2">spontaneous consecutive, 95</p>
			<p class="em-only_endmatter-idx2">strabismus surgery for, 91</p>
			<p class="em-only_endmatter-idx2">types of, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">V-&#173;pattern strabismus associated with, 109, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Etanercept, 322</p>
			<p class="em-only_endmatter-idx1">ETDRS chart, 8</p>
			<p class="em-only_endmatter-idx1">ETROP. <span class="italic">See</span> Early Treatment for Retinopathy of Prematurity</p>
			<p class="em-only_endmatter-idx1">Euryblepharon, 195</p>
			<p class="em-only_endmatter-idx1">Ewing sarcoma, 218</p>
			<p class="em-only_endmatter-idx1">Examination, ocular</p>
			<p class="em-only_endmatter-idx2">anterior segment examination, 10</p>
			<p class="em-only_endmatter-idx2">Br<span class="accent">ü</span>ckner test, 9</p>
			<p class="em-only_endmatter-idx2">communication during, 4</p>
			<p class="em-only_endmatter-idx2">cycloplegic refraction, 10–12</p>
			<p class="em-only_endmatter-idx2">difficult child, 5</p>
			<p class="em-only_endmatter-idx2">distance fixation targets, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">dynamic retinoscopy, 9</p>
			<p class="em-only_endmatter-idx2">fundus, 12</p>
			<p class="em-only_endmatter-idx2">general considerations and strategies for, 3–5</p>
			<p class="em-only_endmatter-idx2">intraocular pressure mea&#173;sure&#173;ment, 10</p>
			<p class="em-only_endmatter-idx2">1 toy, 1 look rule, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in outpatient setting, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">practitioner positioning during, 4</p>
			<p class="em-only_endmatter-idx2">pupil testing, 10</p>
			<p class="em-only_endmatter-idx2">red reflex, 9</p>
			<p class="em-only_endmatter-idx2">“safe” environment for, 4</p>
			<p class="em-only_endmatter-idx2">slit-&#173;lamp examination, 4–5</p>
			<p class="em-only_endmatter-idx2">tonometry, 10</p>
			<p class="em-only_endmatter-idx2">visual acuity assessment. <span class="italic">See</span> &#173;Children, visual acuity assessment</p>
			<p class="em-only_endmatter-idx2">visual field testing, 10</p>
			<p class="em-only_endmatter-idx2">vocabulary during, 4</p>
			<p class="em-only_endmatter-idx1">Excessive blinking, 201–202</p>
			<p class="em-only_endmatter-idx1">Excyclo-&#173; (prefix), 16</p>
			<p class="em-only_endmatter-idx1">Excycloduction, 33</p>
			<p class="em-only_endmatter-idx1">Exo- (prefix), 15</p>
			<p class="em-only_endmatter-idx1">Exodeviations</p>
			<p class="em-only_endmatter-idx2">control of, 100</p>
			<p class="em-only_endmatter-idx2">convergence insufficiency, 103</p>
			<p class="em-only_endmatter-idx2">definition of, 99</p>
			<p class="em-only_endmatter-idx2">exotropia. <span class="italic">See</span> Exotropia</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery amounts for, 160, 161<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">latent, 99</p>
			<p class="em-only_endmatter-idx2">manifest, 99</p>
			<p class="em-only_endmatter-idx2">risk &#173;factors for, 99</p>
			<p class="em-only_endmatter-idx1">Exophoria</p>
			<p class="em-only_endmatter-idx2">definition of, 99</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 99</p>
			<p class="em-only_endmatter-idx1">Exophytic retinoblastoma, 352–353, 353<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Exorbitism, 203</p>
			<p class="em-only_endmatter-idx1">Exotropia</p>
			<p class="em-only_endmatter-idx2">alternate cover test for, 66<span class="italic">f</span>, 99</p>
			<p class="em-only_endmatter-idx2">&#173;angle kappa and, 67</p>
			<p class="em-only_endmatter-idx2">A-&#173;pattern strabismus associated with, 109</p>
			<p class="em-only_endmatter-idx2">consecutive, 16, 104</p>
			<p class="em-only_endmatter-idx2">constant, 103–105, 104<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in craniosynostosis, 208</p>
			<p class="em-only_endmatter-idx2">in Duane retraction syndrome, 105, 132, 132<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">esotropia &#173;after, 95</p>
			<p class="em-only_endmatter-idx2">high myopia and, 143–144</p>
			<p class="em-only_endmatter-idx2">hypertropias associated with, 100</p>
			<p class="em-only_endmatter-idx2">infantile, 103–104, 104<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">intermittent</p>
			<p class="em-only_endmatter-idx3">age at onset, 99</p>
			<p class="em-only_endmatter-idx3">basic, 101</p>
			<p class="em-only_endmatter-idx3">characteristics of, 99–100</p>
			<p class="em-only_endmatter-idx3">control of, 100</p>
			<p class="em-only_endmatter-idx3">course of, 99</p>
			<p class="em-only_endmatter-idx3">dissociated horizontal deviation and, 105</p>
			<p class="em-only_endmatter-idx3">evaluation of, 100–101</p>
			<p class="em-only_endmatter-idx3">nonsurgical management of, 101–102</p>
			<p class="em-only_endmatter-idx3">normal ret&#173;i&#173;nal correspondence in, 99</p>
			<p class="em-only_endmatter-idx3">occlusion therapy for, 102</p>
			<p class="em-only_endmatter-idx3">patch test for, 101</p>
			<p class="em-only_endmatter-idx3">postoperative alignment, 102</p>
			<p class="em-only_endmatter-idx3">prisms for, 102</p>
			<p class="em-only_endmatter-idx3">recurrence of, 103</p>
			<p class="em-only_endmatter-idx3">refractive errors in, 101</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 102–103</p>
			<p class="em-only_endmatter-idx3">tenacious proximal fusion in, 71</p>
			<p class="em-only_endmatter-idx3">treatment of, 101–103</p>
			<p class="em-only_endmatter-idx2">Krimsky test, 67, 68<span class="italic">f</span>, 104<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">large-&#173;angle, 116</p>
			<p class="em-only_endmatter-idx2">neuromuscular abnormalities as cause of, <br />105</p>
			<p class="em-only_endmatter-idx2">postsurgical, 104</p>
			<p class="em-only_endmatter-idx2">primary inferior oblique muscle overaction associated with, 117</p>
			<p class="em-only_endmatter-idx2">pseudoexotropia, 99</p>
			<p class="em-only_endmatter-idx2">risk &#173;factors for, 99</p>
			<p class="em-only_endmatter-idx2">sensory, 104</p>
			<p class="em-only_endmatter-idx2">V-&#173;pattern strabismus with, 108<span class="italic">f</span>, 112</p>
			<p class="em-only_endmatter-idx1">Extorsion</p>
			<p class="em-only_endmatter-idx2">definition of, 33</p>
			<p class="em-only_endmatter-idx2">V-&#173;pattern strabismus caused by, 107, 110</p>
			<p class="em-only_endmatter-idx1">Extraconal fat pads, 28</p>
			<p class="em-only_endmatter-idx1">Extraocular muscles. <span class="italic">See also specific muscle</span></p>
			<p class="em-only_endmatter-idx2">action of</p>
			<p class="em-only_endmatter-idx3">description of, 31–32</p>
			<p class="em-only_endmatter-idx3">gaze position and, 34–37, 35–37<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">primary, 34</p>
			<p class="em-only_endmatter-idx3">secondary, 34</p>
			<p class="em-only_endmatter-idx3">tertiary, 34</p>
			<p class="em-only_endmatter-idx2">arc of contact, 32</p>
			<p class="em-only_endmatter-idx2">arterial system of, 23</p>
			<p class="em-only_endmatter-idx2">blood supply of, 23–24, 30</p>
			<p class="em-only_endmatter-idx2">congenital fibrosis of, 134–135</p>
			<p class="em-only_endmatter-idx2">course of, 19–22</p>
			<p class="em-only_endmatter-idx2">fascial relationships of, 25–28, 26–27<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">fiber structure in, 24</p>
			<p class="em-only_endmatter-idx2">fibrosis of</p>
			<p class="em-only_endmatter-idx3">congenital, 134–135</p>
			<p class="em-only_endmatter-idx3">in thyroid eye disease, 140</p>
			<p class="em-only_endmatter-idx2">global layer of, 24</p>
			<p class="em-only_endmatter-idx2">growth and development of, 181–182</p>
			<p class="em-only_endmatter-idx2">innervation of, 19–22</p>
			<p class="em-only_endmatter-idx2">insertion of, 19–22, 31</p>
			<p class="em-only_endmatter-idx2">lost, 162, 169</p>
			<p class="em-only_endmatter-idx2">myasthenia gravis effects on, 142</p>
			<p class="em-only_endmatter-idx2">ophthalmic artery supply of, 23</p>
			<p class="em-only_endmatter-idx2">orbital layer of, 24</p>
			<p class="em-only_endmatter-idx2">orbital relationships of, 25–28, 26–27<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">origin of, 19–22</p>
			<p class="em-only_endmatter-idx2">pulley system of, 28, 32</p>
			<p class="em-only_endmatter-idx2">retrobulbar injection–&#173;related damage to, 146</p>
			<p class="em-only_endmatter-idx2">slipped, 162, 169, 169<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">structure of, 24, 25<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">3-&#173;step test of, 73–75, 74<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">thyroid eye disease effects, 140</p>
			<p class="em-only_endmatter-idx2">venous system of, 23–24</p>
			<p class="em-only_endmatter-idx2">yoke muscles, 38</p>
			<p class="em-only_endmatter-idx1">Extraocular muscle surgery</p>
			<p class="em-only_endmatter-idx2">adjustable sutures used in, 165</p>
			<p class="em-only_endmatter-idx2">in amblyopia, 160</p>
			<p class="em-only_endmatter-idx2">anesthesia for, 174–175</p>
			<p class="em-only_endmatter-idx2">in awake patients, 165</p>
			<p class="em-only_endmatter-idx2">complications of, 168–174</p>
			<p class="em-only_endmatter-idx3">adherence syndrome, 172</p>
			<p class="em-only_endmatter-idx3">alignment issues, 168</p>
			<p class="em-only_endmatter-idx3">allergic reactions, 170, 171<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">anterior segment ischemia, 172–173, 173<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">anti-&#173;elevation syndrome, 168–169</p>
			<p class="em-only_endmatter-idx3">conjunctival scarring, 171–172, 172<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">delle, 172, 172<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">diplopia, 168</p>
			<p class="em-only_endmatter-idx3">epithelial cyst, 170–171</p>
			<p class="em-only_endmatter-idx3">eyelid position changes, 173, 173<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">foreign-&#173;body granuloma, 170</p>
			<p class="em-only_endmatter-idx3">iatrogenic Brown syndrome, 168</p>
			<p class="em-only_endmatter-idx3">infections, 170, 170<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">lost muscles, 169</p>
			<p class="em-only_endmatter-idx3">orbital cellulitis, 170, 170<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">pulled-&#173;in-&#173;two syndrome, 169–170</p>
			<p class="em-only_endmatter-idx3">pyogenic granuloma, 170, 171<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">refractive changes, 173–174</p>
			<p class="em-only_endmatter-idx3">scleral perforation, 170</p>
			<p class="em-only_endmatter-idx3">slipped muscles, 169, 169<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">unsatisfactory alignment, 168</p>
			<p class="em-only_endmatter-idx2">cyclovertical strabismus, 162</p>
			<p class="em-only_endmatter-idx2">distance–&#173;near incomitance and, 162</p>
			<p class="em-only_endmatter-idx2">for esodeviations, 160, 160<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">esotropia correction with, 159</p>
			<p class="em-only_endmatter-idx2">evaluation before, 159</p>
			<p class="em-only_endmatter-idx2">for exodeviations, 160, 161<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">exotropia &#173;after, 17</p>
			<p class="em-only_endmatter-idx2">formulas for, 160–161<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">fornix incision for, 162–163</p>
			<p class="em-only_endmatter-idx2">hangback recession, 163</p>
			<p class="em-only_endmatter-idx2">horizontal deviations, 161</p>
			<p class="em-only_endmatter-idx2">horizontal incomitance and, 161</p>
			<p class="em-only_endmatter-idx2">hypertropia treated with, 164–165</p>
			<p class="em-only_endmatter-idx2">hypotropia treated with, 164–165</p>
			<p class="em-only_endmatter-idx2">incisions for, 162–163</p>
			<p class="em-only_endmatter-idx2">incomitance and, 161–162</p>
			<p class="em-only_endmatter-idx2">indications for, 159–160</p>
			<p class="em-only_endmatter-idx2">limbal incision for, 163</p>
			<p class="em-only_endmatter-idx2">malignant hyperthermia secondary to, 174–175</p>
			<p class="em-only_endmatter-idx2">monocular horizontal recession-&#173;resection procedures, 161</p>
			<p class="em-only_endmatter-idx2">nystagmus treated with, 155–157, 156<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">oblique muscles</p>
			<p class="em-only_endmatter-idx3">inferior, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx3">tightening procedures, 164<span class="italic">t</span>, 166–167</p>
			<p class="em-only_endmatter-idx3">weakening procedures, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx2">oculocardiac reflex, 174</p>
			<p class="em-only_endmatter-idx2">planning of, 160–162</p>
			<p class="em-only_endmatter-idx2">posterior fixation, 167</p>
			<p class="em-only_endmatter-idx2">postoperative nausea and vomiting secondary to, 174</p>
			<p class="em-only_endmatter-idx2">prior surgery and, 162</p>
			<p class="em-only_endmatter-idx2">reasons for, 159</p>
			<p class="em-only_endmatter-idx2">rectus muscles</p>
			<p class="em-only_endmatter-idx3">hypertropia, 164–165</p>
			<p class="em-only_endmatter-idx3">hypotropia, 164–165</p>
			<p class="em-only_endmatter-idx3">slipped, 169, 169<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">tightening procedures, 163–164, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">weakening procedures, 163, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">stay sutures used in, 167</p>
			<p class="em-only_endmatter-idx2">sutures used in</p>
			<p class="em-only_endmatter-idx3">adjustable, 165</p>
			<p class="em-only_endmatter-idx3">posterior fixation, 167</p>
			<p class="em-only_endmatter-idx3">stay, 167</p>
			<p class="em-only_endmatter-idx2">symmetric, 160–161<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">techniques for, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">tightening procedures</p>
			<p class="em-only_endmatter-idx3">for inferior oblique muscle, 166</p>
			<p class="em-only_endmatter-idx3">for oblique muscles, 164<span class="italic">t</span>, 166–167</p>
			<p class="em-only_endmatter-idx3">for rectus muscles, 163–164, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">for superior oblique muscle, 167</p>
			<p class="em-only_endmatter-idx2">transposition procedures, 167</p>
			<p class="em-only_endmatter-idx2">vertical incomitance and, 161</p>
			<p class="em-only_endmatter-idx2">weakening procedures</p>
			<p class="em-only_endmatter-idx3">for inferior oblique muscle</p>
			<p class="em-only_endmatter-idx4">bilateral, 165</p>
			<p class="em-only_endmatter-idx4">indications for, 118</p>
			<p class="em-only_endmatter-idx4">for superior oblique muscle palsy, 123, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx4">surgical procedures for, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx4">for V-&#173;pattern strabismus, 111</p>
			<p class="em-only_endmatter-idx3">for oblique muscles, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx3">for rectus muscles, 163, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Eye</p>
			<p class="em-only_endmatter-idx2">congenital anomalies of, 182–183, 183<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">dimensions of, 179<span class="italic">t</span>, 179–180</p>
			<p class="em-only_endmatter-idx2">growth and development of</p>
			<p class="em-only_endmatter-idx3">abnormal, 182–183, 183<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">normal, 179–182</p>
			<p class="em-only_endmatter-idx2">malformation of, 182–183</p>
			<p class="em-only_endmatter-idx2">refractive state of, 180<span class="italic">f</span>, 180–181</p>
			<p class="em-only_endmatter-idx1">Eye disorders</p>
			<p class="em-only_endmatter-idx2">atopic keratoconjunctivitis, 249</p>
			<p class="em-only_endmatter-idx2">blepharitis, 244–245, 244–245<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">conjunctivitis. <span class="italic">See</span> Conjunctivitis</p>
			<p class="em-only_endmatter-idx2">ligneous conjunctivitis, 249</p>
			<p class="em-only_endmatter-idx2">ocular allergies, 246<span class="italic">f</span>, 246–249, 247–248<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">ophthalmia neonatorum. <span class="italic">See</span> Ophthalmia neonatorum</p>
			<p class="em-only_endmatter-idx2">vernal keratoconjunctivitis, 248–249, 248–249<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Eyedrops</p>
			<p class="em-only_endmatter-idx2">ocular allergies treated with, 247<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">pediatric administration of, 11–12</p>
			<p class="em-only_endmatter-idx1">Eyelid(s). <span class="italic">See also</span> Lower eyelid; Upper eyelid</p>
			<p class="em-only_endmatter-idx2">botulinum toxin injection into, 146</p>
			<p class="em-only_endmatter-idx2">crease of, 197</p>
			<p class="em-only_endmatter-idx2">laceration to, 378</p>
			<p class="em-only_endmatter-idx2">malformations of, 191</p>
			<p class="em-only_endmatter-idx2">morphologic mea&#173;sure&#173;ments of, 191, 192<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">perforating injury of, 377<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">positional changes in, 173, 173<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">vertical rectus muscle attachment of, 30<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Eyelid disorders</p>
			<p class="em-only_endmatter-idx2">ablepharon, 193</p>
			<p class="em-only_endmatter-idx2">ankyloblepharon, 193–194, 194<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">chalazia, 198–199, 199<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">coloboma, 193, 193<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">congenital, 191–198</p>
			<p class="em-only_endmatter-idx2">congenital tarsal kink, 194–195</p>
			<p class="em-only_endmatter-idx2">cryptophthalmos, 191, 193, 193<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">distichiasis, 195, 195<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">dystopia canthorum, 191, 192<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ectropion, 194</p>
			<p class="em-only_endmatter-idx2">entropion, 194</p>
			<p class="em-only_endmatter-idx2">epiblepharon, 194, 195<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">epicanthus, 196, 196<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">epithelial lesions, 200</p>
			<p class="em-only_endmatter-idx2">euryblepharon, 195</p>
			<p class="em-only_endmatter-idx2">excessive blinking, 201–202</p>
			<p class="em-only_endmatter-idx2">hemangiomas, 199</p>
			<p class="em-only_endmatter-idx2">hordeola, 198–199</p>
			<p class="em-only_endmatter-idx2">infectious, 198–199</p>
			<p class="em-only_endmatter-idx2">inflammatory, 198–199</p>
			<p class="em-only_endmatter-idx2">Marcus Gunn jaw-&#173;winking syndrome, 198</p>
			<p class="em-only_endmatter-idx2">neoplasms, 199–200</p>
			<p class="em-only_endmatter-idx2">nevi, 200–201, 201<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">noninflammatory, 199–201</p>
			<p class="em-only_endmatter-idx2">palpebral fissure slants, 196</p>
			<p class="em-only_endmatter-idx2">pilomatricoma, 200, 200<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">port-&#173;wine stain, 199</p>
			<p class="em-only_endmatter-idx2">ptosis, 196–198, 197<span class="italic">t</span>, 198<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">pyogenic granuloma, 199, 199<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">trichotillomania, 201, 201<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">vascular, 199</p>
			<p class="em-only_endmatter-idx1">Eye movements</p>
			<p class="em-only_endmatter-idx2">abnormalities of</p>
			<p class="em-only_endmatter-idx3">National Eye Institute classification of, 147</p>
			<p class="em-only_endmatter-idx3">nystagmus. <span class="italic">See</span> Nystagmus</p>
			<p class="em-only_endmatter-idx2">active force generation test, 73</p>
			<p class="em-only_endmatter-idx2">binocular</p>
			<p class="em-only_endmatter-idx3">vergences, 37, 39–40</p>
			<p class="em-only_endmatter-idx3">versions, 37–39</p>
			<p class="em-only_endmatter-idx2">electromyography of, 32–33</p>
			<p class="em-only_endmatter-idx2">forced duction test, 73</p>
			<p class="em-only_endmatter-idx2">monocular</p>
			<p class="em-only_endmatter-idx3">ductions, 33</p>
			<p class="em-only_endmatter-idx3">field of action, 33–34</p>
			<p class="em-only_endmatter-idx3">gaze position effects on extraocular muscle action, 34–37, 35–37<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">primary action, 34</p>
			<p class="em-only_endmatter-idx3">secondary action, 34</p>
			<p class="em-only_endmatter-idx3">terminology associated with, 33</p>
			<p class="em-only_endmatter-idx3">tertiary action, 34</p>
			<p class="em-only_endmatter-idx2">motor units, 32–33</p>
			<p class="em-only_endmatter-idx2">optokinetic system of, 40</p>
			<p class="em-only_endmatter-idx2">saccadic system of, 40</p>
			<p class="em-only_endmatter-idx2">saccadic velocity, 73</p>
			<p class="em-only_endmatter-idx2">smooth-&#173;pursuit system of, 40</p>
			<p class="em-only_endmatter-idx2">supranuclear control systems for, 40</p>
			<p class="em-only_endmatter-idx2">vergence system of, 40</p>
			<p class="em-only_endmatter-idx2">vestibular-&#173;ocular system of, 40</p>
			<p class="em-only_endmatter-idx-alpha">Fabry disease, 270, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Facial angiofibromas, 397</p>
			<p class="em-only_endmatter-idx1">Facial asymmetry, torticollis and, 82</p>
			<p class="em-only_endmatter-idx1">Facultative suppression, 49</p>
			<p class="em-only_endmatter-idx1">Fadenoperation, 128, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">FAF. <span class="italic">See</span> Fundus autofluorescence</p>
			<p class="em-only_endmatter-idx1">Familial dysautonomia, 271</p>
			<p class="em-only_endmatter-idx1">Familial exudative vitreoretinopathy (FEVR), 347–348, 348<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Familial juvenile systemic granulomatosis, 319</p>
			<p class="em-only_endmatter-idx1">Familial oculorenal syndromes, 391–392, 391–392<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Farkas canthal index, 191</p>
			<p class="em-only_endmatter-idx1">Fascia, orbital, 27</p>
			<p class="em-only_endmatter-idx1">Fascia bulbi, 26</p>
			<p class="em-only_endmatter-idx1"><span class="italic">FBN1</span> gene, 307</p>
			<p class="em-only_endmatter-idx1">Fells modification of Harada-&#173;Ito procedure, 167</p>
			<p class="em-only_endmatter-idx1">Fetal alcohol syndrome, 183, 211–212, 212<span class="italic">f</span>, 361</p>
			<p class="em-only_endmatter-idx1">FEVR. <span class="italic">See</span> Familial exudative vitreoretinopathy</p>
			<p class="em-only_endmatter-idx1">Fibrillin-1, 307</p>
			<p class="em-only_endmatter-idx1">Fibrin clots, 377</p>
			<p class="em-only_endmatter-idx1">Fibroblast growth &#173;factor receptor genes, 206</p>
			<p class="em-only_endmatter-idx1">Fibrous dysplasia, 222</p>
			<p class="em-only_endmatter-idx1">Fistula, congenital lacrimal, 228, 229<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Fixation</p>
			<p class="em-only_endmatter-idx2">alternating, 16</p>
			<p class="em-only_endmatter-idx2">amblyopia evaluations, 56–57</p>
			<p class="em-only_endmatter-idx2">assessments of, in preverbal &#173;children, 300</p>
			<p class="em-only_endmatter-idx2">eccentric</p>
			<p class="em-only_endmatter-idx3">anomalous ret&#173;i&#173;nal correspondence versus, 51</p>
			<p class="em-only_endmatter-idx3">definition of, 54</p>
			<p class="em-only_endmatter-idx2">maintained, 6</p>
			<p class="em-only_endmatter-idx2">monocular, 16</p>
			<p class="em-only_endmatter-idx2">near, 64</p>
			<p class="em-only_endmatter-idx2">steady, 6</p>
			<p class="em-only_endmatter-idx2">uncentral, 6</p>
			<p class="em-only_endmatter-idx2">uncentral, unsteady, and unmaintained, 6</p>
			<p class="em-only_endmatter-idx2">in visual acuity assessment in &#173;children, 5–6</p>
			<p class="em-only_endmatter-idx1">Fixation reflex, 300</p>
			<p class="em-only_endmatter-idx1">Fleischer rings, 254</p>
			<p class="em-only_endmatter-idx1">Flexner-&#173;Wintersteiner rosettes, 353</p>
			<p class="em-only_endmatter-idx1">Fluorescein angiography</p>
			<p class="em-only_endmatter-idx2">Best disease on, 342, 343<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Coats disease on, 359, 359<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Fluoroquinolones, for bacterial conjunctivitis, 240</p>
			<p class="em-only_endmatter-idx1">Folic acid supplementation, in methotrexate therapy, 322</p>
			<p class="em-only_endmatter-idx1">Follicular conjunctivitis, 241, 243</p>
			<p class="em-only_endmatter-idx1">Fontanelles, 204<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Forced duction testing</p>
			<p class="em-only_endmatter-idx2">for Brown syndrome, 137</p>
			<p class="em-only_endmatter-idx2">for consecutive esotropia, 95</p>
			<p class="em-only_endmatter-idx2">description of, 73</p>
			<p class="em-only_endmatter-idx2">for orbital floor fractures, 379</p>
			<p class="em-only_endmatter-idx1">Foreign body, corneal, 376</p>
			<p class="em-only_endmatter-idx1">Foreign-&#173;body granuloma, 170</p>
			<p class="em-only_endmatter-idx1">Form-&#173;vision deprivation amblyopia, 55</p>
			<p class="em-only_endmatter-idx1">Fornix incision, 162–163</p>
			<p class="em-only_endmatter-idx1">Foster modification, 167</p>
			<p class="em-only_endmatter-idx1">4<span class="greek_1">Δ</span> base-&#173;out prism test, 78<span class="italic">f</span>, 78–79</p>
			<p class="em-only_endmatter-idx1">Fourth nerve palsy, 140</p>
			<p class="em-only_endmatter-idx1">Fovea</p>
			<p class="em-only_endmatter-idx2">cone density in, 44</p>
			<p class="em-only_endmatter-idx2">development of, 44</p>
			<p class="em-only_endmatter-idx2">hypoplasia of, 154, 338, 406</p>
			<p class="em-only_endmatter-idx2">retinoschisis, 344</p>
			<p class="em-only_endmatter-idx1"><span class="italic">FOXC1</span> gene, 265</p>
			<p class="em-only_endmatter-idx1"><span class="italic">FOXL2</span> gene, 197</p>
			<p class="em-only_endmatter-idx1">Fractures</p>
			<p class="em-only_endmatter-idx2">blowout, 379</p>
			<p class="em-only_endmatter-idx2">orbital floor, 127–128, 128<span class="italic">f</span>, 379–380, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">orbital roof, 380, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">Francisella tularensis,</span> 240</p>
			<p class="em-only_endmatter-idx1">Fraser syndrome, 193</p>
			<p class="em-only_endmatter-idx1">Frisby Davis Distance Stereotest, 81</p>
			<p class="em-only_endmatter-idx1"><span class="italic">FRMD7</span> gene, 149, 153</p>
			<p class="em-only_endmatter-idx1">Frontalis suspension, for eyelid ptosis, 197</p>
			<p class="em-only_endmatter-idx1">Fucosidosis, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Full-&#173;time occlusion</p>
			<p class="em-only_endmatter-idx2">amblyopia treated with, 58</p>
			<p class="em-only_endmatter-idx2">reverse amblyopia caused by, 60</p>
			<p class="em-only_endmatter-idx1">Fundus</p>
			<p class="em-only_endmatter-idx2">examination of, in &#173;children, 12</p>
			<p class="em-only_endmatter-idx2">Leber congenital amaurosis findings, 336, 337<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ocular torticollis findings, 84</p>
			<p class="em-only_endmatter-idx2">optic disc drusen evaluations, 374</p>
			<p class="em-only_endmatter-idx2">primary congenital glaucoma–&#173;related findings, 284</p>
			<p class="em-only_endmatter-idx1">Fundus autofluorescence (FAF)</p>
			<p class="em-only_endmatter-idx2">Best disease on, 343<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Gardner syndrome on, 350<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">optic disc drusen on, 373<span class="italic">f</span>, 374</p>
			<p class="em-only_endmatter-idx2">Stargardt disease on, 340</p>
			<p class="em-only_endmatter-idx1">Fundus flavimaculatus, 339</p>
			<p class="em-only_endmatter-idx1">Fungal orbital cellulitis, 215</p>
			<p class="em-only_endmatter-idx1">Fusion</p>
			<p class="em-only_endmatter-idx2">binocular, 60, 91</p>
			<p class="em-only_endmatter-idx2">central, 42</p>
			<p class="em-only_endmatter-idx2">in cyclic strabismus, 93</p>
			<p class="em-only_endmatter-idx2">definition of, 42</p>
			<p class="em-only_endmatter-idx2">motor, 43</p>
			<p class="em-only_endmatter-idx2">peripheral, 51–52</p>
			<p class="em-only_endmatter-idx2">sensory, 43</p>
			<p class="em-only_endmatter-idx2">stereopsis, 43</p>
			<p class="em-only_endmatter-idx1">Fusional convergence, 39, 43, 72</p>
			<p class="em-only_endmatter-idx1">Fusional cyclovergence, 40</p>
			<p class="em-only_endmatter-idx1">Fusional divergence, 40, 72</p>
			<p class="em-only_endmatter-idx1">Fusional vergences, 72, 72<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Fusional vertical divergence, 40</p>
			<p class="em-only_endmatter-idx1">Fusion maldevelopment nystagmus syndrome, 83, 88, 95, 148, 150–151, 151<span class="italic">f</span>, 154</p>
			<p class="em-only_endmatter-idx-alpha">Galactosemia, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Galactosialidosis, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Gangliosidoses, 388–389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Gardner syndrome, 349, 350<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Gaucher disease, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Gaze</p>
			<p class="em-only_endmatter-idx2">cardinal positions of, 31, 32<span class="italic">f</span>, 35, 64</p>
			<p class="em-only_endmatter-idx2">direction of, 147</p>
			<p class="em-only_endmatter-idx2">downgaze, 38</p>
			<p class="em-only_endmatter-idx2">left, 37</p>
			<p class="em-only_endmatter-idx2">positions of, 31</p>
			<p class="em-only_endmatter-idx3">cardinal, 31, 32<span class="italic">f</span>, 35, 64</p>
			<p class="em-only_endmatter-idx3">definition of, 64</p>
			<p class="em-only_endmatter-idx3">diagnostic, 64</p>
			<p class="em-only_endmatter-idx3">extraocular muscle action and, 34–37</p>
			<p class="em-only_endmatter-idx3">field of action, 33</p>
			<p class="em-only_endmatter-idx3">ocular alignment assessment using, 64</p>
			<p class="em-only_endmatter-idx3">primary, 31, 64</p>
			<p class="em-only_endmatter-idx3">secondary diagnostic, 31</p>
			<p class="em-only_endmatter-idx3">for strabismus, 64</p>
			<p class="em-only_endmatter-idx3">tertiary diagnostic, 31</p>
			<p class="em-only_endmatter-idx3">for vertical strabismus, 64</p>
			<p class="em-only_endmatter-idx2">right, 37</p>
			<p class="em-only_endmatter-idx2">upgaze, 37</p>
			<p class="em-only_endmatter-idx1">General anesthesia, 174</p>
			<p class="em-only_endmatter-idx1">Gene therapy</p>
			<p class="em-only_endmatter-idx2">Leber congenital amaurosis treated with, 337</p>
			<p class="em-only_endmatter-idx2">Stargardt disease treated with, 340</p>
			<p class="em-only_endmatter-idx1">German measles, 410</p>
			<p class="em-only_endmatter-idx1">Germline mutations, 358</p>
			<p class="em-only_endmatter-idx1">Glaucoma</p>
			<p class="em-only_endmatter-idx2">&#173;after cataract surgery, 304</p>
			<p class="em-only_endmatter-idx2">childhood. <span class="italic">See</span> Childhood glaucoma</p>
			<p class="em-only_endmatter-idx2">corticosteroids as cause of, 321</p>
			<p class="em-only_endmatter-idx2">infantile, 230</p>
			<p class="em-only_endmatter-idx2">pediatric. <span class="italic">See</span> Childhood glaucoma</p>
			<p class="em-only_endmatter-idx2">port-&#173;wine stain and, 199</p>
			<p class="em-only_endmatter-idx2">retinopathy of prematurity as risk &#173;factor for, <br />334</p>
			<p class="em-only_endmatter-idx2">in Sturge-&#173;Weber syndrome, 401–402</p>
			<p class="em-only_endmatter-idx1">Glaucoma surgery, in uveitis patients, 323</p>
			<p class="em-only_endmatter-idx1">Global layer, of extraocular muscles, 24, 27</p>
			<p class="em-only_endmatter-idx1">Globe</p>
			<p class="em-only_endmatter-idx2">congenital and developmental anomalies of, 263</p>
			<p class="em-only_endmatter-idx2">luxation of, 207–208</p>
			<p class="em-only_endmatter-idx2">penetrating injury to, 376</p>
			<p class="em-only_endmatter-idx2">retraction of</p>
			<p class="em-only_endmatter-idx3">in Duane retraction syndrome, 134</p>
			<p class="em-only_endmatter-idx3">in induced convergence-&#173;retraction, 153</p>
			<p class="em-only_endmatter-idx1">Glycoproteinosis, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">GM<span class="subscript _idGenCharOverride-1">1</span> gangliosidoses, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">GM<span class="subscript _idGenCharOverride-1">2</span> gangliosidoses, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Goldenhar syndrome</p>
			<p class="em-only_endmatter-idx2">craniofacial malformations associated with, 210<span class="italic">f</span>, 210–211</p>
			<p class="em-only_endmatter-idx2">dermolipomas associated with, 256</p>
			<p class="em-only_endmatter-idx2">description of, 131</p>
			<p class="em-only_endmatter-idx2">epibulbar dermoids associated with, 256, 256<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Goldmann applanation, 281</p>
			<p class="em-only_endmatter-idx1">Gonioscopy, 282, 282<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Goniotomy</p>
			<p class="em-only_endmatter-idx2">primary congenital glaucoma treated with, 285, <br />286<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in uveitis patients, 323</p>
			<p class="em-only_endmatter-idx1"><span class="italic">GPR143</span> gene, 407</p>
			<p class="em-only_endmatter-idx1">Gradient method, for accommodative convergence/accommodation ratio mea&#173;sure&#173;ment, 71</p>
			<p class="em-only_endmatter-idx1">Granulocytic sarcoma, 218</p>
			<p class="em-only_endmatter-idx1">Granuloma</p>
			<p class="em-only_endmatter-idx2">foreign-&#173;body, 170</p>
			<p class="em-only_endmatter-idx2">macular, 317<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">pyogenic, 170, 171<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">unifocal eosinophilic, 219, 219<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Granulomatous arthritis, pediatric, 318</p>
			<p class="em-only_endmatter-idx1">Grating acuity</p>
			<p class="em-only_endmatter-idx2">definition of, 54</p>
			<p class="em-only_endmatter-idx2">in strabismic amblyopia, 54</p>
			<p class="em-only_endmatter-idx2">testing for, 8, 9<span class="italic">f</span>, 56–57</p>
			<p class="em-only_endmatter-idx1">Ground-in prisms, for nystagmus, 155</p>
			<p class="em-only_endmatter-idx-alpha">Haab striae, 260, 261<span class="italic">f</span>, 280<span class="italic">f</span>, 280–281</p>
			<p class="em-only_endmatter-idx1">Hagberg-&#173;Santavuori disease, infantile, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hangback recession, 163</p>
			<p class="em-only_endmatter-idx1">Harada-&#173;Ito procedure</p>
			<p class="em-only_endmatter-idx2">description of, 124</p>
			<p class="em-only_endmatter-idx2">Fells modification of, 167</p>
			<p class="em-only_endmatter-idx1">Harboyan syndrome, 259</p>
			<p class="em-only_endmatter-idx1">Harmonious anomalous ret&#173;i&#173;nal correspondence, 76</p>
			<p class="em-only_endmatter-idx1">Hay-&#173;Wells syndrome, 194</p>
			<p class="em-only_endmatter-idx1">Head trauma, abusive, 381–384, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Heimann-&#173;Bielschowsky phenomenon, 152</p>
			<p class="em-only_endmatter-idx1">Hemangioblastomas, 353, 400, 400<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hemangioma</p>
			<p class="em-only_endmatter-idx2">definition of, 219</p>
			<p class="em-only_endmatter-idx2">eyelid, 199</p>
			<p class="em-only_endmatter-idx2">orbital, 219–221</p>
			<p class="em-only_endmatter-idx2">plaque, 220, 220<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">propranolol for, 220, 221<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">systemic disease associated with, 220</p>
			<p class="em-only_endmatter-idx2">treatment of, 220–221</p>
			<p class="em-only_endmatter-idx1">Hemifacial microsomia, 210, 210<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Hemifacial spasm, 202</p>
			<p class="em-only_endmatter-idx1">Hemorrhages</p>
			<p class="em-only_endmatter-idx2">intralesional, 221, 221<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">peripapillary, 373</p>
			<p class="em-only_endmatter-idx2">ret&#173;i&#173;nal</p>
			<p class="em-only_endmatter-idx3">in abusive head trauma, 382–383, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">in leukemia, 414</p>
			<p class="em-only_endmatter-idx2">subarachnoid, 382</p>
			<p class="em-only_endmatter-idx2">subret&#173;i&#173;nal, 373</p>
			<p class="em-only_endmatter-idx1">Hepatolenticular degeneration. <span class="italic">See</span> Wilson disease</p>
			<p class="em-only_endmatter-idx1">Hereditary macular dystrophies</p>
			<p class="em-only_endmatter-idx2">Best disease, 340–342, 342<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Stargardt disease, 339–340, 340–341<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Hereditary vitreoretinopathies, familial exudative, 347–348, 348<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Hering’s law of motor correspondence, 38, 115–116, <br />121</p>
			<p class="em-only_endmatter-idx1">Hermansky-&#173;Pudlak syndrome, 407</p>
			<p class="em-only_endmatter-idx1">Herpes simplex virus (HSV)</p>
			<p class="em-only_endmatter-idx2">conjunctivitis caused by, 239, 242</p>
			<p class="em-only_endmatter-idx2">keratitis caused by, 269</p>
			<p class="em-only_endmatter-idx2">neonatal, 412</p>
			<p class="em-only_endmatter-idx2">ocular manifestations of, 412</p>
			<p class="em-only_endmatter-idx2">ophthalmia neonatorum caused by, 239</p>
			<p class="em-only_endmatter-idx1">Herpes zoster, 243, 243<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Hess screen, 120</p>
			<p class="em-only_endmatter-idx1">Heterochromia, pediatric iris, 274, 274<span class="italic">t</span>, 274<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Heteronymous diplopia, 75</p>
			<p class="em-only_endmatter-idx1">Heterophoria</p>
			<p class="em-only_endmatter-idx2">definition of, 15</p>
			<p class="em-only_endmatter-idx2">heterotropia versus, 64</p>
			<p class="em-only_endmatter-idx1">Heterophoria method, for accommodative convergence/accommodation ratio mea&#173;sure&#173;ment, 71</p>
			<p class="em-only_endmatter-idx1">Heterotopy, 28</p>
			<p class="em-only_endmatter-idx1">Heterotropia</p>
			<p class="em-only_endmatter-idx2">alternating, 64</p>
			<p class="em-only_endmatter-idx2">definition of, 15</p>
			<p class="em-only_endmatter-idx2">heterophoria versus, 64</p>
			<p class="em-only_endmatter-idx2">in monofixation syndrome, 51</p>
			<p class="em-only_endmatter-idx1">Hexosaminidase activator deficiency, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">High AC/A ratio</p>
			<p class="em-only_endmatter-idx2">in accommodative esotropia, 90–92</p>
			<p class="em-only_endmatter-idx2">bifocal glasses for, 102</p>
			<p class="em-only_endmatter-idx2">in intermittent exotropia, 100</p>
			<p class="em-only_endmatter-idx1">High myopia</p>
			<p class="em-only_endmatter-idx2">esotropia associated with, 97, 143–144</p>
			<p class="em-only_endmatter-idx2">exotropia associated with, 143–144</p>
			<p class="em-only_endmatter-idx1">Hirschberg test, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Histiocytosis&#160;X. <span class="italic">See</span> Langerhans cell histiocytosis</p>
			<p class="em-only_endmatter-idx1">HIV. <span class="italic">See</span> &#173;Human immunodeficiency virus</p>
			<p class="em-only_endmatter-idx1">Homer Wright rosettes, 353</p>
			<p class="em-only_endmatter-idx1">Homocystinuria, 308–309, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Homonymous diplopia, 75</p>
			<p class="em-only_endmatter-idx1">Homonymous hemianopia, 83</p>
			<p class="em-only_endmatter-idx1">Hordeola, 198–199</p>
			<p class="em-only_endmatter-idx1">Horizontal deviations</p>
			<p class="em-only_endmatter-idx2">in craniosynostosis, 208</p>
			<p class="em-only_endmatter-idx2">dissociated, 17, 105, 105<span class="italic">f</span>, 129</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery for, 161</p>
			<p class="em-only_endmatter-idx2">Maddox rod test for, 69</p>
			<p class="em-only_endmatter-idx1">Horizontal rectus muscles</p>
			<p class="em-only_endmatter-idx2">anatomy of, 20, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">inferior zone of, 24</p>
			<p class="em-only_endmatter-idx2">innervation of, 34</p>
			<p class="em-only_endmatter-idx2">in pattern strabismus, 109–110</p>
			<p class="em-only_endmatter-idx2">primary position of, 35, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">recession/resection of</p>
			<p class="em-only_endmatter-idx3">description of, 139</p>
			<p class="em-only_endmatter-idx3">for esodeviations, 160</p>
			<p class="em-only_endmatter-idx3">monocular, 161</p>
			<p class="em-only_endmatter-idx3">for nystagmus correction, 157</p>
			<p class="em-only_endmatter-idx2">superior zone of, 24</p>
			<p class="em-only_endmatter-idx2">transposition of, 110, 112</p>
			<p class="em-only_endmatter-idx1">Horizontal rotations, 31</p>
			<p class="em-only_endmatter-idx1">Horner syndrome, 274–275, 415<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Horner-&#173;Trantas dot, 248, 249<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Horopter</p>
			<p class="em-only_endmatter-idx2">definition of, 41</p>
			<p class="em-only_endmatter-idx2">empirical, 41, 42<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Horror fusionis, 48</p>
			<p class="em-only_endmatter-idx1">HOTV test, 6, 6<span class="italic">t</span>, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">HSV. <span class="italic">See</span> Herpes simplex virus</p>
			<p class="em-only_endmatter-idx1">&#173;Human immunodeficiency virus, 348</p>
			<p class="em-only_endmatter-idx1">Hunter syndrome, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hurler syndrome, 270, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hutchinson triad, 412</p>
			<p class="em-only_endmatter-idx1">Hyaloid artery, 366</p>
			<p class="em-only_endmatter-idx1">Hyper- (prefix), 15</p>
			<p class="em-only_endmatter-idx1">Hyperchromic heterochromia, 274<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hyperemia, conjunctival, 237, 238<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hyperopia, 180</p>
			<p class="em-only_endmatter-idx1">Hyperplasia, 183<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hypertelorism, ocular, 191</p>
			<p class="em-only_endmatter-idx1">Hypertropia</p>
			<p class="em-only_endmatter-idx2">dissociated vertical deviation and, 115</p>
			<p class="em-only_endmatter-idx2">exotropia associated with, 100</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery for, 164–165</p>
			<p class="em-only_endmatter-idx2">incomitant, 125</p>
			<p class="em-only_endmatter-idx2">inferior rectus muscle weakness as cause of, 128</p>
			<p class="em-only_endmatter-idx2">rectus muscle surgery for, 164–165</p>
			<p class="em-only_endmatter-idx2">superior oblique muscle palsy associated with, <br />123</p>
			<p class="em-only_endmatter-idx1">Hyphema, 378<span class="italic">f</span>, 378–379</p>
			<p class="em-only_endmatter-idx1">Hypo- (prefix), 16</p>
			<p class="em-only_endmatter-idx1">Hypoaccommodation, 9</p>
			<p class="em-only_endmatter-idx1">Hypochromic heterochromia, 274<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hypoplasia, 183<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Hypotelorism</p>
			<p class="em-only_endmatter-idx2">ocular, 191</p>
			<p class="em-only_endmatter-idx2">orbital, 203</p>
			<p class="em-only_endmatter-idx1">Hypotropia</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery for, 164–165</p>
			<p class="em-only_endmatter-idx2">high myopia associated with, 143–144</p>
			<p class="em-only_endmatter-idx2">in monocular elevation deficiency, 126, 126<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">primary position, with Brown syndrome, 137</p>
			<p class="em-only_endmatter-idx2">pseudoptosis associated with, 30</p>
			<p class="em-only_endmatter-idx2">rectus muscle surgery for, 164–165</p>
			<p class="em-only_endmatter-idx-alpha">Iatrogenic Brown syndrome, 168</p>
			<p class="em-only_endmatter-idx1">Icare tonometer, 10, 281</p>
			<p class="em-only_endmatter-idx1">I-&#173;cell disease, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">ICE syndrome. <span class="italic">See</span> Iridocorneal endothelial (ICE) syndrome</p>
			<p class="em-only_endmatter-idx1">ICP. <span class="italic">See</span> Intracranial pressure</p>
			<p class="em-only_endmatter-idx1">ICRB. <span class="italic">See</span> International Classification of Retinoblastoma</p>
			<p class="em-only_endmatter-idx1">ICROP. <span class="italic">See</span> International Classification of Retinopathy of Prematurity</p>
			<p class="em-only_endmatter-idx1">Idiopathic intracranial hypertension (IIH), 370<span class="italic">f</span>, 370–371</p>
			<p class="em-only_endmatter-idx1">IEP. <span class="italic">See</span> Individualized education plan</p>
			<p class="em-only_endmatter-idx1">IGF-&#173;I. <span class="italic">See</span> Insulin-&#173;like growth &#173;factor I, in retinopathy of prematurity pathophysiology</p>
			<p class="em-only_endmatter-idx1">IIH. <span class="italic">See</span> Idiopathic intracranial hypertension</p>
			<p class="em-only_endmatter-idx1"><span class="italic">IKBKAP</span> gene, 271</p>
			<p class="em-only_endmatter-idx1">Inborn errors of metabolism</p>
			<p class="em-only_endmatter-idx2">lens dislocation and, 306</p>
			<p class="em-only_endmatter-idx2">ocular findings in, 385, 387<span class="italic">f</span>, 388–389<span class="italic">t</span>, 390<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">prevalence of, 385</p>
			<p class="em-only_endmatter-idx1">Incisions</p>
			<p class="em-only_endmatter-idx2">fornix, 162–163</p>
			<p class="em-only_endmatter-idx2">limbal, 163</p>
			<p class="em-only_endmatter-idx1">Inclusion cysts, 250</p>
			<p class="em-only_endmatter-idx1">Incomitant deviation, 16</p>
			<p class="em-only_endmatter-idx1">Incomitant esotropia, 95–97, 96<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Incomitant strabismus</p>
			<p class="em-only_endmatter-idx2">abnormal head position caused by, 83</p>
			<p class="em-only_endmatter-idx2">prism alternate cover test for, 66</p>
			<p class="em-only_endmatter-idx1">Incomplete achromatopsia, 337</p>
			<p class="em-only_endmatter-idx1">Incontinentia pigmenti, 393<span class="italic">t</span>, 404<span class="italic">t</span>, 404–405, 404–405<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Incyclo- (prefix), 16</p>
			<p class="em-only_endmatter-idx1">Incyclodiplopia, 119</p>
			<p class="em-only_endmatter-idx1">Incycloduction, 33</p>
			<p class="em-only_endmatter-idx1">Individualized Education Plan (IEP), 188</p>
			<p class="em-only_endmatter-idx1">Induced convergence-&#173;retraction, 152–153</p>
			<p class="em-only_endmatter-idx1">Induced tropia test, 6</p>
			<p class="em-only_endmatter-idx1">Infant(s). <span class="italic">See also</span> Newborns</p>
			<p class="em-only_endmatter-idx2">abusive head trauma, 381–384, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">cataracts in, 293</p>
			<p class="em-only_endmatter-idx2">chlamydial infection in, 239</p>
			<p class="em-only_endmatter-idx2">cytomegalovirus infection in, 411, 411<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">delayed visual maturation in, 186–187</p>
			<p class="em-only_endmatter-idx2">extraocular muscles in, 181–182</p>
			<p class="em-only_endmatter-idx2">intraocular pressure in</p>
			<p class="em-only_endmatter-idx3">mea&#173;sure&#173;ment of, 181</p>
			<p class="em-only_endmatter-idx3">normal level of, 282</p>
			<p class="em-only_endmatter-idx2">ret&#173;i&#173;nal hemorrhage in, 382–383, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">vision in</p>
			<p class="em-only_endmatter-idx3">decreased, 187–188</p>
			<p class="em-only_endmatter-idx3">development of, 185</p>
			<p class="em-only_endmatter-idx3">impairments in, 186–187</p>
			<p class="em-only_endmatter-idx1">Infantile esotropia, 86<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">amblyopia associated with, 87–89</p>
			<p class="em-only_endmatter-idx2">botulinum toxin injections for, 89</p>
			<p class="em-only_endmatter-idx2">Chavasse theory of, 87</p>
			<p class="em-only_endmatter-idx2">Ciancia syndrome, 88, 95</p>
			<p class="em-only_endmatter-idx2">clinical features of, 87–88</p>
			<p class="em-only_endmatter-idx2">cross-&#173;fixation associated with, 87–88, 88<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">cyclopegic refraction for, 88</p>
			<p class="em-only_endmatter-idx2">definition of, 87</p>
			<p class="em-only_endmatter-idx2">evaluation of, 87–88</p>
			<p class="em-only_endmatter-idx2">management of, 88–89</p>
			<p class="em-only_endmatter-idx2">medial rectus muscle recession for, 89</p>
			<p class="em-only_endmatter-idx2">&#173;mental illness and, 87</p>
			<p class="em-only_endmatter-idx2">ocular alignment in, 88–89</p>
			<p class="em-only_endmatter-idx2">pathogenesis of, 87</p>
			<p class="em-only_endmatter-idx2">prematurity as risk &#173;factor for, 87</p>
			<p class="em-only_endmatter-idx2">smooth-&#173;pursuit asymmetry associated with, 88</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 89</p>
			<p class="em-only_endmatter-idx2">V-&#173;pattern strabismus associated with, 109, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">Worth “sensory” concept of, 87</p>
			<p class="em-only_endmatter-idx1">Infantile exotropia, 103–104, 104<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Infantile glaucoma. <span class="italic">See also</span> Primary congenital glaucoma</p>
			<p class="em-only_endmatter-idx2">corneal opacities associated with, 257<span class="italic">t</span>, 260, 261<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">description of, 230</p>
			<p class="em-only_endmatter-idx1">Infantile Hagberg-&#173;Santavuori disease, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Infantile malignant osteopetrosis, 212</p>
			<p class="em-only_endmatter-idx1">Infantile nystagmus syndrome, 83, 148–149, 149<span class="italic">t</span>, 156<span class="italic">f</span>, 187, 335</p>
			<p class="em-only_endmatter-idx1">Infantile strabismus</p>
			<p class="em-only_endmatter-idx2">description of, 16</p>
			<p class="em-only_endmatter-idx2">dissociated vertical deviation associated with, 129</p>
			<p class="em-only_endmatter-idx2">fusion maldevelopment nystagmus syndrome associated with, 151, 154</p>
			<p class="em-only_endmatter-idx2">primary inferior oblique muscle overaction associated with, 117</p>
			<p class="em-only_endmatter-idx1">Infection</p>
			<p class="em-only_endmatter-idx2">corneal, 257<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">eyelid disorders caused by, 198–199</p>
			<p class="em-only_endmatter-idx2">postoperative, 170, 170<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">preseptal cellulitis caused by, 212–213</p>
			<p class="em-only_endmatter-idx1">Inferior oblique muscle</p>
			<p class="em-only_endmatter-idx2">action of, 34<span class="italic">t</span>, 38<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">advancement of, 166</p>
			<p class="em-only_endmatter-idx2">anatomy of, 19<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">anteriorization/anterior transposition of</p>
			<p class="em-only_endmatter-idx3">anti-&#173;elevation syndrome caused by, 168</p>
			<p class="em-only_endmatter-idx3">description of, 166</p>
			<p class="em-only_endmatter-idx2">characteristics of, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">elevator function of, 73</p>
			<p class="em-only_endmatter-idx2">field of action for, 33</p>
			<p class="em-only_endmatter-idx2">innervation of</p>
			<p class="em-only_endmatter-idx3">description of, 19</p>
			<p class="em-only_endmatter-idx3">surgical considerations and, 29</p>
			<p class="em-only_endmatter-idx2">origin of, 20, 21<span class="italic">t</span>, 28</p>
			<p class="em-only_endmatter-idx2">overaction of</p>
			<p class="em-only_endmatter-idx3">bilateral, 117</p>
			<p class="em-only_endmatter-idx3">clinical features of, 117–118</p>
			<p class="em-only_endmatter-idx3">in craniosynostosis, 208</p>
			<p class="em-only_endmatter-idx3">description of, 17</p>
			<p class="em-only_endmatter-idx3">latent dissociated vertical deviation versus, 129–130</p>
			<p class="em-only_endmatter-idx3">management of, 118</p>
			<p class="em-only_endmatter-idx3">overelevation in adduction caused by, 117<span class="italic">f</span>, 117–118</p>
			<p class="em-only_endmatter-idx3">primary, 117</p>
			<p class="em-only_endmatter-idx3">secondary, 117</p>
			<p class="em-only_endmatter-idx3">in superior oblique muscle paralysis, 166</p>
			<p class="em-only_endmatter-idx3">V-&#173;pattern strabismus caused by, 107</p>
			<p class="em-only_endmatter-idx3">Y-&#173;pattern strabismus caused by, 113</p>
			<p class="em-only_endmatter-idx2">palsy of</p>
			<p class="em-only_endmatter-idx3">Brown syndrome versus, 124, 125<span class="italic">t</span>, 137</p>
			<p class="em-only_endmatter-idx3">clinical features of, 124, 124<span class="italic">f</span>, 125<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">management of, 124–125</p>
			<p class="em-only_endmatter-idx2">pseudo-&#173;overaction of, 109, 113</p>
			<p class="em-only_endmatter-idx2">pulley system, 28</p>
			<p class="em-only_endmatter-idx2">tightening of, 166</p>
			<p class="em-only_endmatter-idx2">transposition of</p>
			<p class="em-only_endmatter-idx3">anterior, 166</p>
			<p class="em-only_endmatter-idx2">underaction of, 17</p>
			<p class="em-only_endmatter-idx2">weakening of</p>
			<p class="em-only_endmatter-idx3">bilateral, 165</p>
			<p class="em-only_endmatter-idx3">indications for, 118</p>
			<p class="em-only_endmatter-idx3">for superior oblique muscle palsy, 123, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">surgical procedures for, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx3">for V-&#173;pattern strabismus, 111</p>
			<p class="em-only_endmatter-idx1">Inferior orbital vein, 23</p>
			<p class="em-only_endmatter-idx1">Inferior rectus muscle</p>
			<p class="em-only_endmatter-idx2">action of, 34<span class="italic">t</span>, 36<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">depressor function of, 73</p>
			<p class="em-only_endmatter-idx2">flap tears of, 127–128</p>
			<p class="em-only_endmatter-idx2">innervation of, 19</p>
			<p class="em-only_endmatter-idx2">lateral border of, 29</p>
			<p class="em-only_endmatter-idx2">neurofibrovascular bundle, 29</p>
			<p class="em-only_endmatter-idx2">origin of, 20, 22<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">recession/resection of</p>
			<p class="em-only_endmatter-idx3">description of, 29</p>
			<p class="em-only_endmatter-idx3">eyelid position affected by, 173</p>
			<p class="em-only_endmatter-idx2">surgery considerations for, 29</p>
			<p class="em-only_endmatter-idx2">weakening of</p>
			<p class="em-only_endmatter-idx3">for nystagmus, 156</p>
			<p class="em-only_endmatter-idx3">procedures for, 163, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Inferior rectus tendon, 19<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Inferonasal disc coloboma, 365<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Inflammation</p>
			<p class="em-only_endmatter-idx2">eyelid disorders associated with, 198–199</p>
			<p class="em-only_endmatter-idx2">nonspecific orbital, 215–216, 216<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">orbital, 215–216</p>
			<p class="em-only_endmatter-idx2">in uveitis, 320–322</p>
			<p class="em-only_endmatter-idx1">Infliximab, 322</p>
			<p class="em-only_endmatter-idx1">Infraduction, 33</p>
			<p class="em-only_endmatter-idx1">Infraorbital artery, 23</p>
			<p class="em-only_endmatter-idx1">INO. <span class="italic">See</span> Internuclear ophthalmoplegia</p>
			<p class="em-only_endmatter-idx1">Insulin-&#173;dependent diabetes mellitus, 408</p>
			<p class="em-only_endmatter-idx1">Insulin-&#173;like growth &#173;factor I (IGF-&#173;I), in retinopathy of prematurity pathophysiology, 325, 326<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Intermediate uveitis, 312<span class="italic">t</span>, 316, 316<span class="italic">f</span>, 320, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Intermittent exotropia</p>
			<p class="em-only_endmatter-idx2">age at onset, 99</p>
			<p class="em-only_endmatter-idx2">basic, 101</p>
			<p class="em-only_endmatter-idx2">characteristics of, 99–100</p>
			<p class="em-only_endmatter-idx2">control of, 100</p>
			<p class="em-only_endmatter-idx2">course of, 99</p>
			<p class="em-only_endmatter-idx2">dissociated horizontal deviation and, 105</p>
			<p class="em-only_endmatter-idx2">evaluation of, 100–101</p>
			<p class="em-only_endmatter-idx2">nonsurgical management of, 101–102</p>
			<p class="em-only_endmatter-idx2">normal ret&#173;i&#173;nal correspondence in, 99</p>
			<p class="em-only_endmatter-idx2">occlusion therapy for, 102</p>
			<p class="em-only_endmatter-idx2">patch test for, 101</p>
			<p class="em-only_endmatter-idx2">postoperative alignment, 102</p>
			<p class="em-only_endmatter-idx2">prisms for, 102</p>
			<p class="em-only_endmatter-idx2">recurrence of, 103</p>
			<p class="em-only_endmatter-idx2">refractive errors in, 101</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 102–103</p>
			<p class="em-only_endmatter-idx2">tenacious proximal fusion in, 71</p>
			<p class="em-only_endmatter-idx2">treatment of, 101–103</p>
			<p class="em-only_endmatter-idx1">Intermittent strabismus, 182</p>
			<p class="em-only_endmatter-idx1">Intermuscular septum, 28–29</p>
			<p class="em-only_endmatter-idx1">International Classification of Retinoblastoma (ICRB), 354, 356<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">International Classification of Retinopathy of Prematurity (ICROP), 325, 327<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Internuclear ophthalmoplegia (INO), 144</p>
			<p class="em-only_endmatter-idx1">Interpupillary distance, 203</p>
			<p class="em-only_endmatter-idx1">Intorsion</p>
			<p class="em-only_endmatter-idx2">A-&#173;pattern strabismus caused by, 107, 110</p>
			<p class="em-only_endmatter-idx2">definition of, 33</p>
			<p class="em-only_endmatter-idx1">Intraconal fat pads, 28</p>
			<p class="em-only_endmatter-idx1">Intraconal orbital abscesses, 214</p>
			<p class="em-only_endmatter-idx1">Intracranial pressure (ICP), 209, 370</p>
			<p class="em-only_endmatter-idx1">Intralesional hemorrhage, 221, 221<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Intranasal cysts, 229</p>
			<p class="em-only_endmatter-idx1">Intraocular lens (IOL)</p>
			<p class="em-only_endmatter-idx2">description of, 301</p>
			<p class="em-only_endmatter-idx2">issues associated with, 303–304</p>
			<p class="em-only_endmatter-idx2">lens dislocation treated with, 310</p>
			<p class="em-only_endmatter-idx2">lensectomy with, 302–304</p>
			<p class="em-only_endmatter-idx2">posterior capsulectomy/vitrectomy with, 303</p>
			<p class="em-only_endmatter-idx2">power calculations, 303</p>
			<p class="em-only_endmatter-idx1">Intraocular pressure (IOP)</p>
			<p class="em-only_endmatter-idx2">in childhood glaucoma, 277, 279, 290–291</p>
			<p class="em-only_endmatter-idx2">digital palpation of, 10</p>
			<p class="em-only_endmatter-idx2">follow-up for, 290–291</p>
			<p class="em-only_endmatter-idx2">in hyphema, 378</p>
			<p class="em-only_endmatter-idx2">mea&#173;sure&#173;ment of, in &#173;children</p>
			<p class="em-only_endmatter-idx3">description of, 10, 181</p>
			<p class="em-only_endmatter-idx3">tonometry for, 281</p>
			<p class="em-only_endmatter-idx2">medi&#173;cations for reducing, 288, 289<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">normal level of, 282</p>
			<p class="em-only_endmatter-idx1">Intrapapillary drusen, 373<span class="italic">f</span>, 373–374</p>
			<p class="em-only_endmatter-idx1">Intrauterine/perinatal infections</p>
			<p class="em-only_endmatter-idx2">cytomegalovirus, 411, 411<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">description of, 409</p>
			<p class="em-only_endmatter-idx2">herpes simplex virus, 412</p>
			<p class="em-only_endmatter-idx2">lymphocytic choriomeningitis, 413</p>
			<p class="em-only_endmatter-idx2">rubella, 410<span class="italic">f</span>, 410–411</p>
			<p class="em-only_endmatter-idx2">syphilis, 412–413</p>
			<p class="em-only_endmatter-idx2">toxoplasmosis, 409–410, 410<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Zika virus, 413</p>
			<p class="em-only_endmatter-idx1">Inverse Knapp procedure, 128</p>
			<p class="em-only_endmatter-idx1">IOL. <span class="italic">See</span> Intraocular lens</p>
			<p class="em-only_endmatter-idx1">IOP. <span class="italic">See</span> Intraocular pressure</p>
			<p class="em-only_endmatter-idx1">Iridocorneal endothelial (ICE) syndrome, 268</p>
			<p class="em-only_endmatter-idx1">Iridocyclitis, 412</p>
			<p class="em-only_endmatter-idx1">Iridodonesis, 306, 308</p>
			<p class="em-only_endmatter-idx1">Iris</p>
			<p class="em-only_endmatter-idx2">abnormalities of, 264–267, 264–267<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">aniridia, 266<span class="italic">f</span>, 266–267</p>
			<p class="em-only_endmatter-idx2">in Axenfeld-&#173;Rieger syndrome, 264–265, 264–265<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Brushfield spots of, 272</p>
			<p class="em-only_endmatter-idx2">coloboma of, 266, 266<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">congenital ectropion of, 267</p>
			<p class="em-only_endmatter-idx2">cysts of, 272<span class="italic">f</span>, 272–273</p>
			<p class="em-only_endmatter-idx2">in familial dysautonomia, 270</p>
			<p class="em-only_endmatter-idx2">growth and development of, 181</p>
			<p class="em-only_endmatter-idx2">heterochromia of, 274, 274<span class="italic">t</span>, 274<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">hypoplasia of, 264–267, 264–267<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">juvenile xanthogranuloma of, 271</p>
			<p class="em-only_endmatter-idx2">Lisch nodules of, 271–272, 272<span class="italic">f</span>, 392, 395<span class="italic">f</span>, 397</p>
			<p class="em-only_endmatter-idx2">mammillations of, 271–272, 272<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">nodules of, 271–272, 272<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">per&#173;sis&#173;tent pupillary membrane, 264, 264<span class="italic">f</span>, 266<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">pigment epithelium cysts, 272, 272<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">systemic conditions that affect, 269–270</p>
			<p class="em-only_endmatter-idx2">transillumination of, 265, 406, 407<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">tumors of, 271–273, 272<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in Waardenburg syndrome, 270</p>
			<p class="em-only_endmatter-idx1">Iris bomb<span class="accent">é</span>, 285</p>
			<p class="em-only_endmatter-idx1">Iris-&#173;claw lenses, 310</p>
			<p class="em-only_endmatter-idx1">Iritis, 412</p>
			<p class="em-only_endmatter-idx1">Isoametropic amblyopia, 55</p>
			<p class="em-only_endmatter-idx1">Isolated/simple ectopia lentis, 307</p>
			<p class="em-only_endmatter-idx-alpha">Jerk nystagmus, 147</p>
			<p class="em-only_endmatter-idx1">JIA. <span class="italic">See</span> Juvenile idiopathic arthritis</p>
			<p class="em-only_endmatter-idx1">JOAG. <span class="italic">See</span> Juvenile open-angle glaucoma</p>
			<p class="em-only_endmatter-idx1">Joubert syndrome, 144, 392, 392<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Juvenile ankylosing spondylitis, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Juvenile fibromatosis, 222</p>
			<p class="em-only_endmatter-idx1">Juvenile idiopathic arthritis (JIA), 312–315, 313–314<span class="italic">t</span>, 314<span class="italic">f</span>, 322</p>
			<p class="em-only_endmatter-idx1">Juvenile macular degeneration. <span class="italic">See</span> Stargardt disease</p>
			<p class="em-only_endmatter-idx1">Juvenile-&#173;onset vitelliform macular dystrophy. <span class="italic">See</span> Best disease</p>
			<p class="em-only_endmatter-idx1">Juvenile open-&#173;angle glaucoma (JOAG), 278, 284</p>
			<p class="em-only_endmatter-idx1">Juvenile ossifying fibroma, 222</p>
			<p class="em-only_endmatter-idx1">Juvenile psoriatic arthritis, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Juvenile ret&#173;i&#173;nal dystrophy, 390<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Juvenile retinoschisis</p>
			<p class="em-only_endmatter-idx2">abusive head trauma as cause of, 383</p>
			<p class="em-only_endmatter-idx2">description of, 342–343</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 344–345<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">treatment of, 344</p>
			<p class="em-only_endmatter-idx1">Juvenile spondyloarthropathies, 315, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Juvenile xanthogranuloma, 271</p>
			<p class="em-only_endmatter-idx-alpha">Kabuki syndrome, 195</p>
			<p class="em-only_endmatter-idx1">Kasabach-&#173;Merritt syndrome, 220</p>
			<p class="em-only_endmatter-idx1">Kawasaki disease, 316</p>
			<p class="em-only_endmatter-idx1">Kayser-&#173;Fleischer ring, 270</p>
			<p class="em-only_endmatter-idx1">Kearns-&#173;Sayre syndrome, 142</p>
			<p class="em-only_endmatter-idx1"><span class="italic">KERA</span> gene, 255</p>
			<p class="em-only_endmatter-idx1">Keratitis</p>
			<p class="em-only_endmatter-idx2">adenovirus caused by, 269</p>
			<p class="em-only_endmatter-idx2">congenital syphilis as cause of, 269</p>
			<p class="em-only_endmatter-idx2">corneal involvement, 269</p>
			<p class="em-only_endmatter-idx2">corneal scarring caused by, 245<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">diffuse superficial, 242</p>
			<p class="em-only_endmatter-idx2">in herpes simplex virus, 412</p>
			<p class="em-only_endmatter-idx2">herpes simplex virus as cause of, 269</p>
			<p class="em-only_endmatter-idx2">infectious, 269</p>
			<p class="em-only_endmatter-idx2">interstitial, 269</p>
			<p class="em-only_endmatter-idx2">noninfectious, 269</p>
			<p class="em-only_endmatter-idx2">nummular, 243</p>
			<p class="em-only_endmatter-idx2">punctate epithelial, 269</p>
			<p class="em-only_endmatter-idx2">Thygeson superficial punctate, 269</p>
			<p class="em-only_endmatter-idx1">Keratoconjunctivitis</p>
			<p class="em-only_endmatter-idx2">atopic, 249</p>
			<p class="em-only_endmatter-idx2">vernal, 248–249, 248–249<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Keratoconus, 254, 259</p>
			<p class="em-only_endmatter-idx1">Keratoglobus, 254</p>
			<p class="em-only_endmatter-idx1">Kerato-&#173;irido-&#173;lenticular dysgenesis. <span class="italic">See</span> Peters anomaly</p>
			<p class="em-only_endmatter-idx1">Keratoplasty, for corneal disorders, 262–263</p>
			<p class="em-only_endmatter-idx1">Kestenbaum procedure, for nystagmus, 155, 156<span class="italic">f</span>, 156<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Kleeblattsch<span class="accent">ä</span>del, 205</p>
			<p class="em-only_endmatter-idx1">Klippel-&#173;Tr<span class="accent">é</span>naunay syndrome (KTS), 406</p>
			<p class="em-only_endmatter-idx1">Klippel-&#173;Tr<span class="accent">é</span>naunay-&#173;Weber syndrome, 199, 251, <br />394<span class="italic">t</span>, 406</p>
			<p class="em-only_endmatter-idx1">Knapp procedure, 127</p>
			<p class="em-only_endmatter-idx2">inverse, 128</p>
			<p class="em-only_endmatter-idx1">Knobloch syndrome, 346<span class="italic">f</span>, 346–347</p>
			<p class="em-only_endmatter-idx1">Koeppe-&#173;type goniolens, 282, 282<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Krabbe disease, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Krimsky test, 67, 68<span class="italic">f</span>, 104<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">KTS. <span class="italic">See</span> Klippel-&#173;Tr<span class="accent">é</span>naunay syndrome</p>
			<p class="em-only_endmatter-idx-alpha">Labyrinth, 40</p>
			<p class="em-only_endmatter-idx1">Lacerations</p>
			<p class="em-only_endmatter-idx2">corneoscleral, 377</p>
			<p class="em-only_endmatter-idx2">eyelid, 378</p>
			<p class="em-only_endmatter-idx2">medial rectus muscle, 146</p>
			<p class="em-only_endmatter-idx1">Lacrimal artery, 23</p>
			<p class="em-only_endmatter-idx1">Lacrimal canaliculi atresia, 227–228, 228<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Lacrimal drainage system abnormalities</p>
			<p class="em-only_endmatter-idx2">congenital, 227–230</p>
			<p class="em-only_endmatter-idx2">congenital lacrimal fistula, 228, 229<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">dacryocystocele, 213, 225, 228–230, 229<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">lacrimal puncta or canaliculi atresia, 227–228, 228<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">obstruction. <span class="italic">See</span> Nasolacrimal duct obstruction</p>
			<p class="em-only_endmatter-idx1">Lacrimal fistula, congenital, 228, 229<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Lacrimal fossa, 181</p>
			<p class="em-only_endmatter-idx1">Lacrimal gland, ec&#173;topic, 226</p>
			<p class="em-only_endmatter-idx1">Lacrimal puncta atresia, 227–228, 228<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">λ-pattern strabismus</p>
			<p class="em-only_endmatter-idx2">clinical features of, 110</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 113</p>
			<p class="em-only_endmatter-idx1">Lamellar cataracts, 55, 296, 296<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Lamina cribrosa, 364</p>
			<p class="em-only_endmatter-idx1">Lancaster red-&#173;green test, 69, 120</p>
			<p class="em-only_endmatter-idx1">Langerhans cell histiocytosis (LCH), 218–219</p>
			<p class="em-only_endmatter-idx1">Lang stereopsis tests, 81</p>
			<p class="em-only_endmatter-idx1">Large-&#173;angle esotropias, 87</p>
			<p class="em-only_endmatter-idx1">Latent exodeviations, 99</p>
			<p class="em-only_endmatter-idx1">Latent nystagmus, 88, 95, 129, 150–151, 154</p>
			<p class="em-only_endmatter-idx1">Latent strabismus, 15</p>
			<p class="em-only_endmatter-idx1">Latent transforming growth &#173;factor beta-&#173;binding <br />protein 2 (LTBP2), 306</p>
			<p class="em-only_endmatter-idx1">Lateral geniculate body</p>
			<p class="em-only_endmatter-idx2">description of, 43</p>
			<p class="em-only_endmatter-idx2">neurons of, 44</p>
			<p class="em-only_endmatter-idx1">Lateral rectus muscle</p>
			<p class="em-only_endmatter-idx2">abduction of, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">action of, 34<span class="italic">t</span>, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">anomalous innervation of, 109</p>
			<p class="em-only_endmatter-idx2">characteristics of, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">contracture of, 109</p>
			<p class="em-only_endmatter-idx2">field of action, 33</p>
			<p class="em-only_endmatter-idx2">innervation of, 19</p>
			<p class="em-only_endmatter-idx2">lost, 95</p>
			<p class="em-only_endmatter-idx2">origin of, 20, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">recession/resection of</p>
			<p class="em-only_endmatter-idx3">for Duane retraction syndrome, 134</p>
			<p class="em-only_endmatter-idx3">for exodeviations, 160</p>
			<p class="em-only_endmatter-idx3">for high myopia, 143</p>
			<p class="em-only_endmatter-idx3">for intermittent exotropia, 102</p>
			<p class="em-only_endmatter-idx3">for third nerve palsy, 139</p>
			<p class="em-only_endmatter-idx3">for X-&#173;pattern strabismus, 113</p>
			<p class="em-only_endmatter-idx2">slipped, 95</p>
			<p class="em-only_endmatter-idx2">superior transposition of, 113</p>
			<p class="em-only_endmatter-idx1">Lateral rectus tendon, 19<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">LCA. <span class="italic">See</span> Leber congenital amaurosis</p>
			<p class="em-only_endmatter-idx1">LCH. <span class="italic">See</span> Langerhans cell histiocytosis</p>
			<p class="em-only_endmatter-idx1">LCMV. <span class="italic">See</span> Lymphocytic choriomeningitis virus</p>
			<p class="em-only_endmatter-idx1">LEA Grating Acuity Test, 8</p>
			<p class="em-only_endmatter-idx1">LEA symbols, 6, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Leber congenital amaurosis (LCA), 335–336, 337<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Leber hereditary optic neuropathy, 368</p>
			<p class="em-only_endmatter-idx1">Left hypotropia (LHoT), 17</p>
			<p class="em-only_endmatter-idx1">Left jerk nystagmus, 148<span class="italic">f</span>, 150</p>
			<p class="em-only_endmatter-idx1">Lens</p>
			<p class="em-only_endmatter-idx2">dislocation of</p>
			<p class="em-only_endmatter-idx3">conditions associated with, 306<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">description of, 306</p>
			<p class="em-only_endmatter-idx3">ectopia lentis et pupillae, 267–268, 307, 307<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">in homocystinuria, 308–309</p>
			<p class="em-only_endmatter-idx3">illustration of, 306<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">inborn errors of metabolism and, 306</p>
			<p class="em-only_endmatter-idx3">iridodonesis with, 306</p>
			<p class="em-only_endmatter-idx3">isolated/simple ectopia lentis, 307</p>
			<p class="em-only_endmatter-idx3">in Marfan syndrome, 307–308, 308<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">refractive error caused by, 310</p>
			<p class="em-only_endmatter-idx3">in sulfite oxidase deficiency, 310</p>
			<p class="em-only_endmatter-idx3">treatment of, 310</p>
			<p class="em-only_endmatter-idx3">in Weill-&#173;Marchesani syndrome, 309</p>
			<p class="em-only_endmatter-idx2">iris-&#173;claw, 310</p>
			<p class="em-only_endmatter-idx2">luxated, 268, 306, 390<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">subluxation of</p>
			<p class="em-only_endmatter-idx3">description of, 268, 306</p>
			<p class="em-only_endmatter-idx3">in homocystinuria, 309</p>
			<p class="em-only_endmatter-idx3">in Marfan syndrome, 308<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">surgery for, 310</p>
			<p class="em-only_endmatter-idx1">Lens disorders</p>
			<p class="em-only_endmatter-idx2">coloboma, 305<span class="italic">f</span>, 305–306</p>
			<p class="em-only_endmatter-idx2">congenital aphakia, 305</p>
			<p class="em-only_endmatter-idx2">spherophakia, 305</p>
			<p class="em-only_endmatter-idx1">Lensectomy, 302, 410</p>
			<p class="em-only_endmatter-idx1">Lentiglobus, 296</p>
			<p class="em-only_endmatter-idx1">Leptomeningeal vascular malformation, 401<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Leukemia, 218, 413–414</p>
			<p class="em-only_endmatter-idx1">Leukocoria, 299, 351, 351<span class="italic">t</span>, 351<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Levator palpebrae superioris muscle</p>
			<p class="em-only_endmatter-idx2">action of, 34<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">anatomy of, 19<span class="italic">f</span>, 26<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">characteristics of, 21<span class="italic">t</span>, 22</p>
			<p class="em-only_endmatter-idx2">innervation of, 19</p>
			<p class="em-only_endmatter-idx2">origin of, 21<span class="italic">t</span>, 22</p>
			<p class="em-only_endmatter-idx2">superior rectus muscle attachment to, 29</p>
			<p class="em-only_endmatter-idx1">Levocycloversion, 38</p>
			<p class="em-only_endmatter-idx1">Levoversion, 37</p>
			<p class="em-only_endmatter-idx1">LHoT. <span class="italic">See</span> Left hypotropia</p>
			<p class="em-only_endmatter-idx1">Light&#173;house chart, 7</p>
			<p class="em-only_endmatter-idx1">Ligneous conjunctivitis, 249</p>
			<p class="em-only_endmatter-idx1">Limbal incision, 163</p>
			<p class="em-only_endmatter-idx1">Limbal vernal keratoconjunctivitis, 248, 249<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Lipidoses, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Lipodermoids, 210</p>
			<p class="em-only_endmatter-idx1">Lipofuscin, 340</p>
			<p class="em-only_endmatter-idx1">Lisch nodules, 271–272, 272<span class="italic">f</span>, 392, 395<span class="italic">f</span>, 397</p>
			<p class="em-only_endmatter-idx1">Listing’s law, 31</p>
			<p class="em-only_endmatter-idx1">Listing’s plane, 31</p>
			<p class="em-only_endmatter-idx1">Lobular capillary hemangioma. <span class="italic">See</span> Pyogenic granuloma</p>
			<p class="em-only_endmatter-idx1">Lockwood ligament, 28</p>
			<p class="em-only_endmatter-idx1">LogMAR visual acuity chart, 7<span class="italic">f</span>, 8</p>
			<p class="em-only_endmatter-idx1">Louis-&#173;Bar syndrome. <span class="italic">See</span> Ataxia-&#173;telangiectasia</p>
			<p class="em-only_endmatter-idx1">Lower eyelid, inferior rectus muscle attachment to, 30<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Lowe syndrome, 391</p>
			<p class="em-only_endmatter-idx1">Low vision</p>
			<p class="em-only_endmatter-idx2">information sources on, 189<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">rehabilitation for, 188–189, 189<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">LTBP2. <span class="italic">See</span> Latent transforming growth &#173;factor <br />beta-&#173;binding protein 2</p>
			<p class="em-only_endmatter-idx1"><span class="italic">LTBP2</span> gene, 277</p>
			<p class="em-only_endmatter-idx1">Lymphangioma, 221</p>
			<p class="em-only_endmatter-idx1">Lymphatic malformation, orbital, 221–222</p>
			<p class="em-only_endmatter-idx1">Lymphocytic choriomeningitis virus (LCMV), 413</p>
			<p class="em-only_endmatter-idx1">Lymphoma</p>
			<p class="em-only_endmatter-idx2">Burkitt, 218</p>
			<p class="em-only_endmatter-idx2">orbital, 218</p>
			<p class="em-only_endmatter-idx-alpha">MAC. <span class="italic">See</span> Microphthalmia, anophthalmia, coloboma</p>
			<p class="em-only_endmatter-idx1">Macrolides, for blepharitis, 245</p>
			<p class="em-only_endmatter-idx1">Macular dragging, in retinopathy of prematurity, 334, 334<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Macular dystrophies, hereditary</p>
			<p class="em-only_endmatter-idx2">Best disease, 340–342, 342<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Stargardt disease, 339–340, 340–341<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Macular edema, &#173;after cataract surgery, 304–305</p>
			<p class="em-only_endmatter-idx1">Macular granuloma, 317<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Maddox rod test</p>
			<p class="em-only_endmatter-idx2">double, 69, 69<span class="italic">f</span>, 120</p>
			<p class="em-only_endmatter-idx2">ocular alignment assessments using, 68–69, 69<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Magnetic resonance imaging</p>
			<p class="em-only_endmatter-idx2">optic nerve on, 363<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Sturge-&#173;Weber syndrome findings, 402<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Maintained fixation, 6</p>
			<p class="em-only_endmatter-idx1">Major amblyoscope, 70, 70<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Malherbe calcifying epitheliomas. <span class="italic">See</span> Pilomatricoma</p>
			<p class="em-only_endmatter-idx1">Malignant hyperthermia (MH), 174–175</p>
			<p class="em-only_endmatter-idx1">Malignant osteopetrosis, infantile, 212</p>
			<p class="em-only_endmatter-idx1">Mammillations, iris, 271–272, 272<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Mandibulofacial dysostosis. <span class="italic">See</span> Treacher Collins syndrome</p>
			<p class="em-only_endmatter-idx1">Manifest exodeviations, 99</p>
			<p class="em-only_endmatter-idx1">Manifest latent nystagmus, 88, 95, 151</p>
			<p class="em-only_endmatter-idx1">Manifest strabismus, 15</p>
			<p class="em-only_endmatter-idx1">Mannosidosis, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Marcus Gunn jaw-&#173;winking syndrome, 198</p>
			<p class="em-only_endmatter-idx1">Marfan syndrome</p>
			<p class="em-only_endmatter-idx2">cardiovascular abnormalities associated with, 307–308</p>
			<p class="em-only_endmatter-idx2">clinical features of, 307, 308<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">lens dislocation associated with, 307–308, 308<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ocular abnormalities associated with, 308, 308<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Marginal myotomy, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Margin–&#173;reflex distance (MRD), 197</p>
			<p class="em-only_endmatter-idx1">Maroteaux-&#173;Lamy syndrome, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Masked bilateral superior oblique muscle palsy, 122</p>
			<p class="em-only_endmatter-idx1">Mast-&#173;cell stabilizers, for ocular allergies, 247<span class="italic">t</span>, 248</p>
			<p class="em-only_endmatter-idx1">Medial longitudinal fasciculus (MLF), 144</p>
			<p class="em-only_endmatter-idx1">Medial rectus muscle</p>
			<p class="em-only_endmatter-idx2">action of, 31, 34<span class="italic">t</span>, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">adduction of, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">botulinum toxin injection of, 97</p>
			<p class="em-only_endmatter-idx2">characteristics of, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">displacement of, for A-&#173;pattern strabismus, 110, 111<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">excision of, 146</p>
			<p class="em-only_endmatter-idx2">field of action, 33</p>
			<p class="em-only_endmatter-idx2">inadvertent excision of, 146</p>
			<p class="em-only_endmatter-idx2">innervation of, 19</p>
			<p class="em-only_endmatter-idx2">laceration of, 146</p>
			<p class="em-only_endmatter-idx2">origin of, 20, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">recession/resection of</p>
			<p class="em-only_endmatter-idx3">for convergence insufficiency, 103</p>
			<p class="em-only_endmatter-idx3">for Duane retraction syndrome, 133</p>
			<p class="em-only_endmatter-idx3">for esotropia from nystagmus blockage syndrome, 155</p>
			<p class="em-only_endmatter-idx3">for infantile esotropia, 89</p>
			<p class="em-only_endmatter-idx3">for internuclear ophthalmoplegia, 144</p>
			<p class="em-only_endmatter-idx3">for M<span class="accent">ö</span>bius syndrome, 136</p>
			<p class="em-only_endmatter-idx2">restriction of, 97</p>
			<p class="em-only_endmatter-idx2">slipped, 169, 169<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">surgery considerations for, 29</p>
			<p class="em-only_endmatter-idx1">Medial rectus tendon, 19<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Medulloepithelioma, 273<span class="italic">f</span>, 273–274</p>
			<p class="em-only_endmatter-idx1">Megalocornea, 253<span class="italic">f</span>, 253–254</p>
			<p class="em-only_endmatter-idx1">Megalopapilla, 366</p>
			<p class="em-only_endmatter-idx1">Meibomian glands</p>
			<p class="em-only_endmatter-idx2">blepharitis with dysfunction of, 244, 244<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">distichiasis of, 195, 195<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Melanocytic lesions, 392, 395<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Melanocytoma, of optic disc, 367, 367<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Melanocytosis, ocular, 250–251, 251<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Melanosis oculi, 250–251</p>
			<p class="em-only_endmatter-idx1">Melphalan, 357</p>
			<p class="em-only_endmatter-idx1">Membranous conjunctivitis, 251</p>
			<p class="em-only_endmatter-idx1">Meningioma, orbital, 223</p>
			<p class="em-only_endmatter-idx1">Meningocele, 225</p>
			<p class="em-only_endmatter-idx1">Metachromatic leukodystrophy, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Metastases</p>
			<p class="em-only_endmatter-idx2">orbital neuroblastoma, 414, 415<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">orbital tumors, 218</p>
			<p class="em-only_endmatter-idx1">Methicillin-&#173;resistant <span class="italic">Staphylococcus aureus</span> (MRSA), 213, 240</p>
			<p class="em-only_endmatter-idx1">Methotrexate, for uveitis, 322</p>
			<p class="em-only_endmatter-idx1"><span class="italic">MFRP</span> gene, 263</p>
			<p class="em-only_endmatter-idx1">MGDA. <span class="italic">See</span> Morning glory disc anomaly</p>
			<p class="em-only_endmatter-idx1">MH. <span class="italic">See</span> Malignant hyperthermia</p>
			<p class="em-only_endmatter-idx1">Microcornea, 254, 254<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Microphthalmia</p>
			<p class="em-only_endmatter-idx2">with cyst, 224, 225<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">description of, 209</p>
			<p class="em-only_endmatter-idx1">Microphthalmia, anophthalmia, coloboma (MAC), 263</p>
			<p class="em-only_endmatter-idx1">Microspherophakia, 307</p>
			<p class="em-only_endmatter-idx1">Microtropia, 51</p>
			<p class="em-only_endmatter-idx1">Mitten deformity, 206, 207<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Mittendorf dot, 298</p>
			<p class="em-only_endmatter-idx1">MLF. <span class="italic">See</span> Medial longitudinal fasciculus</p>
			<p class="em-only_endmatter-idx1">M<span class="accent">ö</span>bius syndrome, 97, 135–136, 136<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">“Molar tooth” sign, 392<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Molluscum contagiosum, 199, 243, 244</p>
			<p class="em-only_endmatter-idx1">Molybdenum cofactor deficiency. <span class="italic">See</span> Sulfite oxidase deficiency</p>
			<p class="em-only_endmatter-idx1">Monocanalicular stents, 234</p>
			<p class="em-only_endmatter-idx1">Monochromatism</p>
			<p class="em-only_endmatter-idx2">blue-&#173;cone, 337–338</p>
			<p class="em-only_endmatter-idx2">rod, 337</p>
			<p class="em-only_endmatter-idx1">Monoclonal antibodies, 322</p>
			<p class="em-only_endmatter-idx1">Monocular cover-&#173;uncover test, 64, 65<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Monocular elevation deficiency, 125–127, 126<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Monocular eye movements</p>
			<p class="em-only_endmatter-idx2">ductions, 33</p>
			<p class="em-only_endmatter-idx2">field of action, 33–34</p>
			<p class="em-only_endmatter-idx2">gaze position effects on extraocular muscle action, 34–37, 35–37<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">primary action, 34</p>
			<p class="em-only_endmatter-idx2">secondary action, 34</p>
			<p class="em-only_endmatter-idx2">terminology associated with, 33</p>
			<p class="em-only_endmatter-idx2">tertiary action, 34</p>
			<p class="em-only_endmatter-idx1">Monocular fixation, 16</p>
			<p class="em-only_endmatter-idx1">Monocular nystagmus, 152</p>
			<p class="em-only_endmatter-idx1">Monocular visual deprivation</p>
			<p class="em-only_endmatter-idx2">binocularity affected by, 45</p>
			<p class="em-only_endmatter-idx2">description of, 44</p>
			<p class="em-only_endmatter-idx2">visual cortex affected by, 45</p>
			<p class="em-only_endmatter-idx1">Monofixation syndrome</p>
			<p class="em-only_endmatter-idx2">amblyopia and, 52</p>
			<p class="em-only_endmatter-idx2">definition of, 51</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 51–52</p>
			<p class="em-only_endmatter-idx2">management of, 52</p>
			<p class="em-only_endmatter-idx2">Worth 4-&#173;dot test for, 81</p>
			<p class="em-only_endmatter-idx1">Monosomy X, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Morning glory disc anomaly (MGDA), 362–363, 364<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Morquio syndrome, 270</p>
			<p class="em-only_endmatter-idx1">Motility disorders</p>
			<p class="em-only_endmatter-idx2">chronic progressive external ophthalmoplegia (CPEO), 141–142, 143<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">esotropia and hypotropia associated with high myopia, 143–144</p>
			<p class="em-only_endmatter-idx2">internuclear ophthalmoplegia, 144</p>
			<p class="em-only_endmatter-idx2">myasthenia gravis, 142<span class="italic">f</span>, 142–143, 143<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">ocular motor apraxia, 144–145</p>
			<p class="em-only_endmatter-idx2">superior oblique myokymia, 145</p>
			<p class="em-only_endmatter-idx2">thyroid eye disease, 140–141, 141<span class="italic">f</span>, 143<span class="italic">t</span>, 215</p>
			<p class="em-only_endmatter-idx1">Motor fusion, 43</p>
			<p class="em-only_endmatter-idx1">Motor physiology</p>
			<p class="em-only_endmatter-idx2">eye movements. <span class="italic">See</span> Eye movements</p>
			<p class="em-only_endmatter-idx2">gaze positions, 31</p>
			<p class="em-only_endmatter-idx2">ocular rotations, 31</p>
			<p class="em-only_endmatter-idx2">princi&#173;ples of, 31–32</p>
			<p class="em-only_endmatter-idx2">terminology associated with, 31–32</p>
			<p class="em-only_endmatter-idx1">Motor units</p>
			<p class="em-only_endmatter-idx2">description of, 32–33</p>
			<p class="em-only_endmatter-idx2">recruitment of, during fixation or following movement, 33</p>
			<p class="em-only_endmatter-idx1">Moyamoya disease, 363</p>
			<p class="em-only_endmatter-idx1">MPS. <span class="italic">See</span> Mucopolysaccharidoses</p>
			<p class="em-only_endmatter-idx1">MRD. <span class="italic">See</span> Margin–reflex distance</p>
			<p class="em-only_endmatter-idx1">MRSA. <span class="italic">See</span> Methicillin-&#173;resistant <span class="italic">Staphylococcus aureus</span></p>
			<p class="em-only_endmatter-idx1">Mucocele, 224</p>
			<p class="em-only_endmatter-idx1">Mucocutaneous lymph node syndrome. <span class="italic">See</span> Kawasaki disease</p>
			<p class="em-only_endmatter-idx1">Mucolipidoses, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Mucopolysaccharidoses (MPSs), corneal disorders in, 257<span class="italic">t</span>, 270, 385, 387<span class="italic">f</span>, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Mucormycosis, 215, 215<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Multifocal choroiditis, 319</p>
			<p class="em-only_endmatter-idx1">Multifocal eosinophilic granuloma, 219</p>
			<p class="em-only_endmatter-idx1">Muscle cone, 26, 26<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Myasthenia gravis, 142<span class="italic">f</span>, 142–143, 143<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">Mycobacterium leprae,</span> 240</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Mycobacterium tuberculosis,</span> 240</p>
			<p class="em-only_endmatter-idx1">Mycophenolate mofetil, for uveitis, 322</p>
			<p class="em-only_endmatter-idx1">Mydriasis, congenital, 268</p>
			<p class="em-only_endmatter-idx1">Myectomy, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Myelinated ret&#173;i&#173;nal nerve fiber layer, 365, 365<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Myelin sheaths, 44</p>
			<p class="em-only_endmatter-idx1">Myofibromas, 222</p>
			<p class="em-only_endmatter-idx1">Myokymia, superior oblique, 145</p>
			<p class="em-only_endmatter-idx1">Myopia</p>
			<p class="em-only_endmatter-idx2">high</p>
			<p class="em-only_endmatter-idx3">esotropia associated with, 97, 143–144</p>
			<p class="em-only_endmatter-idx3">exotropia associated with, 143–144</p>
			<p class="em-only_endmatter-idx2">prevalence of, 180</p>
			<p class="em-only_endmatter-idx2">in retinopathy of prematurity, 334</p>
			<p class="em-only_endmatter-idx1">Myotomy, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx-alpha">Nanophthalmos, 263</p>
			<p class="em-only_endmatter-idx1">Nasal endoscopy, for nasolacrimal duct obstruction, 235</p>
			<p class="em-only_endmatter-idx1">Nasolacrimal duct obstruction (NLDO)</p>
			<p class="em-only_endmatter-idx2">congenital</p>
			<p class="em-only_endmatter-idx3">antibiotics for, 231–232, 234</p>
			<p class="em-only_endmatter-idx3">balloon dacryoplasty for, 234–235, 235<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">bilateral, 232<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">clinical features of, 230, 232<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">complex, 230, 233–234</p>
			<p class="em-only_endmatter-idx3">description of, 227, 230</p>
			<p class="em-only_endmatter-idx3">examination of, 230</p>
			<p class="em-only_endmatter-idx3">infantile glaucoma versus, 230</p>
			<p class="em-only_endmatter-idx3">intubation for, 234–235</p>
			<p class="em-only_endmatter-idx3">massage for, 231–232</p>
			<p class="em-only_endmatter-idx3">nasolacrimal probing for, 232–235, 233<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">nonsurgical management of, 231–232</p>
			<p class="em-only_endmatter-idx3">prevalence of, 230</p>
			<p class="em-only_endmatter-idx3">recurrence of, 234</p>
			<p class="em-only_endmatter-idx3">&#173;simple, 230, 231<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">spontaneous resolution of, 231</p>
			<p class="em-only_endmatter-idx3">stents for, 234–235</p>
			<p class="em-only_endmatter-idx3">surgical management of, 232–233</p>
			<p class="em-only_endmatter-idx3">tearing caused by, 230</p>
			<p class="em-only_endmatter-idx2">dacryocystorhinostomy for, 236</p>
			<p class="em-only_endmatter-idx2">nasal endoscopy for, 235</p>
			<p class="em-only_endmatter-idx2">in older &#173;children, 235</p>
			<p class="em-only_endmatter-idx2">recurrent, 234</p>
			<p class="em-only_endmatter-idx1">Nasolacrimal probing, for congenital nasolacrimal duct obstruction, 232–235, 233<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">National Eye Institute (NEI) classification of eye movement abnormalities, 147</p>
			<p class="em-only_endmatter-idx1"><span class="italic">NDP</span> gene, 347</p>
			<p class="em-only_endmatter-idx1">Nd:YAG &#173;laser capsulotomy, 302</p>
			<p class="em-only_endmatter-idx1">Near fixation, 64</p>
			<p class="em-only_endmatter-idx1">Near point of convergence, 71</p>
			<p class="em-only_endmatter-idx1">Near reflex spasm, 94</p>
			<p class="em-only_endmatter-idx1">Near synkinesis, 39</p>
			<p class="em-only_endmatter-idx1">Near triad, 39</p>
			<p class="em-only_endmatter-idx1">Negative &#173;angle kappa, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">NEI classification of eye movement abnormalities, 147</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Neisseria gonorrhoeae,</span> 238<span class="italic">f</span>, 238–239</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Neisseria meningitidis,</span> 238</p>
			<p class="em-only_endmatter-idx1">Neonatal inclusion conjunctivitis, 238</p>
			<p class="em-only_endmatter-idx1">Neoplasms, orbital. <span class="italic">See also</span> Tumor(s)</p>
			<p class="em-only_endmatter-idx2">benign, 219–223</p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 216–217</p>
			<p class="em-only_endmatter-idx2">eyelid, 199–200</p>
			<p class="em-only_endmatter-idx2">hemangiomas, 219–221</p>
			<p class="em-only_endmatter-idx2">hematopoietic, 218–219</p>
			<p class="em-only_endmatter-idx2">histiocytic, 218–219</p>
			<p class="em-only_endmatter-idx2">Langerhans cell histiocytosis, 218–219</p>
			<p class="em-only_endmatter-idx2">leukemia, 218</p>
			<p class="em-only_endmatter-idx2">lymphoma, 218</p>
			<p class="em-only_endmatter-idx2">lymphoproliferative, 218–219</p>
			<p class="em-only_endmatter-idx2">metastatic, 218</p>
			<p class="em-only_endmatter-idx2">neuroblastoma, 218</p>
			<p class="em-only_endmatter-idx2">primary malignant, 217–218</p>
			<p class="em-only_endmatter-idx2">rhabdomyosarcoma, 217<span class="italic">f</span>, 217–218</p>
			<p class="em-only_endmatter-idx2">sarcomas, 218</p>
			<p class="em-only_endmatter-idx2">vascular, 219–221, 220–221<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Nettleship-&#173;Falls ocular albinism, 407</p>
			<p class="em-only_endmatter-idx1">Neural tumors, 223</p>
			<p class="em-only_endmatter-idx1">Neuroblastoma, 218, 414–415, 415<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Neurofibromatosis type 1 (NF1)</p>
			<p class="em-only_endmatter-idx2">clinical features of, 393<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">manifestations of, 396–397</p>
			<p class="em-only_endmatter-idx2">melanocytic lesions in, 392, 395<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">neuroglial lesions in, 395<span class="italic">f</span>, 395–396</p>
			<p class="em-only_endmatter-idx2">plexiform neurofibromas in, 395<span class="italic">f</span>, 395–396</p>
			<p class="em-only_endmatter-idx2">sphenoid dysplasia associated with, 397</p>
			<p class="em-only_endmatter-idx1">Neurofibromatosis type 2 (NF2), 393<span class="italic">t</span>, 397</p>
			<p class="em-only_endmatter-idx1">Neurofibrovascular bundle, 29</p>
			<p class="em-only_endmatter-idx1">Neuroglial lesions, 395<span class="italic">f</span>, 395–396</p>
			<p class="em-only_endmatter-idx1">Neuroimaging</p>
			<p class="em-only_endmatter-idx2">ce&#173;re&#173;bral visual impairment evaluations, 188</p>
			<p class="em-only_endmatter-idx2">superior oblique muscle palsy evaluations, 119</p>
			<p class="em-only_endmatter-idx1">Neuromuscular blocking agents, 174</p>
			<p class="em-only_endmatter-idx1">Neuronal ceroid lipofuscinosis, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Neuro-&#173;oculocutaneous syndromes</p>
			<p class="em-only_endmatter-idx2">ataxia-&#173;telangiectasia, 393<span class="italic">t</span>, 403<span class="italic">f</span>, 403<span class="italic">t</span>, 403–404</p>
			<p class="em-only_endmatter-idx2">characteristics of, 392</p>
			<p class="em-only_endmatter-idx2">clinical features of, 393–394<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">incontinentia pigmenti, 393<span class="italic">t</span>, 404<span class="italic">t</span>, 404–405, 404–405<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Klippel-&#173;Tr<span class="accent">é</span>naunay syndrome (KTS), 406</p>
			<p class="em-only_endmatter-idx2">neurofibromatosis type 1. <span class="italic">See</span> Neurofibromatosis type 1</p>
			<p class="em-only_endmatter-idx2">neurofibromatosis type 2, 393<span class="italic">t</span>, 397</p>
			<p class="em-only_endmatter-idx2">tuberous sclerosis, 393<span class="italic">t</span>, 397–399, 398<span class="italic">f</span>, 398<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">von Hippel–&#173;Lindau syndrome, 393<span class="italic">t</span>, 399–401, 400<span class="italic">f</span>, 400<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">Wyburn-&#173;Mason syndrome, 222, 394<span class="italic">t</span>, 405<span class="italic">t</span>, 405–406</p>
			<p class="em-only_endmatter-idx1">Neuroretinitis, 369, 369<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Neutral density filter effect, 54</p>
			<p class="em-only_endmatter-idx1">Nevi/nevus</p>
			<p class="em-only_endmatter-idx2">conjunctival, 250, 250<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">eyelid, 200–201, 201<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">flammeus. <span class="italic">See</span> Port-&#173;wine stain</p>
			<p class="em-only_endmatter-idx2">of Ota, 251</p>
			<p class="em-only_endmatter-idx1">Newborns. <span class="italic">See also</span> Infant(s)</p>
			<p class="em-only_endmatter-idx2">dysconjugate eye movements in, 185</p>
			<p class="em-only_endmatter-idx2">extraocular muscles in, 182</p>
			<p class="em-only_endmatter-idx2">pupils in, 10</p>
			<p class="em-only_endmatter-idx2">skew deviation in, 185</p>
			<p class="em-only_endmatter-idx2">sunsetting in, 185</p>
			<p class="em-only_endmatter-idx2">visual acuity of, 44</p>
			<p class="em-only_endmatter-idx2">visual development in, 185</p>
			<p class="em-only_endmatter-idx1">Newcastle Control Score for Intermittent Exotropia, 100</p>
			<p class="em-only_endmatter-idx1">Next-&#173;generation gene sequencing, 301</p>
			<p class="em-only_endmatter-idx1">NF1. <span class="italic">See</span> Neurofibromatosis type 1</p>
			<p class="em-only_endmatter-idx1">NF2. <span class="italic">See</span> Neurofibromatosis type 2</p>
			<p class="em-only_endmatter-idx1">Niemann-&#173;Pick disease, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">NLDO. <span class="italic">See</span> Nasolacrimal duct obstruction</p>
			<p class="em-only_endmatter-idx1"><span class="italic">NOD2</span> gene, 319</p>
			<p class="em-only_endmatter-idx1">Nonaccidental trauma</p>
			<p class="em-only_endmatter-idx2">abusive head trauma, 381–384, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ocular injury secondary to, 384</p>
			<p class="em-only_endmatter-idx1">Nonalternating suppression, 49</p>
			<p class="em-only_endmatter-idx1">Nonrefractive accommodative esotropia, 90</p>
			<p class="em-only_endmatter-idx1">Nonspecific orbital inflammation (NSOI), 215–216, 216<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Nonsteroidal anti-&#173;inflammatory drugs, for ocular allergies, 247<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Normal ret&#173;i&#173;nal correspondence (NRC)</p>
			<p class="em-only_endmatter-idx2">afterimage test for, 79<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in intermittent exotropia, 100</p>
			<p class="em-only_endmatter-idx2">strabismus and, 48, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">testing for, 51</p>
			<p class="em-only_endmatter-idx1">Norrie disease, 347</p>
			<p class="em-only_endmatter-idx1">NRC. <span class="italic">See</span> Normal ret&#173;i&#173;nal correspondence</p>
			<p class="em-only_endmatter-idx1">NSOI. <span class="italic">See</span> Nonspecific orbital inflammation</p>
			<p class="em-only_endmatter-idx1">Nuclear cataracts</p>
			<p class="em-only_endmatter-idx2">infantile, 295, 296<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in rubella, 410</p>
			<p class="em-only_endmatter-idx1">Null point/zone</p>
			<p class="em-only_endmatter-idx2">in congenital motor nystagmus, 148, 156</p>
			<p class="em-only_endmatter-idx2">in jerk nystagmus, 147</p>
			<p class="em-only_endmatter-idx1">Nummular keratitis, 243</p>
			<p class="em-only_endmatter-idx1">Nystagmus</p>
			<p class="em-only_endmatter-idx2">acquired, 151–152</p>
			<p class="em-only_endmatter-idx2">Anderson procedure for, 155</p>
			<p class="em-only_endmatter-idx2">central vestibular instability, 149</p>
			<p class="em-only_endmatter-idx2">chin-&#173;down position, 156</p>
			<p class="em-only_endmatter-idx2">chin-up position, 156</p>
			<p class="em-only_endmatter-idx2">congenital motor, 148–149, 149<span class="italic">t</span>, 153–154</p>
			<p class="em-only_endmatter-idx2">congenital sensory, 149, 150<span class="italic">t</span>, 154</p>
			<p class="em-only_endmatter-idx2">convergence-&#173;retraction, 152–153</p>
			<p class="em-only_endmatter-idx2">definition of, 147</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 84</p>
			<p class="em-only_endmatter-idx2">downbeat, 152</p>
			<p class="em-only_endmatter-idx2">dysconjugate, 151–152</p>
			<p class="em-only_endmatter-idx2">esotropia and, 86<span class="italic">t</span>, 95</p>
			<p class="em-only_endmatter-idx2">evaluation of, 153–154</p>
			<p class="em-only_endmatter-idx2">features of, 147</p>
			<p class="em-only_endmatter-idx2">fusion maldevelopment nystagmus syndrome, 83, 88, 95, 148, 150–151, 151<span class="italic">f</span>, 154</p>
			<p class="em-only_endmatter-idx2">gaze direction and, 147</p>
			<p class="em-only_endmatter-idx2">head-tilt correction in, 156</p>
			<p class="em-only_endmatter-idx2">in hereditary ret&#173;i&#173;nal disease, 335</p>
			<p class="em-only_endmatter-idx2">history-&#173;taking for, 153</p>
			<p class="em-only_endmatter-idx2">horizontal rectus muscle surgery for, 157</p>
			<p class="em-only_endmatter-idx2">induced convergence-&#173;retraction, 152–153</p>
			<p class="em-only_endmatter-idx2">infantile nystagmus syndrome, 83, 148–149, 149<span class="italic">t</span>, 156<span class="italic">f</span>, 187, 335</p>
			<p class="em-only_endmatter-idx2">inheritance patterns, 153</p>
			<p class="em-only_endmatter-idx2">jerk, 147</p>
			<p class="em-only_endmatter-idx2">Kestenbaum procedure for, 155, 156<span class="italic">f</span>, 156<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">latent, 88, 95, 129, 150–151, 154</p>
			<p class="em-only_endmatter-idx2">manifest latent, 88, 95, 151</p>
			<p class="em-only_endmatter-idx2">monocular, 152</p>
			<p class="em-only_endmatter-idx2">monocular occlusion effects on intensity of, 154</p>
			<p class="em-only_endmatter-idx2">nomenclature for, 147</p>
			<p class="em-only_endmatter-idx2">ocular examination for, 153–154</p>
			<p class="em-only_endmatter-idx2">pendular, 147</p>
			<p class="em-only_endmatter-idx2">periodic alternating, 149</p>
			<p class="em-only_endmatter-idx2">prevalence of, 147</p>
			<p class="em-only_endmatter-idx2">prisms for, 155</p>
			<p class="em-only_endmatter-idx2">pupil responses in, 154</p>
			<p class="em-only_endmatter-idx2">ret&#173;i&#173;nal dystrophy and, 391<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">see-&#173;saw, 152</p>
			<p class="em-only_endmatter-idx2">sensory, 187</p>
			<p class="em-only_endmatter-idx2">spasmus nutans syndrome, 151–152</p>
			<p class="em-only_endmatter-idx2">strabismus associated with, 154, 156–157</p>
			<p class="em-only_endmatter-idx2">surgery for, 155–157, 156<span class="italic">f</span>, 156<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">treatment of, 155–157</p>
			<p class="em-only_endmatter-idx2">vertical, 152</p>
			<p class="em-only_endmatter-idx2">visual acuity assessments in, 8, 153–154</p>
			<p class="em-only_endmatter-idx1">Nystagmus blockage syndrome, 95, 148, 155</p>
			<p class="em-only_endmatter-idx1">Nystagmus-&#173;like disorders, 152–153</p>
			<p class="em-only_endmatter-idx-alpha">Oblique muscles</p>
			<p class="em-only_endmatter-idx2">anatomy of, 20–22, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">inferior. <span class="italic">See</span> Inferior oblique muscle</p>
			<p class="em-only_endmatter-idx2">overactions of, 17, 117</p>
			<p class="em-only_endmatter-idx2">pseudo-&#173;overactions, 116</p>
			<p class="em-only_endmatter-idx2">superior. <span class="italic">See</span> Superior oblique muscle</p>
			<p class="em-only_endmatter-idx2">tightening procedures for, 164<span class="italic">t</span>, 166–167</p>
			<p class="em-only_endmatter-idx2">weakening procedures for, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx1">Occlusion therapy</p>
			<p class="em-only_endmatter-idx2">adherence to, 60</p>
			<p class="em-only_endmatter-idx2">amblyopia treated with, 58, 96, 102</p>
			<p class="em-only_endmatter-idx2">basic acquired nonaccommodative esotropia secondary to, 93</p>
			<p class="em-only_endmatter-idx2">full-&#173;time, 58, 60</p>
			<p class="em-only_endmatter-idx2">intermittent exotropia treated with, 102</p>
			<p class="em-only_endmatter-idx2">part-&#173;time, 58</p>
			<p class="em-only_endmatter-idx2">reverse amblyopia caused by, 60</p>
			<p class="em-only_endmatter-idx1"><span class="italic">OCRL</span> gene, 391</p>
			<p class="em-only_endmatter-idx1">OCT. <span class="italic">See</span> Optical coherence tomography</p>
			<p class="em-only_endmatter-idx1">Ocular adnexa</p>
			<p class="em-only_endmatter-idx2">abnormalities of, in craniosynostosis, 209</p>
			<p class="em-only_endmatter-idx2">description of, 181</p>
			<p class="em-only_endmatter-idx1">Ocular albinism, 406–407. <span class="italic">See also</span> Albinism</p>
			<p class="em-only_endmatter-idx1">Ocular alignment</p>
			<p class="em-only_endmatter-idx2">assessment of</p>
			<p class="em-only_endmatter-idx3">alternate cover test, 65–66, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">corneal light reflex tests, 67–68, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">cover tests, 64–67, 65–66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">diagnostic positions of gaze, 64</p>
			<p class="em-only_endmatter-idx3">Lancaster red-&#173;green test for, 69</p>
			<p class="em-only_endmatter-idx3">Maddox rod test, 68–69, 69<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">major amblyoscope for, 70, 70<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">monocular cover test, 64, 65<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">prism alternate cover test, 65–66, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">red reflex tests, 67–68</p>
			<p class="em-only_endmatter-idx3">simultaneous prism and cover test, 66–67</p>
			<p class="em-only_endmatter-idx3">subjective tests for, 68–70</p>
			<p class="em-only_endmatter-idx2">&#173;after extraocular muscle surgery, 168</p>
			<p class="em-only_endmatter-idx2">in infantile esotropia, 88–89</p>
			<p class="em-only_endmatter-idx1">Ocular allergies, 246<span class="italic">f</span>, 246–249, 247<span class="italic">t</span>, 248<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Ocular hypertelorism, 191</p>
			<p class="em-only_endmatter-idx1">Ocular hypotelorism, 191</p>
			<p class="em-only_endmatter-idx1">Ocular instability of infancy, 87</p>
			<p class="em-only_endmatter-idx1">Ocular melanocytosis, 250–251, 251<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ocular motor apraxia, 144–145</p>
			<p class="em-only_endmatter-idx1">Ocular rotations</p>
			<p class="em-only_endmatter-idx2">assessment of, 71</p>
			<p class="em-only_endmatter-idx2">definition of, 31</p>
			<p class="em-only_endmatter-idx2">horizontal, 31</p>
			<p class="em-only_endmatter-idx2">torsional, 31</p>
			<p class="em-only_endmatter-idx2">tube shunt effects on, 146</p>
			<p class="em-only_endmatter-idx2">vertical, 31</p>
			<p class="em-only_endmatter-idx1">“Ocular splits,” 133</p>
			<p class="em-only_endmatter-idx1">Ocular tics, 201–202</p>
			<p class="em-only_endmatter-idx1">Ocular torsion, 107</p>
			<p class="em-only_endmatter-idx1">Ocular torticollis, 82–84, 83<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Oculocardiac reflex, 174</p>
			<p class="em-only_endmatter-idx1">Oculocerebrorenal syndrome. <span class="italic">See</span> Lowe syndrome</p>
			<p class="em-only_endmatter-idx1">Oculocutaneous albinism. <span class="italic">See</span> Albinism</p>
			<p class="em-only_endmatter-idx1">Oculodermal melanocytosis, 251</p>
			<p class="em-only_endmatter-idx1">Oculodigital reflex, 185</p>
			<p class="em-only_endmatter-idx1">Oculomotor nerve</p>
			<p class="em-only_endmatter-idx2">divisions of, 19</p>
			<p class="em-only_endmatter-idx2">extraocular muscle innervation by, 19–20</p>
			<p class="em-only_endmatter-idx2">palsy of. <span class="italic">See</span> Third nerve palsy</p>
			<p class="em-only_endmatter-idx2">superior division palsy of, 128</p>
			<p class="em-only_endmatter-idx1">ODAd. <span class="italic">See</span> Overdepression in adduction</p>
			<p class="em-only_endmatter-idx1">OEAd. <span class="italic">See</span> Overelevation in adduction</p>
			<p class="em-only_endmatter-idx1">OMIM, 294</p>
			<p class="em-only_endmatter-idx1">1 toy, 1 look rule, for pediatric eye examination, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">OPA1</span> gene, 367</p>
			<p class="em-only_endmatter-idx1">Open-&#173;angle glaucoma</p>
			<p class="em-only_endmatter-idx2">aphakic, 285</p>
			<p class="em-only_endmatter-idx2">juvenile, 278, 284</p>
			<p class="em-only_endmatter-idx1">Ophthalmia neonatorum</p>
			<p class="em-only_endmatter-idx2"><span class="italic">Chlamydia trachomatis</span> as cause of, 238–239, 239<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">definition of, 237</p>
			<p class="em-only_endmatter-idx2">epidemiology of, 237</p>
			<p class="em-only_endmatter-idx2">etiology of, 237</p>
			<p class="em-only_endmatter-idx2">herpes simplex virus as cause of, 239</p>
			<p class="em-only_endmatter-idx2"><span class="italic">Neisseria gonorrhoeae</span> as cause of, 238<span class="italic">f</span>, 238–239</p>
			<p class="em-only_endmatter-idx2"><span class="italic">Neisseria meningitidis</span> as cause of, 238</p>
			<p class="em-only_endmatter-idx2">prevalence of, 237</p>
			<p class="em-only_endmatter-idx2">prophylaxis for, 239</p>
			<p class="em-only_endmatter-idx1">Ophthalmic artery, 23</p>
			<p class="em-only_endmatter-idx1">Ophthalmic examination, in &#173;children</p>
			<p class="em-only_endmatter-idx2">anterior segment examination, 10</p>
			<p class="em-only_endmatter-idx2">Br<span class="accent">ü</span>ckner test, 9</p>
			<p class="em-only_endmatter-idx2">communication during, 4</p>
			<p class="em-only_endmatter-idx2">cycloplegic refraction, 10–12</p>
			<p class="em-only_endmatter-idx2">difficult child, 5</p>
			<p class="em-only_endmatter-idx2">distance fixation targets, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">dynamic retinoscopy, 9</p>
			<p class="em-only_endmatter-idx2">fundus, 12</p>
			<p class="em-only_endmatter-idx2">general considerations and strategies for, 3–5</p>
			<p class="em-only_endmatter-idx2">intraocular pressure mea&#173;sure&#173;ment, 10</p>
			<p class="em-only_endmatter-idx2">1 toy, 1 look rule, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in outpatient setting, 3, 4<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">practitioner positioning during, 4</p>
			<p class="em-only_endmatter-idx2">pupil testing, 10</p>
			<p class="em-only_endmatter-idx2">red reflex, 9</p>
			<p class="em-only_endmatter-idx2">“safe” environment for, 4</p>
			<p class="em-only_endmatter-idx2">slit-&#173;lamp examination, 4–5</p>
			<p class="em-only_endmatter-idx2">tonometry, 10</p>
			<p class="em-only_endmatter-idx2">visual acuity assessment. <span class="italic">See</span> &#173;Children, visual acuity assessment</p>
			<p class="em-only_endmatter-idx2">visual field testing, 10</p>
			<p class="em-only_endmatter-idx2">vocabulary during, 4</p>
			<p class="em-only_endmatter-idx1">Opsoclonus, 153, 415</p>
			<p class="em-only_endmatter-idx1">Optical coherence tomography (OCT)</p>
			<p class="em-only_endmatter-idx2">optic disc drusen on, 373<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in primary congenital glaucoma evaluations, <br />283</p>
			<p class="em-only_endmatter-idx1">Optic atrophy</p>
			<p class="em-only_endmatter-idx2">Behr, 368</p>
			<p class="em-only_endmatter-idx2">&#173;causes of, 367, 367<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">dominant, 367–368, 368<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Leber hereditary optic neuropathy, 368</p>
			<p class="em-only_endmatter-idx2">recessive, 368</p>
			<p class="em-only_endmatter-idx1">Optic disc</p>
			<p class="em-only_endmatter-idx2">coloboma of, 339<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">cupping of, 187, 402<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">drusen of, 373<span class="italic">f</span>, 373–374</p>
			<p class="em-only_endmatter-idx2">megalopapilla, 366</p>
			<p class="em-only_endmatter-idx2">melanocytoma of, 367, 367<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">papilledema of</p>
			<p class="em-only_endmatter-idx3">definition of, 370</p>
			<p class="em-only_endmatter-idx3">idiopathic intracranial hypertension and, 370<span class="italic">f</span>, 370–371</p>
			<p class="em-only_endmatter-idx2">peripapillary staphyloma of, 366</p>
			<p class="em-only_endmatter-idx2">pseudopapilledema of, 372–373<span class="italic">f</span>, 372–374</p>
			<p class="em-only_endmatter-idx2">swelling of, 371<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">tilted, 365–366, 366<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Optic disc cup, 282, 283<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Optic nerve</p>
			<p class="em-only_endmatter-idx2">aplasia of, 366</p>
			<p class="em-only_endmatter-idx2">coloboma of, 364–365<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">craniosynostosis-&#173;related abnormalities of, 208–209</p>
			<p class="em-only_endmatter-idx2">decussation of, 43</p>
			<p class="em-only_endmatter-idx2">developmental anomalies of, 361–367, 362–367<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">hypoplasia of, 154, 361–362, 362<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">leukemic infiltration of, 414, 414<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">magnetic resonance imaging of, 363<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">morning glory disc anomaly of, 362–363, 364<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">myelination of, 365, 365<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in primary congenital glaucoma, 282–283, 283<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Optic nerve pit, 364–365, 365<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Optic neuritis, 369, 369<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Optic neuropathy, traumatic, 381</p>
			<p class="em-only_endmatter-idx1">Optic pathway glioma, 223, 396, 396<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Optokinetic system, 40</p>
			<p class="em-only_endmatter-idx1">Optotypes</p>
			<p class="em-only_endmatter-idx2">age-&#173;appropriate, 8</p>
			<p class="em-only_endmatter-idx2">contour interaction bars around, 7<span class="italic">f</span>, 8, 54</p>
			<p class="em-only_endmatter-idx2">crowding phenomenon for, 54</p>
			<p class="em-only_endmatter-idx2">LEA symbols, 6, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">for visual acuity assessment in &#173;children, 6<span class="italic">t</span>, 6–8, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Orbit</p>
			<p class="em-only_endmatter-idx2">adipose tissue in, 25</p>
			<p class="em-only_endmatter-idx2">development of, 181</p>
			<p class="em-only_endmatter-idx2">extraocular muscles in, 25–28, 26–27<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">fascia of, 27</p>
			<p class="em-only_endmatter-idx2">morphologic mea&#173;sure&#173;ments of, 191, 192<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Orbital cellulitis, 170, 170<span class="italic">f</span>, 213–215, 214<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Orbital disorders</p>
			<p class="em-only_endmatter-idx2">craniosynostosis. <span class="italic">See</span> Craniosynostosis</p>
			<p class="em-only_endmatter-idx2">dermoid cysts, 223–224, 223–224<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ec&#173;topic lacrimal gland, 226</p>
			<p class="em-only_endmatter-idx2">ec&#173;topic tissue masses, 223–225<span class="italic">f</span>, 223–226</p>
			<p class="em-only_endmatter-idx2">encephalocele, 225</p>
			<p class="em-only_endmatter-idx2">inflammation, 215–216</p>
			<p class="em-only_endmatter-idx2">malformations</p>
			<p class="em-only_endmatter-idx3">arteriovenous, 222</p>
			<p class="em-only_endmatter-idx3">lymphatic, 221–222</p>
			<p class="em-only_endmatter-idx3">vascular, 221–222</p>
			<p class="em-only_endmatter-idx3">venous, 222</p>
			<p class="em-only_endmatter-idx2">meningocele, 225</p>
			<p class="em-only_endmatter-idx2">metastatic tumors, 218</p>
			<p class="em-only_endmatter-idx2">microphthalmia with cyst, 224, 225<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">mucocele, 224</p>
			<p class="em-only_endmatter-idx2">mucormycosis, 215, 215<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">neoplasms</p>
			<p class="em-only_endmatter-idx3">benign, 219–223</p>
			<p class="em-only_endmatter-idx3">differential diagnosis of, 216–217</p>
			<p class="em-only_endmatter-idx3">hemangiomas, 219–221</p>
			<p class="em-only_endmatter-idx3">hematopoietic, 218–219</p>
			<p class="em-only_endmatter-idx3">histiocytic, 218–219</p>
			<p class="em-only_endmatter-idx3">Langerhans cell histiocytosis, 218–219</p>
			<p class="em-only_endmatter-idx3">leukemia, 218</p>
			<p class="em-only_endmatter-idx3">lymphoma, 218</p>
			<p class="em-only_endmatter-idx3">lymphoproliferative, 218–219</p>
			<p class="em-only_endmatter-idx3">metastatic, 218</p>
			<p class="em-only_endmatter-idx3">neuroblastoma, 218</p>
			<p class="em-only_endmatter-idx3">primary malignant, 217–218</p>
			<p class="em-only_endmatter-idx3">rhabdomyosarcoma, 217<span class="italic">f</span>, 217–218</p>
			<p class="em-only_endmatter-idx3">sarcomas, 218</p>
			<p class="em-only_endmatter-idx3">vascular, 219–221, 220–221<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">orbital cellulitis, 213–215, 214<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">preseptal cellulitis, 212–214</p>
			<p class="em-only_endmatter-idx2">space-&#173;occupying lesions, 216</p>
			<p class="em-only_endmatter-idx2">teratoma, 225<span class="italic">f</span>, 225–226</p>
			<p class="em-only_endmatter-idx2">tumors</p>
			<p class="em-only_endmatter-idx3">bony, 222</p>
			<p class="em-only_endmatter-idx3">connective tissue origin, 222</p>
			<p class="em-only_endmatter-idx3">neural origin, 223</p>
			<p class="em-only_endmatter-idx1">Orbital floor fractures, 127–128, 128<span class="italic">f</span>, 379–380, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Orbital layer, of extraocular muscles, 24</p>
			<p class="em-only_endmatter-idx1">Orbital myositis, 216</p>
			<p class="em-only_endmatter-idx1">Orbital roof fractures, 380, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Orbital veins, 23</p>
			<p class="em-only_endmatter-idx1">Orthophoria</p>
			<p class="em-only_endmatter-idx2">abbreviation for, 17</p>
			<p class="em-only_endmatter-idx2">definition of, 15</p>
			<p class="em-only_endmatter-idx1">Orthoptics</p>
			<p class="em-only_endmatter-idx2">convergence insufficiency treated with, 103</p>
			<p class="em-only_endmatter-idx2">fusional vergence affected by, 72</p>
			<p class="em-only_endmatter-idx2">for suppression, 50</p>
			<p class="em-only_endmatter-idx1">Orthotropia</p>
			<p class="em-only_endmatter-idx2">definition of, 15</p>
			<p class="em-only_endmatter-idx2">treatment of, 58</p>
			<p class="em-only_endmatter-idx1">Otoliths, 40</p>
			<p class="em-only_endmatter-idx1">Overdepression in adduction (ODAd)</p>
			<p class="em-only_endmatter-idx2">&#173;causes of, 17, 116<span class="italic">t</span>, 116–118</p>
			<p class="em-only_endmatter-idx2">description of, 17</p>
			<p class="em-only_endmatter-idx2">pattern strabismus and, 107, 108<span class="italic">f</span>, 109</p>
			<p class="em-only_endmatter-idx2">superior oblique muscle overaction as cause of, 118, 118<span class="italic">f</span>, 137</p>
			<p class="em-only_endmatter-idx1">Overelevation in adduction (OEAd)</p>
			<p class="em-only_endmatter-idx2">&#173;causes of, 17, 116<span class="italic">t</span>, 116–118</p>
			<p class="em-only_endmatter-idx2">description of, 17</p>
			<p class="em-only_endmatter-idx2">inferior oblique muscle overaction as cause of, 117<span class="italic">f</span>, 117–118</p>
			<p class="em-only_endmatter-idx2">pattern strabismus and, 107, 108<span class="italic">f</span>, 109</p>
			<p class="em-only_endmatter-idx-alpha">Palpebral fissure</p>
			<p class="em-only_endmatter-idx2">in blepharophimosis–&#173;ptosis–&#173;epicanthus inversus syndrome (BPES), 198</p>
			<p class="em-only_endmatter-idx2">in Brown syndrome, 137</p>
			<p class="em-only_endmatter-idx2">in cryptophthalmos, 191</p>
			<p class="em-only_endmatter-idx2">dermolipomas of, 257</p>
			<p class="em-only_endmatter-idx2">downward-&#173;slanting</p>
			<p class="em-only_endmatter-idx3">description of, 196</p>
			<p class="em-only_endmatter-idx3">pattern strabismus and, 107, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">syndromes with, 196</p>
			<p class="em-only_endmatter-idx2">growth and development of, 181</p>
			<p class="em-only_endmatter-idx2">inferior rectus muscle alteration effect on, 29, 30<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in M<span class="accent">ö</span>bius syndrome, 135</p>
			<p class="em-only_endmatter-idx2">slants of, 196</p>
			<p class="em-only_endmatter-idx1">Palpebral vernal keratoconjunctivitis, 248, 248<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Panret&#173;i&#173;nal photocoagulation, for retinopathy of prematurity, 332, 333<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Panum’s area of single binocular vision, 42, 42<span class="italic">f</span>, 48</p>
			<p class="em-only_endmatter-idx1">Panuveitis, 318<span class="italic">f</span>, 318–319</p>
			<p class="em-only_endmatter-idx1">Papilledema</p>
			<p class="em-only_endmatter-idx2">definition of, 370</p>
			<p class="em-only_endmatter-idx2">idiopathic intracranial hypertension and, 370<span class="italic">f</span>, 370–371</p>
			<p class="em-only_endmatter-idx1">Papillomas, 250</p>
			<p class="em-only_endmatter-idx1">Paradoxical diplopia, 50, 50<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Paradoxical pupils, 335, 336<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Paralysis, convergence, 105–106</p>
			<p class="em-only_endmatter-idx1">Paralytic strabismus</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery for, 161</p>
			<p class="em-only_endmatter-idx2">Hering’s law of motor correspondence and, 38</p>
			<p class="em-only_endmatter-idx1">Paranasal sinusitis, 213, 214<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Parasympathomimetics, 289<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Parinaud oculoglandular syndrome, 240<span class="italic">f</span>, 240–241</p>
			<p class="em-only_endmatter-idx1">Parkinson disease, convergence insufficiency associated with, 103</p>
			<p class="em-only_endmatter-idx1">Parks-&#173;Bielschowsky 3-&#173;step test, 73, 120</p>
			<p class="em-only_endmatter-idx1">Pars planitis, 316</p>
			<p class="em-only_endmatter-idx1">Partially accommodative esotropia, 90–92</p>
			<p class="em-only_endmatter-idx1">Part-&#173;time occlusion, for amblyopia, 58</p>
			<p class="em-only_endmatter-idx1">Patau syndrome, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Patching. <span class="italic">See</span> Occlusion therapy</p>
			<p class="em-only_endmatter-idx1">Pathologic suppression, 48</p>
			<p class="em-only_endmatter-idx1">Pattern strabismus</p>
			<p class="em-only_endmatter-idx2">A-</p>
			<p class="em-only_endmatter-idx3">clinical features of, 109</p>
			<p class="em-only_endmatter-idx3">clinically significant, 109</p>
			<p class="em-only_endmatter-idx3">definition of, 107</p>
			<p class="em-only_endmatter-idx3">etiology of, 107–109, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">exotropia, 108<span class="italic">f</span>, 112</p>
			<p class="em-only_endmatter-idx3">in exotropia, 109</p>
			<p class="em-only_endmatter-idx3">horizontal rectus muscle transposition for, 112</p>
			<p class="em-only_endmatter-idx3">identification of, 109</p>
			<p class="em-only_endmatter-idx3">intorsion as cause of, 107, 110</p>
			<p class="em-only_endmatter-idx3">medial rectus muscle displacement for, 110, 111<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">palpebral fissure slanting associated with, 196</p>
			<p class="em-only_endmatter-idx3">superior oblique muscle overaction associated with, 107</p>
			<p class="em-only_endmatter-idx3">superior oblique tenotomy for, 112</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 112, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">anomalous innervation as cause of, 109</p>
			<p class="em-only_endmatter-idx2"><span class="greek_1">λ</span>-</p>
			<p class="em-only_endmatter-idx3">clinical features of, 110</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 113</p>
			<p class="em-only_endmatter-idx2">management of, 110–113, 111<span class="italic">f</span>, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">ocular torsion as cause of, 107</p>
			<p class="em-only_endmatter-idx2">surgical correction of, 110–113, 111<span class="italic">f</span>, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">types of, 107</p>
			<p class="em-only_endmatter-idx2">V-</p>
			<p class="em-only_endmatter-idx3">bilateral superior oblique palsy and, 122</p>
			<p class="em-only_endmatter-idx3">in Brown syndrome, 137</p>
			<p class="em-only_endmatter-idx3">clinical features of, 109</p>
			<p class="em-only_endmatter-idx3">clinically significant, 109</p>
			<p class="em-only_endmatter-idx3">craniofacial anomalies and, 107</p>
			<p class="em-only_endmatter-idx3">in craniosynostosis, 208</p>
			<p class="em-only_endmatter-idx3">definition of, 107</p>
			<p class="em-only_endmatter-idx3">etiology of, 107–109, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">exotropia with, 108<span class="italic">f</span>, 111</p>
			<p class="em-only_endmatter-idx3">extorsion as cause of, 107, 110</p>
			<p class="em-only_endmatter-idx3">heterotopy as cause of, 28</p>
			<p class="em-only_endmatter-idx3">identification of, 109</p>
			<p class="em-only_endmatter-idx3">infantile esotropia associated with, 109, 112</p>
			<p class="em-only_endmatter-idx3">inferior oblique muscle overaction associated with, 107</p>
			<p class="em-only_endmatter-idx3">palpebral fissure slanting associated with, 196</p>
			<p class="em-only_endmatter-idx4">clinical features of, 109–110</p>
			<p class="em-only_endmatter-idx4">definition of, 107</p>
			<p class="em-only_endmatter-idx4">downward-&#173;slanting palpebral fissures and, 107, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx4">etiology of, 107–109, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx4">horizontal rectus muscles and, 109</p>
			<p class="em-only_endmatter-idx4">identification of, 109–110</p>
			<p class="em-only_endmatter-idx3">superior oblique palsy and, 122</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 111–112, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">X-</p>
			<p class="em-only_endmatter-idx3">clinical features of, 110</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 113</p>
			<p class="em-only_endmatter-idx2">Y-</p>
			<p class="em-only_endmatter-idx3">clinical features of, 109–110</p>
			<p class="em-only_endmatter-idx3">surgical treatment of, 113</p>
			<p class="em-only_endmatter-idx1">Patti Stripes Square Wave Grating Paddles, 8</p>
			<p class="em-only_endmatter-idx1">Pauciarticular juvenile idiopathic arthritis, 313, 314<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">PAX6</span> gene, 267, 338</p>
			<p class="em-only_endmatter-idx1">PCG. <span class="italic">See</span> Primary congenital glaucoma</p>
			<p class="em-only_endmatter-idx1">Pediatric glaucoma. <span class="italic">See</span> Childhood glaucoma</p>
			<p class="em-only_endmatter-idx1">Pediatric granulomatous arthritis, 318</p>
			<p class="em-only_endmatter-idx1">PEDs. <span class="italic">See</span> Pigment epithelial detachments</p>
			<p class="em-only_endmatter-idx1">Pendular nystagmus, 147</p>
			<p class="em-only_endmatter-idx1">Penetrating injury, 376–378, 377<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Penicillin G, for syphilis, 413</p>
			<p class="em-only_endmatter-idx1">Perennial allergic conjunctivitis, 246–248</p>
			<p class="em-only_endmatter-idx1">Perforating injury, 376–378, 377<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Peribulbar anesthesia, 174</p>
			<p class="em-only_endmatter-idx1">Perimacular folds, in abusive head trauma, 382–383</p>
			<p class="em-only_endmatter-idx1">Perinatal infections. <span class="italic">See</span> Intrauterine/perinatal infections</p>
			<p class="em-only_endmatter-idx1">Periodic alternating nystagmus, 149</p>
			<p class="em-only_endmatter-idx1">Periorbital ecchymoses, 379, 384</p>
			<p class="em-only_endmatter-idx1">Peripapillary hemorrhages, 373</p>
			<p class="em-only_endmatter-idx1">Peripapillary staphyloma, 366</p>
			<p class="em-only_endmatter-idx1">Peripheral corneal transparency abnormalities, 255–256<span class="italic">f</span>, 255–257</p>
			<p class="em-only_endmatter-idx1">Peripheral fusion, 51–52</p>
			<p class="em-only_endmatter-idx1">Peripheral suppression, 48</p>
			<p class="em-only_endmatter-idx1">Peripheral vacuolar cataracts, 298</p>
			<p class="em-only_endmatter-idx1">Peritomy, 163</p>
			<p class="em-only_endmatter-idx1">Periventricular leukomalacia, 187, 361–362</p>
			<p class="em-only_endmatter-idx1">Perkins Tonometer, 10, 281</p>
			<p class="em-only_endmatter-idx1">Per&#173;sis&#173;tent fetal vasculature (PFV), 298<span class="italic">f</span>, 298–299, 301</p>
			<p class="em-only_endmatter-idx1">Per&#173;sis&#173;tent pupillary membrane, 264, 264<span class="italic">f</span>, 266<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Peters anomaly, 259, 260<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Peters-&#173;plus syndrome, 259</p>
			<p class="em-only_endmatter-idx1">Pfeiffer syndrome, 207</p>
			<p class="em-only_endmatter-idx1">PFV. <span class="italic">See</span> Per&#173;sis&#173;tent fetal vasculature</p>
			<p class="em-only_endmatter-idx1">PHACE syndrome, 220, 363</p>
			<p class="em-only_endmatter-idx1">Phakomas, ret&#173;i&#173;nal, 397, 399</p>
			<p class="em-only_endmatter-idx1">Pharyngoconjunctival fever, 242</p>
			<p class="em-only_endmatter-idx1">-&#173;phoria (suffix), 16</p>
			<p class="em-only_endmatter-idx1">Photocoagulation, for retinopathy of prematurity, 332, 333<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Photoreceptors, 44</p>
			<p class="em-only_endmatter-idx1">Phototherapeutic keratectomy, for band keratopathy, 322</p>
			<p class="em-only_endmatter-idx1">Physiologic anisocoria, 275</p>
			<p class="em-only_endmatter-idx1">Physiologic suppression, 48</p>
			<p class="em-only_endmatter-idx1">Pierre Robin sequence, 183, 211</p>
			<p class="em-only_endmatter-idx1">Pigment epithelial detachments (PEDs), 342</p>
			<p class="em-only_endmatter-idx1">Pigment epithelium cysts, of iris, 272, 272<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Pilocytic astrocytoma, 396</p>
			<p class="em-only_endmatter-idx1">Pilomatricoma, 200, 200<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">PITS. <span class="italic">See</span> Pulled-in-two syndrome</p>
			<p class="em-only_endmatter-idx1"><span class="italic">PITX2</span> gene, 265</p>
			<p class="em-only_endmatter-idx1">Plagiocephaly, 204–205</p>
			<p class="em-only_endmatter-idx1">Plaque hemangioma, 220, 220<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Plexiform neurofibromas, 223, 395<span class="italic">f</span>, 395–396</p>
			<p class="em-only_endmatter-idx1">Plica semilunaris</p>
			<p class="em-only_endmatter-idx2">advancement of, 171</p>
			<p class="em-only_endmatter-idx2">hypertrophy of, 172<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Plication, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Plus disease, 326, 327<span class="italic">t</span>, 330<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Plus lenses</p>
			<p class="em-only_endmatter-idx2">amblyopia treated with, 59</p>
			<p class="em-only_endmatter-idx2">convergence paralysis treated with, 106</p>
			<p class="em-only_endmatter-idx1">PMMA lenses, 302</p>
			<p class="em-only_endmatter-idx1">PNET. <span class="italic">See</span> Primitive neuroectodermal tumor</p>
			<p class="em-only_endmatter-idx1">Poland syndrome, 135</p>
			<p class="em-only_endmatter-idx1">Polar cataracts, anterior, 55, 295, 295<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Polarized Worth 4-&#173;dot test, 80</p>
			<p class="em-only_endmatter-idx1">Polyarticular juvenile idiopathic arthritis, 313, 314<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Polydactyly, 391, 391<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Polymethyl methacrylate (PMMA) lenses, 302</p>
			<p class="em-only_endmatter-idx1">Port-&#173;wine stain (PWS), 199, 401, 401<span class="italic">t</span>, 402<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Positive &#173;angle kappa, 67, 68<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Posterior capsular cataract, 387<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Posterior capsulectomy, 303</p>
			<p class="em-only_endmatter-idx1">Posterior capsule opacification, 302</p>
			<p class="em-only_endmatter-idx1">Posterior corneal depression, 259</p>
			<p class="em-only_endmatter-idx1">Posterior embryotoxon, 255, 255<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Posterior fixation</p>
			<p class="em-only_endmatter-idx2">definition of, 164<span class="italic">t</span>, 167</p>
			<p class="em-only_endmatter-idx2">suture for, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Posterior fossa malformations, hemangiomas, arterial lesions, and eye anomalies. <span class="italic">See</span> PHACE syndrome</p>
			<p class="em-only_endmatter-idx1">Posterior lenticonus, 296–297, 297<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Posterior microphthalmos, 263</p>
			<p class="em-only_endmatter-idx1">Posterior pole</p>
			<p class="em-only_endmatter-idx2">distortion of, 317<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">familial exudative vitreoretinopathy findings, 347, 348<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">traction of, 334<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Posterior subscapular cataracts (PSCs), 297</p>
			<p class="em-only_endmatter-idx1">Posterior uveitis</p>
			<p class="em-only_endmatter-idx2">definition of, 317</p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 312<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">inflammation in, 320</p>
			<p class="em-only_endmatter-idx2">laboratory tests for, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">toxocariasis as cause of, 317<span class="italic">f</span>, 317–318</p>
			<p class="em-only_endmatter-idx2">toxoplasmosis as cause of, 317</p>
			<p class="em-only_endmatter-idx1">Posterior vitrectomy, 303</p>
			<p class="em-only_endmatter-idx1">Posterior vitreous detachment, 347</p>
			<p class="em-only_endmatter-idx1">Postoperative nausea and vomiting, 174</p>
			<p class="em-only_endmatter-idx1">Postsurgical consecutive esotropia, 95</p>
			<p class="em-only_endmatter-idx1">Postsurgical esotropia, 102</p>
			<p class="em-only_endmatter-idx1">Postsurgical exotropia, 104</p>
			<p class="em-only_endmatter-idx1"><span class="italic">PRDM5</span> gene, 254</p>
			<p class="em-only_endmatter-idx1">Preferential looking, for visual acuity assessment, 5, 8–9, 9<span class="italic">f</span>, 182, 300</p>
			<p class="em-only_endmatter-idx1">Pregeniculate visual impairment, 186–187</p>
			<p class="em-only_endmatter-idx1">Preliterate &#173;children, optotypes for visual acuity assessment in, 6<span class="italic">t</span>, 6–7, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Pre–&#173;plus disease, 326, 327<span class="italic">t</span>, 330<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Preseptal cellulitis, 170, 212–214</p>
			<p class="em-only_endmatter-idx1">Press-on prisms, for diplopia, 96</p>
			<p class="em-only_endmatter-idx1">Prethreshold disease, 326</p>
			<p class="em-only_endmatter-idx1">Preverbal &#173;children</p>
			<p class="em-only_endmatter-idx2">fixation assessments in, 300</p>
			<p class="em-only_endmatter-idx2">visual acuity assessment methods in, 8–9, 154</p>
			<p class="em-only_endmatter-idx1">Primary congenital glaucoma (PCG)</p>
			<p class="em-only_endmatter-idx2">anterior segment findings in, 282, 282<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">axial length in, 283</p>
			<p class="em-only_endmatter-idx2">central corneal thickness in, 281</p>
			<p class="em-only_endmatter-idx2">clinical manifestations of, 279–280, 280<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">corneal edema in, 279–280</p>
			<p class="em-only_endmatter-idx2">corneal findings in, 280<span class="italic">f</span>, 280–281</p>
			<p class="em-only_endmatter-idx2">definition of, 278</p>
			<p class="em-only_endmatter-idx2">diagnostic examination for, 280–283, 282–283<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 281<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">ge&#173;ne&#173;tics of, 277–278</p>
			<p class="em-only_endmatter-idx2">gonioscopy for, 282, 282<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">goniotomy for, 285, 286<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">incidence of, 278</p>
			<p class="em-only_endmatter-idx2">natu&#173;ral history of, 283–284</p>
			<p class="em-only_endmatter-idx2">optical coherence tomography of, 283</p>
			<p class="em-only_endmatter-idx2">optic nerve findings in, 282–283, 283<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">pathophysiology of, 278</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 285–287, 286<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">tonometry in, 281–282</p>
			<p class="em-only_endmatter-idx2">trabeculotomy, 286<span class="italic">f</span>, 286–287</p>
			<p class="em-only_endmatter-idx1">Primary deviation</p>
			<p class="em-only_endmatter-idx2">definition of, 38</p>
			<p class="em-only_endmatter-idx2">secondary deviation versus, 115</p>
			<p class="em-only_endmatter-idx1">Primary divergence insufficiency, 94</p>
			<p class="em-only_endmatter-idx1">Primary megalocornea, 253–254</p>
			<p class="em-only_endmatter-idx1">Primary position hypotropia, with Brown syndrome, 137</p>
			<p class="em-only_endmatter-idx1">Primary position of gaze, 31, 64</p>
			<p class="em-only_endmatter-idx1">Primary posterior capsulectomy, 303</p>
			<p class="em-only_endmatter-idx1">Primary telecanthus, 203</p>
			<p class="em-only_endmatter-idx1">Primary visual cortex, abnormal visual experience effects on, 53</p>
			<p class="em-only_endmatter-idx1">Primitive neuroectodermal tumor (PNET), 357–358</p>
			<p class="em-only_endmatter-idx1">Prism(s)</p>
			<p class="em-only_endmatter-idx2">base-&#173;out</p>
			<p class="em-only_endmatter-idx3">convergence insufficiency and, 103</p>
			<p class="em-only_endmatter-idx3">convergence paralysis and, 106</p>
			<p class="em-only_endmatter-idx3">dissociated vertical deviation and, 129</p>
			<p class="em-only_endmatter-idx3">nystagmus treated with, 155</p>
			<p class="em-only_endmatter-idx2">convergence insufficiency treated with, 103</p>
			<p class="em-only_endmatter-idx2">convergence paralysis treated with, 106</p>
			<p class="em-only_endmatter-idx2">diplopia treated with, 72</p>
			<p class="em-only_endmatter-idx2">intermittent exotropia treated with, 102</p>
			<p class="em-only_endmatter-idx2">nystagmus treated with, 155</p>
			<p class="em-only_endmatter-idx2">visual acuity assessment in &#173;children using, 6</p>
			<p class="em-only_endmatter-idx1">Prism Adaptation Study, 93</p>
			<p class="em-only_endmatter-idx1">Prism adaptation test, 82</p>
			<p class="em-only_endmatter-idx1">Prism alternate cover test, 65–66, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Prism and cover test</p>
			<p class="em-only_endmatter-idx2">exodeviation evaluations, 100</p>
			<p class="em-only_endmatter-idx2">simultaneous, 66–67</p>
			<p class="em-only_endmatter-idx1">Probing, for congenital nasolacrimal duct obstruction, 232–234, 233<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Propranolol, for hemangioma, 220, 221<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Proptosis</p>
			<p class="em-only_endmatter-idx2">in craniosynostosis, 207</p>
			<p class="em-only_endmatter-idx2">nonspecific orbital inflammation as cause of, 215</p>
			<p class="em-only_endmatter-idx1">Prostaglandin analogues, 289<span class="italic">t</span>, 290</p>
			<p class="em-only_endmatter-idx1">Proximal (instrument) convergence, 39</p>
			<p class="em-only_endmatter-idx1"><span class="italic">PRSS56</span> gene, 263</p>
			<p class="em-only_endmatter-idx1">PSCs. <span class="italic">See</span> Posterior subscapular cataracts</p>
			<p class="em-only_endmatter-idx1">Pseudocolobomas, 211</p>
			<p class="em-only_endmatter-idx1">Pseudoesotropia, 85–87, 86<span class="italic">f</span>, 99</p>
			<p class="em-only_endmatter-idx1">Pseudoexotropia</p>
			<p class="em-only_endmatter-idx2">description of, 99</p>
			<p class="em-only_endmatter-idx2">in retinopathy of prematurity, 334, 335<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Pseudo-&#173;Hurler polydystrophy, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Pseudohypopyon, 342</p>
			<p class="em-only_endmatter-idx1">Pseudomembranous conjunctivitis, 251</p>
			<p class="em-only_endmatter-idx1">Pseudopapilledema, 372–373<span class="italic">f</span>, 372–374</p>
			<p class="em-only_endmatter-idx1">Pseudopolycoria, 268, 268<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Pseudoproptosis, 217, 283</p>
			<p class="em-only_endmatter-idx1">Pseudoptosis, in hypotropia, 30</p>
			<p class="em-only_endmatter-idx1">Pseudotumor cerebri. <span class="italic">See</span> Idiopathic intracranial hypertension</p>
			<p class="em-only_endmatter-idx1">Ptosis</p>
			<p class="em-only_endmatter-idx2">classification of, 197<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">congenital, 196–198, 197<span class="italic">t</span>, 198<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">evaluation of, 197</p>
			<p class="em-only_endmatter-idx1">Pulled-&#173;in-&#173;two syndrome (PITS), 169–170</p>
			<p class="em-only_endmatter-idx1">Pulley system</p>
			<p class="em-only_endmatter-idx2">abnormalities of, 107</p>
			<p class="em-only_endmatter-idx2">of extraocular muscles, 28, 32</p>
			<p class="em-only_endmatter-idx1">Punctate epithelial keratitis, 269</p>
			<p class="em-only_endmatter-idx1">Punctate keratitis, 197</p>
			<p class="em-only_endmatter-idx1">Pupil</p>
			<p class="em-only_endmatter-idx2">abnormalities of, 267–268, 268<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">anisocoria of, 275</p>
			<p class="em-only_endmatter-idx2">congenital miosis of, 267–268</p>
			<p class="em-only_endmatter-idx2">corectopia of, 268</p>
			<p class="em-only_endmatter-idx2">dilation of, for retinopathy of prematurity examination, 331</p>
			<p class="em-only_endmatter-idx2">dyscoria of, 267</p>
			<p class="em-only_endmatter-idx2">growth and development of, 181</p>
			<p class="em-only_endmatter-idx2">mydriasis of, 268</p>
			<p class="em-only_endmatter-idx2">paradoxical, 335, 336<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">pseudopolycoria of, 268, 268<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">tonic, 275</p>
			<p class="em-only_endmatter-idx1">Pupillary light reflex</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 10</p>
			<p class="em-only_endmatter-idx2">development of, 181</p>
			<p class="em-only_endmatter-idx1">Pupil testing</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 10</p>
			<p class="em-only_endmatter-idx2">in nystagmus evaluations, 154</p>
			<p class="em-only_endmatter-idx1">Pursuit latency, 40</p>
			<p class="em-only_endmatter-idx1">PWS. <span class="italic">See</span> Port-wine stain</p>
			<p class="em-only_endmatter-idx1">Pyogenic granuloma, 170, 171<span class="italic">f</span>, 199, 199<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Pyrimethamine, for toxoplasmosis, 409</p>
			<p class="em-only_endmatter-idx-alpha">Random-&#173;Dot E test, 81</p>
			<p class="em-only_endmatter-idx1">Random-&#173;dot stereopsis tests, 81</p>
			<p class="em-only_endmatter-idx1">Randot test, 81</p>
			<p class="em-only_endmatter-idx1">Ranibizumab, for retinopathy of prematurity, 333</p>
			<p class="em-only_endmatter-idx1"><span class="italic">RB1</span> gene, 354, 358</p>
			<p class="em-only_endmatter-idx1">Reactive arthritis, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Recession/resection</p>
			<p class="em-only_endmatter-idx2">definition of, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">of horizontal rectus muscles</p>
			<p class="em-only_endmatter-idx3">description of, 139</p>
			<p class="em-only_endmatter-idx3">for esodeviations, 160</p>
			<p class="em-only_endmatter-idx3">monocular, 161</p>
			<p class="em-only_endmatter-idx3">for nystagmus correction, 157</p>
			<p class="em-only_endmatter-idx2">of inferior rectus muscle</p>
			<p class="em-only_endmatter-idx3">description of, 29</p>
			<p class="em-only_endmatter-idx3">eyelid position affected by, 173</p>
			<p class="em-only_endmatter-idx2">of lateral rectus muscle</p>
			<p class="em-only_endmatter-idx3">for Duane retraction syndrome, 134</p>
			<p class="em-only_endmatter-idx3">for exodeviations, 160</p>
			<p class="em-only_endmatter-idx3">for high myopia, 143</p>
			<p class="em-only_endmatter-idx3">for intermittent exotropia, 102</p>
			<p class="em-only_endmatter-idx3">for third nerve palsy, 139</p>
			<p class="em-only_endmatter-idx3">for X-&#173;pattern strabismus, 113</p>
			<p class="em-only_endmatter-idx2">of medial rectus muscle</p>
			<p class="em-only_endmatter-idx3">for convergence insufficiency, 103</p>
			<p class="em-only_endmatter-idx3">for Duane retraction syndrome, 133</p>
			<p class="em-only_endmatter-idx3">for esotropia from nystagmus blockage syndrome, 155</p>
			<p class="em-only_endmatter-idx3">for infantile esotropia, 89</p>
			<p class="em-only_endmatter-idx3">for internuclear ophthalmoplegia, 144</p>
			<p class="em-only_endmatter-idx3">for M<span class="accent">ö</span>bius syndrome, 136</p>
			<p class="em-only_endmatter-idx1">Recessive optic atrophy, 368</p>
			<p class="em-only_endmatter-idx1">Recruitment, 33</p>
			<p class="em-only_endmatter-idx1">Rectus muscles. <span class="italic">See also specific muscle</span></p>
			<p class="em-only_endmatter-idx2">capsule of, 26</p>
			<p class="em-only_endmatter-idx2">horizontal</p>
			<p class="em-only_endmatter-idx3">anatomy of, 20, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">inferior zone of, 24</p>
			<p class="em-only_endmatter-idx3">innervation of, 34</p>
			<p class="em-only_endmatter-idx3">in pattern strabismus, 109–110</p>
			<p class="em-only_endmatter-idx3">primary position of, 35, 35<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">recession/resection of</p>
			<p class="em-only_endmatter-idx4">description of, 139</p>
			<p class="em-only_endmatter-idx4">for esodeviations, 160</p>
			<p class="em-only_endmatter-idx4">monocular, 161</p>
			<p class="em-only_endmatter-idx4">for nystagmus correction, 157</p>
			<p class="em-only_endmatter-idx3">superior zone of, 24</p>
			<p class="em-only_endmatter-idx3">transposition of, 110, 112</p>
			<p class="em-only_endmatter-idx2">innervation of, compartmentalization of, 24</p>
			<p class="em-only_endmatter-idx2">insertion of, 22, 23<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">posterior fixation of, 164<span class="italic">t</span>, 167</p>
			<p class="em-only_endmatter-idx2">pulley system for, 28</p>
			<p class="em-only_endmatter-idx2">“restrained shortest-&#173;path model” of, 28</p>
			<p class="em-only_endmatter-idx2">tightening procedures for, 163–164, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">vertical</p>
			<p class="em-only_endmatter-idx3">anatomy of, 20, 22<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">eyelid attachments to, 30<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">insertion of, 22</p>
			<p class="em-only_endmatter-idx3">surgery of</p>
			<p class="em-only_endmatter-idx4">for nystagmus, 156</p>
			<p class="em-only_endmatter-idx4">for pattern strabismus correction, 111</p>
			<p class="em-only_endmatter-idx3">vertical strength of, 35</p>
			<p class="em-only_endmatter-idx2">weakening procedures for, 163, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Red eye. <span class="italic">See</span> Conjunctival hyperemia</p>
			<p class="em-only_endmatter-idx1">Red-&#173;glass test, 51, 75–76, 76<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Red-&#173;green dyschromatopsia, 368</p>
			<p class="em-only_endmatter-idx1">Red reflex</p>
			<p class="em-only_endmatter-idx2">media opacity effects on, 68</p>
			<p class="em-only_endmatter-idx2">refractive error effects on, 68</p>
			<p class="em-only_endmatter-idx2">testing of</p>
			<p class="em-only_endmatter-idx3">in &#173;children, 9</p>
			<p class="em-only_endmatter-idx3">ocular alignment assessments using, 67–68</p>
			<p class="em-only_endmatter-idx1">Reese-&#173;Ellsworth classification, 354</p>
			<p class="em-only_endmatter-idx1">Refractive accommodative esotropia, 90–92</p>
			<p class="em-only_endmatter-idx1">Refractive amblyopia, 54–55</p>
			<p class="em-only_endmatter-idx1">Refractive errors</p>
			<p class="em-only_endmatter-idx2">correction of</p>
			<p class="em-only_endmatter-idx3">in amblyopia, 57–58</p>
			<p class="em-only_endmatter-idx3">in intermittent exotropia, 101</p>
			<p class="em-only_endmatter-idx3">from lens dislocation, 310</p>
			<p class="em-only_endmatter-idx2">extraocular muscle surgery effects on, 173–174</p>
			<p class="em-only_endmatter-idx2">red reflex affected by, 68</p>
			<p class="em-only_endmatter-idx1">Refractive state, 180<span class="italic">f</span>, 180–181</p>
			<p class="em-only_endmatter-idx1">Refsum disease, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Resection. <span class="italic">See</span> Recession/resection</p>
			<p class="em-only_endmatter-idx1">Response accommodative convergence/accommodation ratio, 71</p>
			<p class="em-only_endmatter-idx1">“Restrained shortest-&#173;path model,” 28</p>
			<p class="em-only_endmatter-idx1">Restrictive strabismus, Hering’s law of motor correspondence and, 38</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;na</p>
			<p class="em-only_endmatter-idx2">combined hamartoma of the ret&#173;ina and ret&#173;i&#173;nal pigment epithelium, 350</p>
			<p class="em-only_endmatter-idx2">growth and development of, 182, 325</p>
			<p class="em-only_endmatter-idx2">mesenchymal tissue, 325</p>
			<p class="em-only_endmatter-idx2">phakomas of, 397, 399</p>
			<p class="em-only_endmatter-idx2">splitting of. <span class="italic">See</span> Juvenile retinoschisis</p>
			<p class="em-only_endmatter-idx2">vascularization of, 182, 325</p>
			<p class="em-only_endmatter-idx2">zones of, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal angiomatosis, 400<span class="italic">f. See also</span> von Hippel–Lindau syndrome</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal capillary hemangioblastomas, 400</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal correspondence</p>
			<p class="em-only_endmatter-idx2">anomalous</p>
			<p class="em-only_endmatter-idx3">afterimage test for, 79<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">definition of, 50</p>
			<p class="em-only_endmatter-idx3">diplopia and visual confusion eliminated with, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">eccentric fixation versus, 51</p>
			<p class="em-only_endmatter-idx3">Maddox rod testing in, 68</p>
			<p class="em-only_endmatter-idx3">major amblyoscope for, 70</p>
			<p class="em-only_endmatter-idx3">red-&#173;glass test findings in, 76<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">&#173;after strabismus surgery, 50</p>
			<p class="em-only_endmatter-idx3">testing for, 50–51</p>
			<p class="em-only_endmatter-idx2">description of, 41–42</p>
			<p class="em-only_endmatter-idx2">normal</p>
			<p class="em-only_endmatter-idx3">afterimage test for, 79<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">strabismus and, 48, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">testing for, 51</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal degeneration, 385</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal detachment</p>
			<p class="em-only_endmatter-idx2">&#173;after cataract surgery, 304</p>
			<p class="em-only_endmatter-idx2">extrafoveal, in retinopathy of prematurity, 329<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">retinopathy of prematurity as risk &#173;factor for, 334</p>
			<p class="em-only_endmatter-idx2">rhegmatogenous, child abuse and, 384</p>
			<p class="em-only_endmatter-idx2">scleral perforation as cause of, 170</p>
			<p class="em-only_endmatter-idx2">serous, 362</p>
			<p class="em-only_endmatter-idx2">in Stickler syndrome, 346</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 146</p>
			<p class="em-only_endmatter-idx2">tractional, 348<span class="italic">f</span>, 360</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal disease and disorders</p>
			<p class="em-only_endmatter-idx2">acquired, 358–360, 359<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Coats disease, 358–360, 359<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">combined hamartoma of the ret&#173;ina and ret&#173;i&#173;nal pigment epithelium, 350</p>
			<p class="em-only_endmatter-idx2">hereditary</p>
			<p class="em-only_endmatter-idx3">achromatopsia, 337–338</p>
			<p class="em-only_endmatter-idx3">Aicardi syndrome, 338–339, 339<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">congenital stationary night blindness, 338</p>
			<p class="em-only_endmatter-idx3">evaluative tests for, 335</p>
			<p class="em-only_endmatter-idx3">foveal hypoplasia, 338</p>
			<p class="em-only_endmatter-idx3">Leber congenital amaurosis, 335–336, 337<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">nystagmus associated with, 335</p>
			<p class="em-only_endmatter-idx3">paradoxical pupils associated with, 335, 336<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">&#173;human immunodeficiency virus complications, 348</p>
			<p class="em-only_endmatter-idx2">infectious, 348</p>
			<p class="em-only_endmatter-idx2">macular dystrophies</p>
			<p class="em-only_endmatter-idx3">Best disease, 340–342, 342<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">Stargardt disease, 339–340, 340–341<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">retinoblastoma. <span class="italic">See</span> Retinoblastoma</p>
			<p class="em-only_endmatter-idx2">retinopathy of prematurity. <span class="italic">See</span> Retinopathy of prematurity</p>
			<p class="em-only_endmatter-idx2">tumors, 349–358</p>
			<p class="em-only_endmatter-idx2">vitreoretinopathies</p>
			<p class="em-only_endmatter-idx3">familial exudative, 347–348, 348<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">juvenile retinoschisis. <span class="italic">See</span> Juvenile retinoschisis</p>
			<p class="em-only_endmatter-idx3">Knobloch syndrome, 346<span class="italic">f</span>, 346–347</p>
			<p class="em-only_endmatter-idx3">Norrie disease, 347</p>
			<p class="em-only_endmatter-idx3">Stickler syndrome, 345–346</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal dystrophy</p>
			<p class="em-only_endmatter-idx2">congenital sensory nystagmus from, 154</p>
			<p class="em-only_endmatter-idx2">juvenile, 390<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">nystagmus associated with, 391<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal ganglion cells (RGCs)</p>
			<p class="em-only_endmatter-idx2">apoptosis of, 44</p>
			<p class="em-only_endmatter-idx2">development of, 44</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal hemorrhages</p>
			<p class="em-only_endmatter-idx2">in abusive head trauma, 382–383, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in leukemia, 414</p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal pigment epithelium (RPE)</p>
			<p class="em-only_endmatter-idx2">combined hamartoma of the ret&#173;ina and, 350</p>
			<p class="em-only_endmatter-idx2">congenital hypertrophy of, 349, 349<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in Knobloch syndrome, 346</p>
			<p class="em-only_endmatter-idx2">in Leber congenital amaurosis, 336</p>
			<p class="em-only_endmatter-idx2">lesions of, 349, 349<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in Stargardt disease, 339, 341<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Ret&#173;i&#173;nal rivalry, 47, 47<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Retinitis, cytomegalovirus, 411</p>
			<p class="em-only_endmatter-idx1">Retinoblastoma</p>
			<p class="em-only_endmatter-idx2">bilateral, 357<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">chemotherapy for, 356–357</p>
			<p class="em-only_endmatter-idx2">classification of, 354, 356<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">Coats disease versus, 352–353, 360</p>
			<p class="em-only_endmatter-idx2">description of, 299, 351</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 352–353<span class="italic">f</span>, 352–354</p>
			<p class="em-only_endmatter-idx2">diffuse infiltrative, 353</p>
			<p class="em-only_endmatter-idx2">endophytic, 352, 352<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">evaluation of, 353</p>
			<p class="em-only_endmatter-idx2">exophytic, 352–353, 353<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">extraocular, 357</p>
			<p class="em-only_endmatter-idx2">Flexner-&#173;Wintersteiner rosettes associated with, 353</p>
			<p class="em-only_endmatter-idx2">ge&#173;ne&#173;tics of, 354, 355<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">histologic features of, 353–354</p>
			<p class="em-only_endmatter-idx2">leukocoria associated with, 351, 351<span class="italic">t</span>, 351<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">monitoring of, 358</p>
			<p class="em-only_endmatter-idx2">recurrence of, 358</p>
			<p class="em-only_endmatter-idx2">secondary malignancies in, 358</p>
			<p class="em-only_endmatter-idx2">spontaneous regression of, 353</p>
			<p class="em-only_endmatter-idx2">treatment of, 356–358</p>
			<p class="em-only_endmatter-idx2">trilateral, 357</p>
			<p class="em-only_endmatter-idx1">Retinochoroiditis, cytomegalovirus, 411, 411<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Retinogeniculocortical pathway</p>
			<p class="em-only_endmatter-idx2">abnormal visual experience affecting, 44–47, 45–46<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">development of, 44–47</p>
			<p class="em-only_endmatter-idx1">Retinopathy, diabetic, 408–409</p>
			<p class="em-only_endmatter-idx1">Retinopathy of prematurity (ROP)</p>
			<p class="em-only_endmatter-idx2">aggressive posterior, 326, 327<span class="italic">t</span>, 330<span class="italic">f</span>, 333</p>
			<p class="em-only_endmatter-idx2">anti-&#173;VEGF agents for, 333</p>
			<p class="em-only_endmatter-idx2">bevacizumab for, 333</p>
			<p class="em-only_endmatter-idx2">blindness caused by, 335</p>
			<p class="em-only_endmatter-idx2">cicatricial, 67</p>
			<p class="em-only_endmatter-idx2">classification of, 325–326, 327<span class="italic">t</span>, 328–330<span class="italic">f</span>, 331<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">complications of, 334–335</p>
			<p class="em-only_endmatter-idx2">cryotherapy for, 331</p>
			<p class="em-only_endmatter-idx2">demarcation line in, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">diagnosis of, 329, 331</p>
			<p class="em-only_endmatter-idx2">digital ret&#173;i&#173;nal photography for, 331</p>
			<p class="em-only_endmatter-idx2">discovery of, 325</p>
			<p class="em-only_endmatter-idx2">Early Treatment for Retinopathy of Prematurity classification of, 326, 331<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">extrafoveal ret&#173;i&#173;nal detachment in, 329<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">extraret&#173;i&#173;nal fibrovascular proliferation in, 329<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">follow-up examinations for, 332<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">insulin-&#173;like growth &#173;factor I in, 325, 326<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">International Classification of Retinopathy of Prematurity, 325, 327<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">location of, 327<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">macular dragging associated with, 334, 334<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">myopia associated with, 334</p>
			<p class="em-only_endmatter-idx2">ocular examination for, 329, 331, 332<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">panret&#173;i&#173;nal photocoagulation for, 332, 333<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">pathophysiology of, 325, 326<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">plus disease, 326, 327<span class="italic">t</span>, 330<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">pre–&#173;plus disease, 326, 327<span class="italic">t</span>, 330<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">prethreshold disease, 326</p>
			<p class="em-only_endmatter-idx2">pseudoexotropia associated with, 334, 335<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">ranibizumab for, 333</p>
			<p class="em-only_endmatter-idx2">risk &#173;factors for, 326–327</p>
			<p class="em-only_endmatter-idx2">scleral buckling for, 335</p>
			<p class="em-only_endmatter-idx2">screening for, 329, 331, 332<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">sequelae of, 334–335</p>
			<p class="em-only_endmatter-idx2">stage 1, 327<span class="italic">t</span>, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">stage 2, 327<span class="italic">t</span>, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">stage 3, 327<span class="italic">t</span>, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">stage 4, 327<span class="italic">t</span>, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">stage 5, 327<span class="italic">t</span>, 328<span class="italic">f</span>, 335</p>
			<p class="em-only_endmatter-idx2">supplemental oxygen as risk &#173;factor for, 326–327</p>
			<p class="em-only_endmatter-idx2">telemedicine for, 331</p>
			<p class="em-only_endmatter-idx2">threshold level of, 331</p>
			<p class="em-only_endmatter-idx2">treatment of, 331–334</p>
			<p class="em-only_endmatter-idx2">type 1, 326, 331<span class="italic">t</span>, 332</p>
			<p class="em-only_endmatter-idx2">type 2, 326, 331<span class="italic">t</span>, 332</p>
			<p class="em-only_endmatter-idx2">vascular endothelial growth &#173;factor in, 325, 326<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">vitrectomy for, 335</p>
			<p class="em-only_endmatter-idx2">zones of, 325, 328<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Retinoschisis, juvenile</p>
			<p class="em-only_endmatter-idx2">abusive head trauma as cause of, 383</p>
			<p class="em-only_endmatter-idx2">description of, 342–343</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 344–345<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">treatment of, 344</p>
			<p class="em-only_endmatter-idx1">Retinoscopy</p>
			<p class="em-only_endmatter-idx2">cataract evaluations, 299</p>
			<p class="em-only_endmatter-idx2">dynamic</p>
			<p class="em-only_endmatter-idx3">accommodation mea&#173;sure&#173;ments using, 9</p>
			<p class="em-only_endmatter-idx3">in &#173;children, 9</p>
			<p class="em-only_endmatter-idx1">Retrobulbar anesthesia, 174</p>
			<p class="em-only_endmatter-idx1">Retrogeniculate visual impairment, 186</p>
			<p class="em-only_endmatter-idx1">Reverse amblyopia, 55–56, 59–60</p>
			<p class="em-only_endmatter-idx1">RGCs. <span class="italic">See</span> Retinal ganglion cells</p>
			<p class="em-only_endmatter-idx1">Rhabdomyosarcoma</p>
			<p class="em-only_endmatter-idx2">eyelid, 200</p>
			<p class="em-only_endmatter-idx2">orbital, 217<span class="italic">f</span>, 217–218</p>
			<p class="em-only_endmatter-idx1">Rhegmatogenous ret&#173;i&#173;nal detachment, child abuse and, 384</p>
			<p class="em-only_endmatter-idx1">RHoT. <span class="italic">See</span> Right hypotropia</p>
			<p class="em-only_endmatter-idx1">Richner-&#173;Hanhart syndrome, 270</p>
			<p class="em-only_endmatter-idx1">Right hypotropia (RHoT), 17</p>
			<p class="em-only_endmatter-idx1">Riley-&#173;Day syndrome, 271</p>
			<p class="em-only_endmatter-idx1">Rituximab, 322</p>
			<p class="em-only_endmatter-idx1">Rod monochromatism, 337</p>
			<p class="em-only_endmatter-idx1">ROP. <span class="italic">See</span> Retinopathy of prematurity</p>
			<p class="em-only_endmatter-idx1">Rotations, ocular</p>
			<p class="em-only_endmatter-idx2">definition of, 31</p>
			<p class="em-only_endmatter-idx2">horizontal, 31</p>
			<p class="em-only_endmatter-idx2">torsional, 31</p>
			<p class="em-only_endmatter-idx2">vertical, 31</p>
			<p class="em-only_endmatter-idx1">RPE. <span class="italic">See</span> Ret&#173;i&#173;nal pigment epithelium</p>
			<p class="em-only_endmatter-idx1"><span class="italic">RPE65</span> gene, 337</p>
			<p class="em-only_endmatter-idx1"><span class="italic">RS1</span> gene, 342</p>
			<p class="em-only_endmatter-idx1">Rubella, 410<span class="italic">f</span>, 410–411</p>
			<p class="em-only_endmatter-idx1">Rush disease. <span class="italic">See</span> Aggressive posterior retinopathy of prematurity</p>
			<p class="em-only_endmatter-idx-alpha">Saccadic system, 40</p>
			<p class="em-only_endmatter-idx1">Saccadic velocity, 73</p>
			<p class="em-only_endmatter-idx1">Saccule, 40</p>
			<p class="em-only_endmatter-idx1">Saethre-&#173;Chotzen syndrome, 207, 208<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Salmon patch, 269</p>
			<p class="em-only_endmatter-idx1">Sandhoff disease, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Sanfilippo syndrome, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Sarcoidosis, 318<span class="italic">f</span>, 318–319</p>
			<p class="em-only_endmatter-idx1">Satellite lesion, 409</p>
			<p class="em-only_endmatter-idx1">Scaphocephaly, 205</p>
			<p class="em-only_endmatter-idx1">Scheie syndrome, 270, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Schlemm canal, 286, 286<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Schnyder corneal dystrophy, 270, 387<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Schwalbe line, 255</p>
			<p class="em-only_endmatter-idx1">Schwannoma, orbital, 223</p>
			<p class="em-only_endmatter-idx1">Sclera</p>
			<p class="em-only_endmatter-idx2">surgical perforation of, 30, 170</p>
			<p class="em-only_endmatter-idx2">thinning of, from primary congenital glaucoma, 283</p>
			<p class="em-only_endmatter-idx1">Scleral buckling, for retinopathy of prematurity, 335</p>
			<p class="em-only_endmatter-idx1">Scleral spur, 181</p>
			<p class="em-only_endmatter-idx1">Sclerocornea, 257<span class="italic">t</span>, 260, 261<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Scotoma</p>
			<p class="em-only_endmatter-idx2">central suppression, 4<span class="greek_1">Δ</span> base-&#173;out prism test for, 79</p>
			<p class="em-only_endmatter-idx2">suppression</p>
			<p class="em-only_endmatter-idx3">description of, 49</p>
			<p class="em-only_endmatter-idx3">4<span class="greek_1">Δ</span> base-&#173;out prism test for, 79</p>
			<p class="em-only_endmatter-idx3">Worth 4-&#173;dot test for, 80<span class="italic">f</span>, 80–81</p>
			<p class="em-only_endmatter-idx1">Seasonal allergic conjunctivitis, 246<span class="italic">f</span>, 246–248</p>
			<p class="em-only_endmatter-idx1">Secondary childhood glaucoma</p>
			<p class="em-only_endmatter-idx2">acquired condition, 284</p>
			<p class="em-only_endmatter-idx2">&#173;after cataract surgery, 285</p>
			<p class="em-only_endmatter-idx2">classification of, 278<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">nonacquired conditions associated with, 284<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Secondary deviation</p>
			<p class="em-only_endmatter-idx2">definition of, 39</p>
			<p class="em-only_endmatter-idx2">primary deviation versus, 115</p>
			<p class="em-only_endmatter-idx1">Secondary diagnostic position of gaze, 31</p>
			<p class="em-only_endmatter-idx1">Secondary megalocornea, 254</p>
			<p class="em-only_endmatter-idx1">Sectoral cataracts, 297–298</p>
			<p class="em-only_endmatter-idx1">See-&#173;saw nystagmus, 152</p>
			<p class="em-only_endmatter-idx1">Semicircular canals, 40</p>
			<p class="em-only_endmatter-idx1">Senior-&#173;L<span class="greek CharOverride-1">Ø</span>ken syndrome, 391</p>
			<p class="em-only_endmatter-idx1">Sensory adaptation testing</p>
			<p class="em-only_endmatter-idx2">afterimage test, 79, 79<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">amblyoscope testing, 79–80</p>
			<p class="em-only_endmatter-idx2">Bagolini lenses, 77<span class="italic">f</span>, 77–78</p>
			<p class="em-only_endmatter-idx2">description of, 75</p>
			<p class="em-only_endmatter-idx2">4<span class="greek_1">Δ</span> base-&#173;out prism test, 78<span class="italic">f</span>, 78–79</p>
			<p class="em-only_endmatter-idx2">red-&#173;glass test, 75–76, 76<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Worth 4-&#173;dot test, 80<span class="italic">f</span>, 80–81</p>
			<p class="em-only_endmatter-idx1">Sensory binocularity, 75</p>
			<p class="em-only_endmatter-idx1">Sensory esotropia, 93–94</p>
			<p class="em-only_endmatter-idx1">Sensory exotropia, 104</p>
			<p class="em-only_endmatter-idx1">Sensory fusion, 43</p>
			<p class="em-only_endmatter-idx1">Sensory nystagmus, 187</p>
			<p class="em-only_endmatter-idx1">Septo-&#173;optic dysplasia, 361, 363<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Sequence, 183</p>
			<p class="em-only_endmatter-idx1">Serous ret&#173;i&#173;nal detachments, 362</p>
			<p class="em-only_endmatter-idx1">Shaken baby syndrome. <span class="italic">See</span> Abusive head trauma</p>
			<p class="em-only_endmatter-idx1">Sherrington’s law of reciprocal innervation, 33</p>
			<p class="em-only_endmatter-idx1">Shield ulcer, 248, 249<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Shunting, for idiopathic intracranial hypertension, 371</p>
			<p class="em-only_endmatter-idx1">Sialidosis, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Sickle cell trait/disease, 378</p>
			<p class="em-only_endmatter-idx1">Silver nitrate, for gonorrheal ophthalmia neonatorum, 239</p>
			<p class="em-only_endmatter-idx1">Simultaneous prism and cover test, 66–67</p>
			<p class="em-only_endmatter-idx1">Single binocular vision, 81–82, 82<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Sinusitis, paranasal, 213, 214<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Sixth nerve palsy, 95–97, 96<span class="italic">f</span>, 176</p>
			<p class="em-only_endmatter-idx1">SJS. <span class="italic">See</span> Stevens-&#173;Johnson syndrome</p>
			<p class="em-only_endmatter-idx1">Skew deviation, 125</p>
			<p class="em-only_endmatter-idx1">Skull</p>
			<p class="em-only_endmatter-idx2">abnormal shapes of. <span class="italic">See</span> Craniosynostosis</p>
			<p class="em-only_endmatter-idx2">bony growth of, 203</p>
			<p class="em-only_endmatter-idx2">sutures of, 203–204, 204–205<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">SLC4A11</span> gene, 258</p>
			<p class="em-only_endmatter-idx1">Slit-&#173;lamp examination</p>
			<p class="em-only_endmatter-idx2">in cataract evaluation, 300</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 4–5</p>
			<p class="em-only_endmatter-idx2">in Duane retraction syndrome, 133</p>
			<p class="em-only_endmatter-idx2">in uveitis associated with juvenile idiopathic arthritis, 314<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Sly syndrome, 388<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Smart System PC-&#173;Plus, 81</p>
			<p class="em-only_endmatter-idx1">Smoking, thyroid eye disease and, 140</p>
			<p class="em-only_endmatter-idx1">Smooth-&#173;pursuit system</p>
			<p class="em-only_endmatter-idx2">description of, 40</p>
			<p class="em-only_endmatter-idx2">in infantile esotropia, 88</p>
			<p class="em-only_endmatter-idx1">Snellen letters, monofixation syndrome and, 51</p>
			<p class="em-only_endmatter-idx1">“Snow bank,” 316<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Spasmus nutans syndrome, 151–152</p>
			<p class="em-only_endmatter-idx1">Spectral-&#173;domain optical coherence tomography</p>
			<p class="em-only_endmatter-idx2">Best disease on, 342, 343<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">juvenile retinoschisis on, 344, 344<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Sphenoid dysplasia, 397</p>
			<p class="em-only_endmatter-idx1">Spherophakia, 305</p>
			<p class="em-only_endmatter-idx1">Spiral of Tillaux, 22, 23<span class="italic">f</span>, 169</p>
			<p class="em-only_endmatter-idx1">Spontaneous consecutive esotropia, 95</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Staphylococcus</span> sp</p>
			<p class="em-only_endmatter-idx2">orbital cellulitis caused by, 213</p>
			<p class="em-only_endmatter-idx2">preseptal cellulitis caused by, 213</p>
			<p class="em-only_endmatter-idx2"><span class="italic">S aureus,</span> 213, 240</p>
			<p class="em-only_endmatter-idx1">Staphyloma, peripapillary, 366</p>
			<p class="em-only_endmatter-idx1">Stargardt disease, 339–340, 340–341<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Steady fixation, 6</p>
			<p class="em-only_endmatter-idx1">Stents, for congenital nasolacrimal duct obstruction, 234–235</p>
			<p class="em-only_endmatter-idx1">Stereoacuity</p>
			<p class="em-only_endmatter-idx2">development of, 182</p>
			<p class="em-only_endmatter-idx2">tests of</p>
			<p class="em-only_endmatter-idx3">in monofixation syndrome, 51</p>
			<p class="em-only_endmatter-idx3">sensory adaptation assessments using, 81</p>
			<p class="em-only_endmatter-idx1">Stereopsis</p>
			<p class="em-only_endmatter-idx2">contour, 81</p>
			<p class="em-only_endmatter-idx2">definition of, 43, 81</p>
			<p class="em-only_endmatter-idx2">depth perception versus, 43</p>
			<p class="em-only_endmatter-idx2">development of, 43</p>
			<p class="em-only_endmatter-idx2">random-&#173;dot tests, 81</p>
			<p class="em-only_endmatter-idx2">sensory tests for, 100</p>
			<p class="em-only_endmatter-idx1">Stevens-&#173;Johnson syndrome (SJS), 251–252, 252<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Stickler syndrome, 183, 345–346</p>
			<p class="em-only_endmatter-idx1">Stimulus accommodative convergence/accommodation ratio, 71</p>
			<p class="em-only_endmatter-idx1">Stimulus deprivation amblyopia, 55</p>
			<p class="em-only_endmatter-idx1">Strabismic amblyopia</p>
			<p class="em-only_endmatter-idx2">anisometropic amblyopia versus, 54–55</p>
			<p class="em-only_endmatter-idx2">clinical features of, 54</p>
			<p class="em-only_endmatter-idx2">critical period for, 45</p>
			<p class="em-only_endmatter-idx2">development of, 46–47</p>
			<p class="em-only_endmatter-idx2">eccentric fixation in, 54</p>
			<p class="em-only_endmatter-idx2">grating acuity associated with, 54, 56</p>
			<p class="em-only_endmatter-idx2">occlusion therapy for, 58</p>
			<p class="em-only_endmatter-idx2">pathophysiology of, 54</p>
			<p class="em-only_endmatter-idx2">visual acuity in, 54</p>
			<p class="em-only_endmatter-idx1">Strabismus</p>
			<p class="em-only_endmatter-idx2">abbreviations for, 17</p>
			<p class="em-only_endmatter-idx2">abnormal visual experience caused by, 44</p>
			<p class="em-only_endmatter-idx2">accommodative convergence/accommodation ratio abnormalities as cause of, 39</p>
			<p class="em-only_endmatter-idx2">acquired, 16</p>
			<p class="em-only_endmatter-idx2">acute paralytic, 175</p>
			<p class="em-only_endmatter-idx2">age at onset, 16</p>
			<p class="em-only_endmatter-idx2">amblyopia treatment as cause of, 59–60</p>
			<p class="em-only_endmatter-idx2">animal models of, 46</p>
			<p class="em-only_endmatter-idx2">A-&#173;pattern. <span class="italic">See</span> A-&#173;pattern strabismus</p>
			<p class="em-only_endmatter-idx2">in Apert syndrome, 208, 209<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">Brown syndrome. <span class="italic">See</span> Brown syndrome</p>
			<p class="em-only_endmatter-idx2">&#173;after cataract surgery, 304</p>
			<p class="em-only_endmatter-idx2">classification terms for, 16–17</p>
			<p class="em-only_endmatter-idx2">congenital, 16</p>
			<p class="em-only_endmatter-idx2">consecutive, 16</p>
			<p class="em-only_endmatter-idx2">convergent, 15</p>
			<p class="em-only_endmatter-idx2">in craniosynostosis, 208</p>
			<p class="em-only_endmatter-idx2">cyclic, 93</p>
			<p class="em-only_endmatter-idx2">cyclovertical, 162</p>
			<p class="em-only_endmatter-idx2">definition of, 15</p>
			<p class="em-only_endmatter-idx2">dissociated strabismus complex, 17, 105<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">divergent, 15</p>
			<p class="em-only_endmatter-idx2">early-&#173;onset, 154</p>
			<p class="em-only_endmatter-idx2">history-&#173;taking for, 63</p>
			<p class="em-only_endmatter-idx2">incomitant</p>
			<p class="em-only_endmatter-idx3">abnormal head position caused by, 83</p>
			<p class="em-only_endmatter-idx3">prism alternate cover test for, 66</p>
			<p class="em-only_endmatter-idx2">infantile</p>
			<p class="em-only_endmatter-idx3">description of, 16</p>
			<p class="em-only_endmatter-idx3">dissociated vertical deviation associated with, 129</p>
			<p class="em-only_endmatter-idx3">fusion maldevelopment nystagmus syndrome associated with, 151, 154</p>
			<p class="em-only_endmatter-idx3">primary inferior oblique muscle overaction associated with, 117</p>
			<p class="em-only_endmatter-idx2">intermittent, 182</p>
			<p class="em-only_endmatter-idx2">latent</p>
			<p class="em-only_endmatter-idx3">alternate cover test for, 65, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">description of, 15</p>
			<p class="em-only_endmatter-idx3">exodeviation as, 99</p>
			<p class="em-only_endmatter-idx2">manifest</p>
			<p class="em-only_endmatter-idx3">alternate cover test for, 65, 66<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">description of, 15</p>
			<p class="em-only_endmatter-idx3">exodeviation as, 99</p>
			<p class="em-only_endmatter-idx3">monocular cover-&#173;uncover test for, 64, 65<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">normal ret&#173;i&#173;nal correspondence and, 48–49, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">nystagmus associated with, 154, 156–157</p>
			<p class="em-only_endmatter-idx2">ocular surgery-&#173;related, 145–146</p>
			<p class="em-only_endmatter-idx2">paralytic</p>
			<p class="em-only_endmatter-idx3">extraocular muscle surgery for, 161</p>
			<p class="em-only_endmatter-idx3">Hering’s law of motor correspondence and, 38</p>
			<p class="em-only_endmatter-idx2">pattern. <span class="italic">See</span> Pattern strabismus</p>
			<p class="em-only_endmatter-idx2">prefixes associated with, 15–16</p>
			<p class="em-only_endmatter-idx2">restrictive, 146</p>
			<p class="em-only_endmatter-idx2">screening for, 56</p>
			<p class="em-only_endmatter-idx2">sensory adaptations in</p>
			<p class="em-only_endmatter-idx3">anomalous ret&#173;i&#173;nal correspondence, 50–51</p>
			<p class="em-only_endmatter-idx3">monofixation syndrome, 51–52</p>
			<p class="em-only_endmatter-idx3">suppression, 48–50, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">sensory response to, 75</p>
			<p class="em-only_endmatter-idx2">small-&#173;angle, 89</p>
			<p class="em-only_endmatter-idx2">squinting associated with, 202</p>
			<p class="em-only_endmatter-idx2">suffixes associated with, 15–16</p>
			<p class="em-only_endmatter-idx2">terminology related to, 15–17</p>
			<p class="em-only_endmatter-idx2">third nerve palsy. <span class="italic">See</span> Third nerve palsy</p>
			<p class="em-only_endmatter-idx2">torticollis and, 63</p>
			<p class="em-only_endmatter-idx2">types of, 17</p>
			<p class="em-only_endmatter-idx2">vertical</p>
			<p class="em-only_endmatter-idx3">description of, 15–16</p>
			<p class="em-only_endmatter-idx3">diagnostic positions of gaze for, 64</p>
			<p class="em-only_endmatter-idx2">V-&#173;pattern. <span class="italic">See</span> V-&#173;pattern strabismus</p>
			<p class="em-only_endmatter-idx2">word origin of, 15</p>
			<p class="em-only_endmatter-idx1">Strabismus fixus, 135</p>
			<p class="em-only_endmatter-idx1">Strabismus surgery</p>
			<p class="em-only_endmatter-idx2">anomalous ret&#173;i&#173;nal correspondence &#173;after, 50</p>
			<p class="em-only_endmatter-idx2">esotropia treated with, 91</p>
			<p class="em-only_endmatter-idx2">infantile, monofixation syndrome &#173;after, 51</p>
			<p class="em-only_endmatter-idx2">tightening procedures in, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">weakening procedures in, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">Streptococcus</span> spp</p>
			<p class="em-only_endmatter-idx2">bacterial conjunctivitis caused by, 240</p>
			<p class="em-only_endmatter-idx2">preseptal cellulitis caused by, 213</p>
			<p class="em-only_endmatter-idx2"><span class="italic">S pneumoniae,</span> 213, 240</p>
			<p class="em-only_endmatter-idx2"><span class="italic">S pyogenes,</span> 213</p>
			<p class="em-only_endmatter-idx1">Striate cortex</p>
			<p class="em-only_endmatter-idx2">description of, 44</p>
			<p class="em-only_endmatter-idx2">monocular visual deprivation in, 44, 45</p>
			<p class="em-only_endmatter-idx1">STUMPED mnemonic, for corneal opacities, 257<span class="italic">t</span>, 257–258</p>
			<p class="em-only_endmatter-idx1">Sturge-&#173;Weber syndrome, 199, 251, 285, 349, 394<span class="italic">t</span>, 401<span class="italic">t</span>, 401–403, 402<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Subarachnoid hemorrhage, 382</p>
			<p class="em-only_endmatter-idx1">Subconjunctival disorders, 250–252</p>
			<p class="em-only_endmatter-idx1">Subdural hematoma, 382</p>
			<p class="em-only_endmatter-idx1">Subperiosteal abscess, 213, 214<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Subret&#173;i&#173;nal fibrosis, in Coats disease, 360</p>
			<p class="em-only_endmatter-idx1">Subret&#173;i&#173;nal hemorrhages, 373</p>
			<p class="em-only_endmatter-idx1">Sulfadiazine, for toxoplasmosis, 410</p>
			<p class="em-only_endmatter-idx1">Sulfite oxidase deficiency, 310</p>
			<p class="em-only_endmatter-idx1">Sunsetting, 185</p>
			<p class="em-only_endmatter-idx1">Superior oblique muscle</p>
			<p class="em-only_endmatter-idx2">action of, 34<span class="italic">t</span>, 37<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">characteristics of, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">congenital palsy of, 69</p>
			<p class="em-only_endmatter-idx2">depressor function of, 73</p>
			<p class="em-only_endmatter-idx2">field of action for, 33</p>
			<p class="em-only_endmatter-idx2">innervation of, 19</p>
			<p class="em-only_endmatter-idx2">origin of, 20, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">overaction of</p>
			<p class="em-only_endmatter-idx3">A-&#173;pattern strabismus associated with, 107, <br />111</p>
			<p class="em-only_endmatter-idx3">bilateral, 118<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">description of, 17</p>
			<p class="em-only_endmatter-idx3">horizontal deviation associated with, 118</p>
			<p class="em-only_endmatter-idx3">overdepression in adduction caused by, 118, <br />118<span class="italic">f</span>, 137</p>
			<p class="em-only_endmatter-idx2">palsy of</p>
			<p class="em-only_endmatter-idx3">bilateral, 122–124</p>
			<p class="em-only_endmatter-idx3">&#173;causes of, 119</p>
			<p class="em-only_endmatter-idx3">clinical features of, 119–122</p>
			<p class="em-only_endmatter-idx3">congenital versus acquired, 119</p>
			<p class="em-only_endmatter-idx3">description of, 69</p>
			<p class="em-only_endmatter-idx3">hypertropia associated with, 123</p>
			<p class="em-only_endmatter-idx3">inhibitional palsy of contralateral antagonist, 120–121, 121<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">management of, 122–124, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">masked bilateral, 122</p>
			<p class="em-only_endmatter-idx3">neuroimaging evaluations, 119</p>
			<p class="em-only_endmatter-idx3">right, 120–121<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">surgical management of, 122–124, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">3-&#173;step test for, 120</p>
			<p class="em-only_endmatter-idx3">unilateral, 119–121, 120–121<span class="italic">f</span>, 122–123, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">V-&#173;pattern strabismus associated with, 109</p>
			<p class="em-only_endmatter-idx2">paralysis of, inferior oblique muscle overaction secondary to, 166</p>
			<p class="em-only_endmatter-idx2">right, palsy of, 120–121<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">tenotomy, 112, 138</p>
			<p class="em-only_endmatter-idx2">tightening of, 123, 123<span class="italic">t</span>, 167</p>
			<p class="em-only_endmatter-idx2">underaction of, 17</p>
			<p class="em-only_endmatter-idx2">weakening of</p>
			<p class="em-only_endmatter-idx3">bilateral, 166</p>
			<p class="em-only_endmatter-idx3">for Brown syndrome, 138, 166</p>
			<p class="em-only_endmatter-idx3">for <span class="greek_1">λ</span>-&#173;pattern strabismus, 113</p>
			<p class="em-only_endmatter-idx3">for nystagmus, 156</p>
			<p class="em-only_endmatter-idx3">surgical procedures for, 164<span class="italic">t</span>, 166</p>
			<p class="em-only_endmatter-idx3">tenotomy for, 166</p>
			<p class="em-only_endmatter-idx3">unilateral, 166</p>
			<p class="em-only_endmatter-idx2">weakness of, 119</p>
			<p class="em-only_endmatter-idx1">Superior oblique myokymia, 145</p>
			<p class="em-only_endmatter-idx1">Superior oblique tendon</p>
			<p class="em-only_endmatter-idx2">anatomy of, 19<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">tightening of, 167</p>
			<p class="em-only_endmatter-idx1">Superior orbital vein, 23</p>
			<p class="em-only_endmatter-idx1">Superior rectus muscle</p>
			<p class="em-only_endmatter-idx2">action of, 34<span class="italic">t</span>, 35, 36<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">characteristics of, 21<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">elevator function of, 73</p>
			<p class="em-only_endmatter-idx2">innervation of, 19</p>
			<p class="em-only_endmatter-idx2">intorsion of, 34</p>
			<p class="em-only_endmatter-idx2">Knapp procedure, 127</p>
			<p class="em-only_endmatter-idx2">origin of, 20, 21<span class="italic">t</span>, 22<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">recession of, 30, 128, 130</p>
			<p class="em-only_endmatter-idx2">resection of, 30</p>
			<p class="em-only_endmatter-idx2">surgery considerations for, 29–30</p>
			<p class="em-only_endmatter-idx2">transposition of, 167</p>
			<p class="em-only_endmatter-idx1">Superior rectus tendon, 19<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Supplemental oxygen, retinopathy of prematurity risks secondary to, 326–327</p>
			<p class="em-only_endmatter-idx1">Suppression</p>
			<p class="em-only_endmatter-idx2">alternating, 49</p>
			<p class="em-only_endmatter-idx2">central, 48</p>
			<p class="em-only_endmatter-idx2">constant, 49</p>
			<p class="em-only_endmatter-idx2">definition of, 48</p>
			<p class="em-only_endmatter-idx2">facultative, 49</p>
			<p class="em-only_endmatter-idx2">management of, 50</p>
			<p class="em-only_endmatter-idx2">nonalternating, 49</p>
			<p class="em-only_endmatter-idx2">orthoptic exercises for, 50</p>
			<p class="em-only_endmatter-idx2">pathologic, 48</p>
			<p class="em-only_endmatter-idx2">peripheral, 48</p>
			<p class="em-only_endmatter-idx2">physiologic, 48</p>
			<p class="em-only_endmatter-idx2">red-&#173;glass test findings in, 76<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">as strabismus adaptation, 48–50, 49<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Suppression scotoma</p>
			<p class="em-only_endmatter-idx2">description of, 49</p>
			<p class="em-only_endmatter-idx2">4<span class="greek_1">Δ</span> base-&#173;out prism test for, 79</p>
			<p class="em-only_endmatter-idx2">Worth 4-&#173;dot test for, 80<span class="italic">f</span>, 80–81</p>
			<p class="em-only_endmatter-idx1">Supranuclear control systems, for eye movements, 40</p>
			<p class="em-only_endmatter-idx1">Surgery</p>
			<p class="em-only_endmatter-idx2">cataract. <span class="italic">See</span> Cataract surgery</p>
			<p class="em-only_endmatter-idx2">childhood glaucoma treated with, 285–288, 286<span class="italic">f</span>, 288<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">extraocular muscle. <span class="italic">See</span> Extraocular muscle surgery</p>
			<p class="em-only_endmatter-idx2">high AC/A ratio accommodative esotropia treated with, 92</p>
			<p class="em-only_endmatter-idx2">intermittent exotropia treated with, 102–103</p>
			<p class="em-only_endmatter-idx2">lens subluxation treated with, 310</p>
			<p class="em-only_endmatter-idx2">primary congenital glaucoma treated with, 285–288, 286<span class="italic">f</span>, 288<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Sursumversion, 37</p>
			<p class="em-only_endmatter-idx1">Sutural cysts, 224</p>
			<p class="em-only_endmatter-idx1">Symblepharon, 146</p>
			<p class="em-only_endmatter-idx1">Symbol charts, 7</p>
			<p class="em-only_endmatter-idx1">Symmetric convergence, 41</p>
			<p class="em-only_endmatter-idx1">Syndactyly, in Apert syndrome, 206, 207<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Syndrome, 183. <span class="italic">See also specific syndrome</span></p>
			<p class="em-only_endmatter-idx1">Synergist, 33</p>
			<p class="em-only_endmatter-idx1">Synergistic divergence, 133</p>
			<p class="em-only_endmatter-idx1">Syphilis, congenital, 269, 412–413</p>
			<p class="em-only_endmatter-idx1">Systemic diseases</p>
			<p class="em-only_endmatter-idx2">ataxia-&#173;telangiectasia, 393<span class="italic">t</span>, 403<span class="italic">f</span>, 403<span class="italic">t</span>, 403–404</p>
			<p class="em-only_endmatter-idx2">chromosomal abnormalities, 385, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">diabetes mellitus, 408–409</p>
			<p class="em-only_endmatter-idx2">familial oculorenal syndromes, 391–392, 391–392<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">inborn errors of metabolism. <span class="italic">See</span> Inborn errors of metabolism</p>
			<p class="em-only_endmatter-idx2">intrauterine infections, 409–413</p>
			<p class="em-only_endmatter-idx2">intrauterine/perinatal infections, 409–413</p>
			<p class="em-only_endmatter-idx2">Leber congenital amaurosis-&#173;like phenotypes in, 336</p>
			<p class="em-only_endmatter-idx2">leukemia, 413–414</p>
			<p class="em-only_endmatter-idx2">malignant, 413–415</p>
			<p class="em-only_endmatter-idx2">neuroblastoma, 414–415, 415<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">neuro-&#173;oculocutaneous syndromes. <span class="italic">See</span> Neuro-&#173;oculocutaneous syndromes</p>
			<p class="em-only_endmatter-idx2">ocular manifestations of, 385–415</p>
			<p class="em-only_endmatter-idx2">von Hippel–Lindau syndrome, 393<span class="italic">t</span>, 399–401, <br />400<span class="italic">f</span>, 400<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx-alpha">Tarsal kink, congenital, 194–195</p>
			<p class="em-only_endmatter-idx1">Tarsorrhaphy, 207–208</p>
			<p class="em-only_endmatter-idx1">Tay-&#173;Sachs disease, 389<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">TCOF1</span> gene, 211</p>
			<p class="em-only_endmatter-idx1">TED. <span class="italic">See</span> Thyroid eye disease</p>
			<p class="em-only_endmatter-idx1">Telecanthus, 203</p>
			<p class="em-only_endmatter-idx1">Telemedicine, 331</p>
			<p class="em-only_endmatter-idx1">Teller Acuity Cards II, 8, 9<span class="italic">f</span>, 56, 154, 187</p>
			<p class="em-only_endmatter-idx1">TEN. <span class="italic">See</span> Toxic epidermal necrolysis</p>
			<p class="em-only_endmatter-idx1">Tenacious proximal fusion</p>
			<p class="em-only_endmatter-idx2">definition of, 100</p>
			<p class="em-only_endmatter-idx2">in intermittent exotropia, 71, 100</p>
			<p class="em-only_endmatter-idx1">Tendon–&#173;trochlea complex, 20</p>
			<p class="em-only_endmatter-idx1">Tenectomy, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Tenon capsule</p>
			<p class="em-only_endmatter-idx2">anatomy of, 25–27, 27<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">posterior portion of, 27</p>
			<p class="em-only_endmatter-idx2">scarring of, 171</p>
			<p class="em-only_endmatter-idx2">surgical penetration of, 30</p>
			<p class="em-only_endmatter-idx1">Tenotomy</p>
			<p class="em-only_endmatter-idx2">definition of, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">superior oblique muscle, 112, 138</p>
			<p class="em-only_endmatter-idx1">Teratoma, orbital, 225<span class="italic">f</span>, 225–226</p>
			<p class="em-only_endmatter-idx1">Tertiary diagnostic position of gaze, 31</p>
			<p class="em-only_endmatter-idx1">Thermal injury, 376</p>
			<p class="em-only_endmatter-idx1">Third nerve palsy</p>
			<p class="em-only_endmatter-idx2">acquired, 138</p>
			<p class="em-only_endmatter-idx2">amblyopia with, 138</p>
			<p class="em-only_endmatter-idx2">clinical features of, 138</p>
			<p class="em-only_endmatter-idx2">complete, 139</p>
			<p class="em-only_endmatter-idx2">congenital, 138</p>
			<p class="em-only_endmatter-idx2">diplopia in, 139</p>
			<p class="em-only_endmatter-idx2">incomplete, 139</p>
			<p class="em-only_endmatter-idx2">management of, 138–140</p>
			<p class="em-only_endmatter-idx2">spontaneous recovery of, 138</p>
			<p class="em-only_endmatter-idx2">surgical management of, 139–140</p>
			<p class="em-only_endmatter-idx2">upper eyelid ptosis associated with, 138, 139<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">3-&#173;step test</p>
			<p class="em-only_endmatter-idx2">description of, 73–75, 74<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">unilateral superior oblique muscle palsy diagnosis using, 120</p>
			<p class="em-only_endmatter-idx1">Thygeson superficial punctate keratitis, 269</p>
			<p class="em-only_endmatter-idx1">Thyroid eye disease (TED), 140–141, 141<span class="italic">f</span>, 143<span class="italic">t</span>, 175, 215</p>
			<p class="em-only_endmatter-idx1">Thyroid-&#173;stimulating immunoglobulins, 140</p>
			<p class="em-only_endmatter-idx1">Tics, ocular, 201–202</p>
			<p class="em-only_endmatter-idx1">Tightening procedures</p>
			<p class="em-only_endmatter-idx2">for inferior oblique muscle, 166</p>
			<p class="em-only_endmatter-idx2">for oblique muscles, 164<span class="italic">t</span>, 166–167</p>
			<p class="em-only_endmatter-idx2">for rectus muscles, 163–164, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">for superior oblique muscle, 167</p>
			<p class="em-only_endmatter-idx1">Tilted disc, 365–366, 366<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">TINU. <span class="italic">See</span> Tubulointerstitial nephritis and uveitis syndrome</p>
			<p class="em-only_endmatter-idx1">Titmus test, 81</p>
			<p class="em-only_endmatter-idx1"><span class="italic">TMEM98</span> gene, 263</p>
			<p class="em-only_endmatter-idx1">TNO test, 81</p>
			<p class="em-only_endmatter-idx1">Tonic convergence, 40</p>
			<p class="em-only_endmatter-idx1">Tonic pupil, 275</p>
			<p class="em-only_endmatter-idx1">Tonometry</p>
			<p class="em-only_endmatter-idx2">in &#173;children, 10</p>
			<p class="em-only_endmatter-idx2">in primary congenital glaucoma evaluations, 281–282</p>
			<p class="em-only_endmatter-idx1">Tono-&#173;Pen, 10, 281</p>
			<p class="em-only_endmatter-idx1">Topiramate</p>
			<p class="em-only_endmatter-idx2">glaucoma caused by, 284</p>
			<p class="em-only_endmatter-idx2">idiopathic intracranial hypertension treated with, 371</p>
			<p class="em-only_endmatter-idx1">Torsional deviations, dissociated, 17, 129</p>
			<p class="em-only_endmatter-idx1">Torsional fusional vergence, 72</p>
			<p class="em-only_endmatter-idx1">Torticollis</p>
			<p class="em-only_endmatter-idx2">abnormal head position associated with, 82</p>
			<p class="em-only_endmatter-idx2">definition of, 82</p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 82–84, 83<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">evaluation of, 84</p>
			<p class="em-only_endmatter-idx2">facial asymmetry and, 82</p>
			<p class="em-only_endmatter-idx2">history-&#173;taking for, 63</p>
			<p class="em-only_endmatter-idx2">ocular, 82–84, 83<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">strabismus and, 63</p>
			<p class="em-only_endmatter-idx1">Tourette syndrome, 202</p>
			<p class="em-only_endmatter-idx1">Touton &#173;giant cells, 271</p>
			<p class="em-only_endmatter-idx1">Toxic epidermal necrolysis (TEN), 251–252</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Toxocara canis,</span> 317</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Toxocara cati,</span> 317</p>
			<p class="em-only_endmatter-idx1">Toxocariasis, 317<span class="italic">f</span>, 317–318</p>
			<p class="em-only_endmatter-idx1"><span class="italic">Toxoplasma</span> chorioretinitis, 409, 410<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">Toxoplasma gondii,</span> 409</p>
			<p class="em-only_endmatter-idx1">Toxoplasmosis</p>
			<p class="em-only_endmatter-idx2">anterior uveitis caused by, 317</p>
			<p class="em-only_endmatter-idx2">ocular manifestations of, 409–410, 410<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Trabeculectomy, 323</p>
			<p class="em-only_endmatter-idx1">Trabeculotomy, for primary congenital glaucoma, 286<span class="italic">f</span>, 286–287</p>
			<p class="em-only_endmatter-idx1">Trachoma, 241</p>
			<p class="em-only_endmatter-idx1">Tractional ret&#173;i&#173;nal detachment, 348<span class="italic">f</span>, 360</p>
			<p class="em-only_endmatter-idx1">Transillumination, iris, 265</p>
			<p class="em-only_endmatter-idx1">Trauma, ocular</p>
			<p class="em-only_endmatter-idx2">abusive head trauma, 381–384, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">accidental, 375–381, 377–378<span class="italic">f</span>, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">amblyopia secondary to, 375</p>
			<p class="em-only_endmatter-idx2">anterior uveitis caused by, 316</p>
			<p class="em-only_endmatter-idx2">blunt, 378–379</p>
			<p class="em-only_endmatter-idx2">chemical injury, 376</p>
			<p class="em-only_endmatter-idx2">corneal abrasion, 376</p>
			<p class="em-only_endmatter-idx2">hyphema, 378<span class="italic">f</span>, 378–379</p>
			<p class="em-only_endmatter-idx2">incidence of, 375</p>
			<p class="em-only_endmatter-idx2">management of, 375</p>
			<p class="em-only_endmatter-idx2">nonaccidental</p>
			<p class="em-only_endmatter-idx3">abusive head trauma, 381–384, 382–383<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">ocular injury secondary to, 384</p>
			<p class="em-only_endmatter-idx2">optic neuropathy caused by, 381</p>
			<p class="em-only_endmatter-idx2">orbital floor fractures, 127–128, 128<span class="italic">f</span>, 379–380, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">orbital roof fractures, 380, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">penetrating, 376–378, 377<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">perforating, 376–378, 377<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">thermal injury, 376</p>
			<p class="em-only_endmatter-idx1">Traumatic breaks in Descemet membrane, 262, 262<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Treacher Collins syndrome, 196, 211, 211<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">Treponema pallidum,</span> 240, 412</p>
			<p class="em-only_endmatter-idx1">Trichotillomania, 201, 201<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Trisomy 13, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Trisomy 18, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Trisomy 21. <span class="italic">See</span> Down syndrome</p>
			<p class="em-only_endmatter-idx1">Trochlea</p>
			<p class="em-only_endmatter-idx2">anatomy of, 19<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">function of, 20</p>
			<p class="em-only_endmatter-idx1">Trochlear nerve</p>
			<p class="em-only_endmatter-idx2">extraocular muscle innervation by, 19</p>
			<p class="em-only_endmatter-idx2">palsy of, 140</p>
			<p class="em-only_endmatter-idx1">-&#173;tropia (suffix), 16</p>
			<p class="em-only_endmatter-idx1">Tropicamide, 11, 11<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">TS. <span class="italic">See</span> Tuberous sclerosis</p>
			<p class="em-only_endmatter-idx1"><span class="italic">TSC2</span> gene, 399</p>
			<p class="em-only_endmatter-idx1"><span class="italic">TUBB3</span> gene, 135</p>
			<p class="em-only_endmatter-idx1">Tuberous sclerosis (TS), 393<span class="italic">t</span>, 397–399, 398<span class="italic">f</span>, 398<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Tube shunts, 146, 287, 323</p>
			<p class="em-only_endmatter-idx1">Tubulointerstitial nephritis and uveitis (TINU) syndrome, 316</p>
			<p class="em-only_endmatter-idx1">Tuck, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Tumbling E chart, 7</p>
			<p class="em-only_endmatter-idx1">Tumor(s). <span class="italic">See also</span> Neoplasms</p>
			<p class="em-only_endmatter-idx2">anterior segment, 271–274</p>
			<p class="em-only_endmatter-idx2">bony, 222</p>
			<p class="em-only_endmatter-idx2">choristomatous, 225–226</p>
			<p class="em-only_endmatter-idx2">ciliary body, 273<span class="italic">f</span>, 273–274</p>
			<p class="em-only_endmatter-idx2">connective tissue, 222</p>
			<p class="em-only_endmatter-idx2">corneal, 271</p>
			<p class="em-only_endmatter-idx2">iris, 271–273, 272<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">neural, 223</p>
			<p class="em-only_endmatter-idx1">Tumor necrosis factor-&#173;<span class="greek_1">α</span> inhibitors, 322</p>
			<p class="em-only_endmatter-idx1">Turner syndrome, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1"><span class="italic">TWIST</span> gene, 206</p>
			<p class="em-only_endmatter-idx1">Tyrosinemia type II, 270</p>
			<p class="em-only_endmatter-idx-alpha"><span class="italic">UBIAD1</span> gene, 270</p>
			<p class="em-only_endmatter-idx1">UC fixation. <span class="italic">See</span> Uncentral (UC) fixation</p>
			<p class="em-only_endmatter-idx1">UDAd. <span class="italic">See</span> Underdepression in adduction</p>
			<p class="em-only_endmatter-idx1">UEAd. <span class="italic">See</span> Underelevation in adduction</p>
			<p class="em-only_endmatter-idx1">Ulcers, corneal, 248, 249<span class="italic">f</span>, 262–263</p>
			<p class="em-only_endmatter-idx1">Ultrasonic phacoemulsification, 302</p>
			<p class="em-only_endmatter-idx1">Uncentral, unsteady, and unmaintained fixation, 6</p>
			<p class="em-only_endmatter-idx1">Uncentral (UC) fixation, 6</p>
			<p class="em-only_endmatter-idx1">Uncrossed diplopia, 75</p>
			<p class="em-only_endmatter-idx1">Underdepression in adduction (UDAd), 17</p>
			<p class="em-only_endmatter-idx1">Underelevation in adduction (UEAd), 17</p>
			<p class="em-only_endmatter-idx1">Unharmonious anomalous ret&#173;i&#173;nal correspondence, 76</p>
			<p class="em-only_endmatter-idx1">Unifocal eosinophilic granuloma, 219, 219<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Upgaze, 37</p>
			<p class="em-only_endmatter-idx1">Upper eyelid</p>
			<p class="em-only_endmatter-idx2">hematoma of, in orbital roof fractures, 380, 380<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">in plexiform neurofibromas, 395–396</p>
			<p class="em-only_endmatter-idx2">ptosis of, in third nerve palsy, 138, 139<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">retraction of, in thyroid eye disease, 140, 141<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Utricle, 40</p>
			<p class="em-only_endmatter-idx1">Uveitis</p>
			<p class="em-only_endmatter-idx2">anterior</p>
			<p class="em-only_endmatter-idx3">description of, 312</p>
			<p class="em-only_endmatter-idx3">differential diagnosis of, 312<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">idiopathic &#173;causes of, 316</p>
			<p class="em-only_endmatter-idx3">juvenile idiopathic arthritis as cause of, 312–315, 313–314<span class="italic">t</span>, 314<span class="italic">f</span>, 322</p>
			<p class="em-only_endmatter-idx3">juvenile spondyloarthropathies as cause of, 315, 315<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">Kawasaki disease as cause of, 316</p>
			<p class="em-only_endmatter-idx3">laboratory tests for, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">screening for, 314–315</p>
			<p class="em-only_endmatter-idx3">trauma as cause of, 316</p>
			<p class="em-only_endmatter-idx3">tubulointerstitial nephritis and uveitis syndrome as cause of, 316</p>
			<p class="em-only_endmatter-idx2">band keratopathy caused by, 322</p>
			<p class="em-only_endmatter-idx2">biologic drugs for, 322</p>
			<p class="em-only_endmatter-idx2">cataract surgery in, 323</p>
			<p class="em-only_endmatter-idx2">classification of, 311</p>
			<p class="em-only_endmatter-idx2">complications of, surgical treatment of, 322–323</p>
			<p class="em-only_endmatter-idx2">corticosteroids for, 320–321</p>
			<p class="em-only_endmatter-idx2">definition of, 311</p>
			<p class="em-only_endmatter-idx2">diagnosis of, 319</p>
			<p class="em-only_endmatter-idx2">differential diagnosis of, 312<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">epidemiology of, 311</p>
			<p class="em-only_endmatter-idx2">evaluation of, 319</p>
			<p class="em-only_endmatter-idx2">glaucoma surgery in, 323</p>
			<p class="em-only_endmatter-idx2">imaging for, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">immunosuppressive therapy for, 321–322</p>
			<p class="em-only_endmatter-idx2">inflammation in, 320–322</p>
			<p class="em-only_endmatter-idx2">intermediate, 312<span class="italic">t</span>, 316, 316<span class="italic">f</span>, 320, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">laboratory tests for, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">masquerade syndromes for, 319, 320<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">methotrexate for, 322</p>
			<p class="em-only_endmatter-idx2">panuveitis, 318<span class="italic">f</span>, 318–319</p>
			<p class="em-only_endmatter-idx2">posterior</p>
			<p class="em-only_endmatter-idx3">definition of, 317</p>
			<p class="em-only_endmatter-idx3">differential diagnosis of, 312<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">inflammation in, 320</p>
			<p class="em-only_endmatter-idx3">laboratory tests for, 321<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">toxocariasis as cause of, 317<span class="italic">f</span>, 317–318</p>
			<p class="em-only_endmatter-idx3">toxoplasmosis as cause of, 317</p>
			<p class="em-only_endmatter-idx2">treatment of, 320–322</p>
			<p class="em-only_endmatter-idx-alpha">Valsalva maneuver, 207</p>
			<p class="em-only_endmatter-idx1">Valve of Hasner, 230, 231<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Valve of Rosenm<span class="accent">ü</span>ller, 228</p>
			<p class="em-only_endmatter-idx1">Varicella-&#173;zoster virus (VZV), 242–243</p>
			<p class="em-only_endmatter-idx1">Vascular endothelial growth &#173;factor (VEGF), in retinopathy of prematurity pathophysiology, 325, 326<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Vascular eyelid disorders, 199</p>
			<p class="em-only_endmatter-idx1">Vasoconstrictors, for ocular allergies, 247<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">VEGF. <span class="italic">See</span> Vascular endothelial growth &#173;factor (VEGF), in retinopathy of prematurity pathophysiology</p>
			<p class="em-only_endmatter-idx1">Velocardiofacial syndrome, 255</p>
			<p class="em-only_endmatter-idx1">Venous malformations, orbital, 222</p>
			<p class="em-only_endmatter-idx1">VEP. <span class="italic">See</span> Visual evoked potential</p>
			<p class="em-only_endmatter-idx1">Vergences</p>
			<p class="em-only_endmatter-idx2">convergence, 39–40</p>
			<p class="em-only_endmatter-idx2">definition of, 37, 39, 72</p>
			<p class="em-only_endmatter-idx2">divergence, 40</p>
			<p class="em-only_endmatter-idx2">fusional, 72, 72<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Vergence system, of eye movements, 40</p>
			<p class="em-only_endmatter-idx1">Vernal keratoconjunctivitis (VKC), 248–249, 248–249<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Versions</p>
			<p class="em-only_endmatter-idx2">definition of, 37</p>
			<p class="em-only_endmatter-idx2">deorsumversion, 37</p>
			<p class="em-only_endmatter-idx2">dextrocycloversion, 38</p>
			<p class="em-only_endmatter-idx2">dextroversion, 37</p>
			<p class="em-only_endmatter-idx2">in infantile esotropia, 37</p>
			<p class="em-only_endmatter-idx2">levocycloversion, 38</p>
			<p class="em-only_endmatter-idx2">levoversion, 37</p>
			<p class="em-only_endmatter-idx2">sursumversion, 37</p>
			<p class="em-only_endmatter-idx1">Vertical deviations</p>
			<p class="em-only_endmatter-idx2">characteristics of, 116</p>
			<p class="em-only_endmatter-idx2">clinical approach to, 115–116</p>
			<p class="em-only_endmatter-idx2">dissociated</p>
			<p class="em-only_endmatter-idx3">age at onset, 129</p>
			<p class="em-only_endmatter-idx3">clinical features of, 129, 129<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">definition of, 129</p>
			<p class="em-only_endmatter-idx3">description of, 17, 105, 111, 115–116</p>
			<p class="em-only_endmatter-idx3">hypertropia and, 115</p>
			<p class="em-only_endmatter-idx3">inferior oblique anterior transposition for, 166</p>
			<p class="em-only_endmatter-idx3">inferior oblique muscle overaction versus, 129–130</p>
			<p class="em-only_endmatter-idx3">management of, 130</p>
			<p class="em-only_endmatter-idx2">with horizontal comitance, 125–128</p>
			<p class="em-only_endmatter-idx2">with horizontal incomitance, 116–125</p>
			<p class="em-only_endmatter-idx2">inferior oblique muscle palsy</p>
			<p class="em-only_endmatter-idx3">Brown syndrome versus, 124, 125<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">clinical features of, 124, 124<span class="italic">f</span>, 125<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">management of, 124–125</p>
			<p class="em-only_endmatter-idx2">monocular elevation deficiency, 125–127, 126<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">orbital floor fractures, 127–128, 128<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">overdepression in adduction</p>
			<p class="em-only_endmatter-idx3">&#173;causes of, 17, 116<span class="italic">t</span>, 116–118</p>
			<p class="em-only_endmatter-idx3">description of, 17</p>
			<p class="em-only_endmatter-idx3">pattern strabismus and, 107, 108<span class="italic">f</span>, 109</p>
			<p class="em-only_endmatter-idx3">superior oblique muscle overaction as cause of, 118, 118<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">overelevation in adduction</p>
			<p class="em-only_endmatter-idx3">&#173;causes of, 17, 116<span class="italic">t</span>, 116–118</p>
			<p class="em-only_endmatter-idx3">description of, 17</p>
			<p class="em-only_endmatter-idx3">inferior oblique muscle overaction as cause of, 117<span class="italic">f</span>, 117–118</p>
			<p class="em-only_endmatter-idx3">pattern strabismus and, 107, 108<span class="italic">f</span>, 109</p>
			<p class="em-only_endmatter-idx2">skew deviation, 125</p>
			<p class="em-only_endmatter-idx2">superior oblique muscle palsy</p>
			<p class="em-only_endmatter-idx3">bilateral, 122–124</p>
			<p class="em-only_endmatter-idx3">&#173;causes of, 119</p>
			<p class="em-only_endmatter-idx3">clinical features of, 119–122</p>
			<p class="em-only_endmatter-idx3">congenital versus acquired, 119</p>
			<p class="em-only_endmatter-idx3">description of, 69</p>
			<p class="em-only_endmatter-idx3">hypertropia associated with, 123</p>
			<p class="em-only_endmatter-idx3">inhibitional palsy of contralateral antagonist, 120–121, 121<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">management of, 122–124, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">masked bilateral, 122</p>
			<p class="em-only_endmatter-idx3">neuroimaging evaluations, 119</p>
			<p class="em-only_endmatter-idx3">right, 120–121<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">surgical management of, 122–124, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">3-&#173;step test for, 120</p>
			<p class="em-only_endmatter-idx3">unilateral, 119–121, 120–121<span class="italic">f</span>, 122–123, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">V-&#173;pattern strabismus associated with, 109</p>
			<p class="em-only_endmatter-idx2">thyroid eye disease as cause of, 140</p>
			<p class="em-only_endmatter-idx1">Vertical fusional vergence, 72</p>
			<p class="em-only_endmatter-idx1">Vertical nystagmus, 152</p>
			<p class="em-only_endmatter-idx1">Vertical rectus muscles</p>
			<p class="em-only_endmatter-idx2">anatomy of, 20, 22<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">eyelid attachments to, 30<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">insertion of, 22</p>
			<p class="em-only_endmatter-idx2">surgery of</p>
			<p class="em-only_endmatter-idx3">for nystagmus, 156</p>
			<p class="em-only_endmatter-idx3">for pattern strabismus correction, 111</p>
			<p class="em-only_endmatter-idx2">vertical strength of, 35</p>
			<p class="em-only_endmatter-idx1">Vertical retraction syndrome, 135</p>
			<p class="em-only_endmatter-idx1">Vertical rotations, 31</p>
			<p class="em-only_endmatter-idx1">Vertical strabismus, 15–16</p>
			<p class="em-only_endmatter-idx1">Vestibular-&#173;ocular system, 40</p>
			<p class="em-only_endmatter-idx1"><span class="italic">VHL</span> gene, 399</p>
			<p class="em-only_endmatter-idx1">Vieth-&#173;M<span class="accent">ü</span>ller circle, 41</p>
			<p class="em-only_endmatter-idx1">Vigabatrin, 399</p>
			<p class="em-only_endmatter-idx1">Viral conjunctivitis, 241–243, 243–244<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Virchow’s law, 203, 205<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Visceral larva migrans (VLM), 317</p>
			<p class="em-only_endmatter-idx1">Vision</p>
			<p class="em-only_endmatter-idx2">binocular. <span class="italic">See</span> Binocular vision</p>
			<p class="em-only_endmatter-idx2">decreased, evaluation of, 187–188</p>
			<p class="em-only_endmatter-idx2">development of</p>
			<p class="em-only_endmatter-idx3">abnormal visual experience effects on, 44–47, 45–46<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">amblyopia and, 53</p>
			<p class="em-only_endmatter-idx3">description of, 44</p>
			<p class="em-only_endmatter-idx3">in young infants, 185</p>
			<p class="em-only_endmatter-idx2">low</p>
			<p class="em-only_endmatter-idx3">information sources on, 189<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">rehabilitation for, 188–189, 189<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx2">neurophysiology of, 43–52</p>
			<p class="em-only_endmatter-idx1">Vision loss</p>
			<p class="em-only_endmatter-idx2">amblyopia as cause of, 53, 56</p>
			<p class="em-only_endmatter-idx2">childhood glaucoma as cause of, 290</p>
			<p class="em-only_endmatter-idx1">Vision rehabilitation, 188–189, 189<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Visual acuity</p>
			<p class="em-only_endmatter-idx2">amblyopia effects on, 5</p>
			<p class="em-only_endmatter-idx2">assessments of</p>
			<p class="em-only_endmatter-idx3">for amblyopia diagnosis, 56</p>
			<p class="em-only_endmatter-idx3">in &#173;children. <span class="italic">See</span> Visual acuity, in &#173;children</p>
			<p class="em-only_endmatter-idx3">in nystagmus, 153–154</p>
			<p class="em-only_endmatter-idx2">in &#173;children, assessment of</p>
			<p class="em-only_endmatter-idx3">age-&#173;specific approaches, 5</p>
			<p class="em-only_endmatter-idx3">alternative methods, 8–9</p>
			<p class="em-only_endmatter-idx3">Central, Steady, and Maintained method of, 6</p>
			<p class="em-only_endmatter-idx3">eye charts for, 6<span class="italic">t</span>, 6–8, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">fixation and following be&#173;hav&#173;ior for, 5</p>
			<p class="em-only_endmatter-idx3">fixation be&#173;hav&#173;ior, 5–6</p>
			<p class="em-only_endmatter-idx3">HOTV test, 6, 6<span class="italic">t</span>, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">induced tropia test, 6</p>
			<p class="em-only_endmatter-idx3">in nystagmus, 8</p>
			<p class="em-only_endmatter-idx3">occluders used in, 8</p>
			<p class="em-only_endmatter-idx3">optotypes for, 6<span class="italic">t</span>, 6–8, 7<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx3">preferential looking, 5, 8–9, 9<span class="italic">f</span>, 182, 300</p>
			<p class="em-only_endmatter-idx3">preverbal &#173;children, 8–9, 154</p>
			<p class="em-only_endmatter-idx3">sequence of, 8</p>
			<p class="em-only_endmatter-idx3">symbol charts for, 7</p>
			<p class="em-only_endmatter-idx3">visual evoked potential for, 9, 182, 300</p>
			<p class="em-only_endmatter-idx2">development of, 182</p>
			<p class="em-only_endmatter-idx2">in morning glory disc anomaly, 363</p>
			<p class="em-only_endmatter-idx2">in newborn, 44</p>
			<p class="em-only_endmatter-idx1">Visual axis, 41</p>
			<p class="em-only_endmatter-idx1">Visual confusion, 47, 47<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Visual cortex, 46<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Visual deprivation</p>
			<p class="em-only_endmatter-idx2">abnormal visual experience caused by, 44</p>
			<p class="em-only_endmatter-idx2">monocular, 44, 45<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">Visual deprivation amblyopia</p>
			<p class="em-only_endmatter-idx2">&#173;causes of, 55</p>
			<p class="em-only_endmatter-idx2">congenital cataracts as cause of, 55</p>
			<p class="em-only_endmatter-idx2">congenital nevocellular nevi as cause of, 200</p>
			<p class="em-only_endmatter-idx2">corneal blood staining as cause of, 379</p>
			<p class="em-only_endmatter-idx2">critical period for, 53</p>
			<p class="em-only_endmatter-idx2">reverse amblyopia, 55–56</p>
			<p class="em-only_endmatter-idx1">Visual evoked potential (VEP), for visual acuity assessment in preverbal &#173;children, 9, 182, 300</p>
			<p class="em-only_endmatter-idx1">Visual field testing, 10</p>
			<p class="em-only_endmatter-idx1">Visual impairment</p>
			<p class="em-only_endmatter-idx2">ce&#173;re&#173;bral, 186–187</p>
			<p class="em-only_endmatter-idx2">cortical, 186</p>
			<p class="em-only_endmatter-idx2">delayed visual maturation, 186–187</p>
			<p class="em-only_endmatter-idx2">in infants, 186–187</p>
			<p class="em-only_endmatter-idx2">pregeniculate, 186–187</p>
			<p class="em-only_endmatter-idx2">retrogeniculate, 186</p>
			<p class="em-only_endmatter-idx1">Visual pathways</p>
			<p class="em-only_endmatter-idx2">central, 44</p>
			<p class="em-only_endmatter-idx2">development of, 44</p>
			<p class="em-only_endmatter-idx2">white &#173;matter of, 44</p>
			<p class="em-only_endmatter-idx1">Visual stimulus deprivation amblyopia, 55</p>
			<p class="em-only_endmatter-idx1">Vitreal syneresis, 344</p>
			<p class="em-only_endmatter-idx1">Vitrectomy, for retinopathy of prematurity, 335</p>
			<p class="em-only_endmatter-idx1">Vitrectorhexis, 302</p>
			<p class="em-only_endmatter-idx1">Vitreoretinopathies</p>
			<p class="em-only_endmatter-idx2">familial exudative, 347–348, 348<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">juvenile retinoschisis. <span class="italic">See</span> Juvenile retinoschisis</p>
			<p class="em-only_endmatter-idx2">Knobloch syndrome, 346<span class="italic">f</span>, 346–347</p>
			<p class="em-only_endmatter-idx2">Norrie disease, 347</p>
			<p class="em-only_endmatter-idx2">Stickler syndrome, 345–346</p>
			<p class="em-only_endmatter-idx1">Vitreous veils, 344</p>
			<p class="em-only_endmatter-idx1">VKC. <span class="italic">See</span> Vernal keratoconjunctivitis </p>
			<p class="em-only_endmatter-idx1">VLM. <span class="italic">See</span> Visceral larva migrans </p>
			<p class="em-only_endmatter-idx1">Vogt-&#173;Koyanagi-&#173;Harada syndrome, 319</p>
			<p class="em-only_endmatter-idx1">Vogt striae, 254</p>
			<p class="em-only_endmatter-idx1">Vogt triad, 397</p>
			<p class="em-only_endmatter-idx1">Voluntary convergence, 40</p>
			<p class="em-only_endmatter-idx1">von Hippel internal ulcer, 259</p>
			<p class="em-only_endmatter-idx1">von Hippel–&#173;Lindau syndrome, 393<span class="italic">t</span>, 399–401, 400<span class="italic">f</span>, 400<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">von Recklinghausen disease. <span class="italic">See</span> Neurofibromatosis type 1</p>
			<p class="em-only_endmatter-idx1">Vortex keratopathy, 270</p>
			<p class="em-only_endmatter-idx1">Vortex veins</p>
			<p class="em-only_endmatter-idx2">extraocular muscles supplied by, 23</p>
			<p class="em-only_endmatter-idx2">surgical considerations for, 30</p>
			<p class="em-only_endmatter-idx1">V-&#173;pattern strabismus</p>
			<p class="em-only_endmatter-idx2">bilateral superior oblique palsy and, 122</p>
			<p class="em-only_endmatter-idx2">in Brown syndrome, 137</p>
			<p class="em-only_endmatter-idx2">clinical features of, 109</p>
			<p class="em-only_endmatter-idx2">clinically significant, 109</p>
			<p class="em-only_endmatter-idx2">craniofacial anomalies and, 107</p>
			<p class="em-only_endmatter-idx2">in craniosynostosis, 208</p>
			<p class="em-only_endmatter-idx2">definition of, 107</p>
			<p class="em-only_endmatter-idx2">etiology of, 107–109, 108<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx2">exotropia with, 108<span class="italic">f</span>, 111</p>
			<p class="em-only_endmatter-idx2">extorsion as cause of, 107, 110</p>
			<p class="em-only_endmatter-idx2">heterotopy as cause of, 28</p>
			<p class="em-only_endmatter-idx2">identification of, 109</p>
			<p class="em-only_endmatter-idx2">infantile esotropia associated with, 109, 112</p>
			<p class="em-only_endmatter-idx2">inferior oblique muscle overaction associated with, 107</p>
			<p class="em-only_endmatter-idx2">palpebral fissure slanting associated with, 196</p>
			<p class="em-only_endmatter-idx2">superior oblique palsy and, 122</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 111–112, 112<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">VZV. <span class="italic">See</span> Varicella-&#173;zoster virus</p>
			<p class="em-only_endmatter-idx-alpha">Waardenburg syndrome</p>
			<p class="em-only_endmatter-idx2">description of, 270</p>
			<p class="em-only_endmatter-idx2">type 1, 191, 192<span class="italic">f</span></p>
			<p class="em-only_endmatter-idx1">WAGR syndrome, 267</p>
			<p class="em-only_endmatter-idx1">Weakening procedures</p>
			<p class="em-only_endmatter-idx2">for inferior oblique muscle</p>
			<p class="em-only_endmatter-idx3">bilateral, 165</p>
			<p class="em-only_endmatter-idx3">indications for, 118</p>
			<p class="em-only_endmatter-idx3">for superior oblique muscle palsy, 123, 123<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx3">surgical procedures for, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx3">for V-&#173;pattern strabismus, 111</p>
			<p class="em-only_endmatter-idx2">for oblique muscles, 164<span class="italic">t</span>, 165–166</p>
			<p class="em-only_endmatter-idx2">for rectus muscles, 163, 164<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Weill-&#173;Marchesani syndrome, 309</p>
			<p class="em-only_endmatter-idx1">Well-&#173;differentiated pleomorphic tumors, 217</p>
			<p class="em-only_endmatter-idx1">White-&#173;eyed blowout fracture, 380</p>
			<p class="em-only_endmatter-idx1">Wildervanck syndrome, 131</p>
			<p class="em-only_endmatter-idx1">Wilson disease, 270</p>
			<p class="em-only_endmatter-idx1">Wolfflin nodules, 272</p>
			<p class="em-only_endmatter-idx1">Wolf-&#173;Hirschhorn syndrome, 386<span class="italic">t</span></p>
			<p class="em-only_endmatter-idx1">Worth 4-&#173;dot test, 51–52, 80<span class="italic">f</span>, 80–81</p>
			<p class="em-only_endmatter-idx1"><span class="italic">WT1</span> gene, 267</p>
			<p class="em-only_endmatter-idx1">Wyburn-&#173;Mason syndrome, 222, 394<span class="italic">t</span>, 405<span class="italic">t</span>, 405–406</p>
			<p class="em-only_endmatter-idx-alpha">Xanthocoria, 360</p>
			<p class="em-only_endmatter-idx1">X-&#173;pattern strabismus</p>
			<p class="em-only_endmatter-idx2">clinical features of, 110</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 113</p>
			<p class="em-only_endmatter-idx-alpha"><span class="italic">Yersinia pseudotuberculosis</span>, 240</p>
			<p class="em-only_endmatter-idx1">Yoke muscles, 38</p>
			<p class="em-only_endmatter-idx2">Y-&#173;pattern strabismus</p>
			<p class="em-only_endmatter-idx2">clinical features of, 109–110</p>
			<p class="em-only_endmatter-idx2">surgical treatment of, 113</p>
			<p class="em-only_endmatter-idx-alpha">Zika virus, 413</p>
			<p class="em-only_endmatter-idx1"><span class="italic">ZNF469</span> gene, 254</p>
		</div>
	</body>
</html>
